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I N T R O D U C T I O N

The Need for a Resource Book on 

HIV Prevention Among Drug Users

Drug use is a complex health and social problem that affects all segments of 
American society. How to respond to this problem continues to be at the center of 
national and local debates. Further complicating the issue is the rapid rise in HIV 
infection reported among drug users and their sex partners and children. The pro-
portion of AIDS cases in the United States attributed to injection drug use, for ex-
ample, has steadily increased from 12 percent of cases reported in 1981 to 32 per-
cent of cases reported between July 1995 through June 1996 (CDC, 1996). 
T h rough June 1996, AIDS cases related to injection drug use accounted for fully 
one-third of all AIDS cases reported in the US to date, with women, children, and 
minorities disproportionately affected (CDC, 1996): 
• 46 percent of women with AIDS had injected illicit drugs; 
• 18 percent of women reported with AIDS are sex partners of IDUs; 
• 54 percent of infants reported with AIDS are born to mothers who injected drugs or 
who are sex partners of male IDUs; and 
• 36 percent of all male African Americans reported with AIDS and 37 percent of all 
male Hispanics reported with AIDS are IDUs. 
C l e a rly, HIV preve n t i on efforts must focus on drug injection pra c t i c e s . At the 
same time, h ow eve r, a focus solely on drug injection practices is not adequate to 
prevent the further spread of HIV. Sexual risks associated with drug use, both in­
jection and non-injection, are critical components of the rise in HIV infection. 
Recent estimates suggest that the HIV/AIDS epidemic in the US is curre n t ly 
being driven by subepidemics in three groups (Holmberg, 1996): 
• injection drug users and their sex partners and children 
• heterosexual women who use crack 
• young and minority men who have sex with men (MSM) 
Of these three subepidemics, two are directly associated with drug use and under-
score the importance of drug use and sexual behaviors to the spread of HIV. In ad-
d i t i on , t h e re is some evidence that the third subepidemic is associated with dru g 
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use. Among MSM, non-injection drug use (e.g., current or past heavy alcohol use, 
and current use of stimulants, hallucinogens, and inhalents) has shown to be asso­
ciated with higher-risk sexual behavior (Woody et al., 1996) . 
In the past, HIV prevention efforts often focused on either the injection drug-re­
lated or the sexually - related risk behaviors of individuals, neglecting both the in­
terrelationships among these behaviors and the social context in which they occur. 
The association between non - i n j e c t i on drug use and sexually - related risk behav­
iors has also been ignore d . Now, h ow eve r, those inv o lved in efforts to contain the 
s p read of HIV infe c t i on in drug users ack n owledge a pressing need to focus on 
both dru g - related (injection and non - i n j e c t i on) and sexually - related risk behaviors. 
D eveloping and conducting pro g rams to modify HIV risk behaviors related to 
drug use and to sustain changes in behavior present significant challenges. Addic­
tion, poverty, homelessness, crime, and violence are only a few of the social condi­
t i ons that may affect a drug user’s ability to initiate and maintain risk re d u c t i on 
behaviors related to drug use, sexual practices, and HIV transmission. 
Another significant ch a llenge to the design, d eve l o pm e n t , and implementation of 
e f fe c t i ve HIV preve n t i on pro g rams among drug users is the complex social and 
political issues that surround such programs. Societal attitudes vary on the ways to 
a d d ress sensitive issues such as drug use and sexual risk behaviors. Su p p o rters of 
HIV preve n t i on pro g rams based on drug use abstinence, for example, fear that 
a nything less might send the message that drug use is acceptable and could re s u l t 
in an increase in use. Other preve n t i on advocates believe that low e ring the ri s k s 
related to drug use is a realistic com p onent to contain the continued spread of 
HI V, c on s i d e ring the difficulties encountered in stopping drug use, the high ra t e s 
of relapse after tre a t m e n t , and the lack of available, p u b l i cly-funded drug tre a tment. 
HIV Preve n t i on Com mu n i ty Planning Groups and other HIV preve n t i on plan­
ners and pro g ram managers can make a significant con t ri b u t i on to reducing the 
spread of HIV by supporting comprehensive, community-based programs that ad-
dress drug use as well as sexual behaviors, and that pay attention to the social con­
ditions under which these behaviors occur. Recent research has shown that behav­
ior change is occurri n g. With pro p e rly designed interve n t i on s , d rug users ca n 
make the changes necessary to reduce their risk of HIV infection. 
Community planning for HIV prevention is a decision-making process involving 
broad-based, a c t i ve inv o lvement of persons with a wide range of viewp o i n t s . D i f­
fe rences in back g ro u n d , p e r s p e c t i ve, and experience are essential and valued 
(AED, 1994). Prevention planners and program managers must include both HIV 
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and substance abuse experts as well as com mu n i ty re p re s e n t a t i ves in their effort s , 
and must have access to the knowledge gained through behavioral and social science 
re s e a rch on the theore t i cal foundations and elements of effe c t i ve interve n t i on s . 
HIV Prevention Among Drug Us er s : A Resource Book for Community Planners and 
Pro gram Manager s ( re fe r red to in this document as “the HPDU Resource Book”) is 
intended to support the need of preve n t i on planners and pro g ram managers to 
learn about and understand the critical issues involved in drug use, sexual behavior, 
HIV tra n s m i s s i on , and their interre l a t i on s h i p s . It is on ly through such u n d e r-
standing that wise decisions can be made about pro g ram pri o rities and design. 
Audience and Purpose 
The HPDU Resource Book is designed to be used by HIV prevention planners and 
p ro g ram managers inv o lved in the com mu n i ty planning process and other com­
mu n i ty-based preve n t i on initiatives for drug users and their sex part n e r s . Ot h e r 
potential readers include staff of: 
• state and local drug and alcohol agencies 
• state and local correctional systems 
• local, regional, or national non-governmental organizations 
It was developed in response to needs identified by those directly involved in HIV 
p reve n t i on planning. A group of consultants from national and local organiza­
t i on s , re s e a rch institution s , health depart m e n t s , and com mu n i ty-based pro g ra m s 
p rovided early guidance in determining the design of the book and also prov i d e d 
feedback at key points in its development. Specifically, the HPDU Resource Book is 
intended to increase the reader’s understanding of: 
• drug use and its effects 
• drug use, sexual behavior, and HIV risk 
• social and behavioral theory and its use in selecting and designing effective HIV pre­
vention interventions in drug-using populations 
• public policy and HIV prevention programs for drug users 
• resources for HIV prevention planners and program managers related to HIV preven­
tion in drug-using populations 
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Organization of the 
HPDU Resource Book 
The HPDU Resource Book is organized into five major PA RT S . E a ch PA RT fo­
cuses on a key area related to HIV prevention among drug users: 
PART 1: Drug Use and Its Effects examines the complex nature, consequences, 
and treatment of drug use, abuse, and dependence. Specific topics include: 
• major categories of drugs linked to HIV risk and their effects 
• patterns of drug use in the United States 
• definition and characteristics of drug use, abuse, and dependence 
• key components of the drug treatment system 
• sources of national, state, and local data on drug use 
PA RT 2: Drug Use, Sexual Behavior, and HIV Risk e x p l o res the link betw e e n 
drug use, sexual behavior, and HIV transmission. Specific topics include: 
• drug-using practices, sexual behaviors, and the social context of drug use, and 
how these factors influence risk for HIV infection 
• ch a ra c t e ristics of special groups of drug users who are heavily affected by the HI V 
e p i d e m i c 
• sources of national, state, and local data on trends in transmission of HIV 
among drug users 
PART 3: Social and Behavioral Interventions addresses theoretical and practi­
cal aspects of planning HIV prevention programs among drug users. Specific top­
ics include: 
• the use of social and behavioral theory in the design and implementation of 
effective HIV prevention interventions 
• an approach to systematically deciding HIV prevention interventions 
• components of effective HIV prevention programs 
• results of social and behavioral research on intervention effectiveness 
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PART 4: Public Policy Issues looks at several key public policy issues associated 
with HIV and drug use from a nation a l , s t a t e, l o ca l , and agency perspective . Sp e­
cific topics include: 
• community attitudes and beliefs 
• laws, regulations, and practices 
• agency policies and practices 
PART 5: Resources offers information on an array of federal, national, state, and 
other pro g rams that provide inform a t i on , m a t e ri a l s , and tech n i cal assistance serv i c e s 
related to HIV preve n t i on among drug users. Sp e c i fic re s o u rces described incl u d e : 
• national clearinghouses on HIV and drug use 
• HIV and drug use information resources from federal agencies and national and 
state level non-governmental organizations 
• publication ordering information 
In addition to the five PA RT S ,t h e HPDU Resource Book c ontains five A P PEN D I C ES : 
APPENDIX A c ontains summaries of individual ev a l u a t i on studies conducted on 
successful interventions with various drug-using populations. 
APPENDIX B c ontains summaries of re s o u rces that address behavioral theori e s 
and research on HIV prevention interventions with drug users. 
APPENDIX C is a glossary containing terms and acronyms used in the HPDU Re-
source Book. 
APPENDIX D is a bibliography containing all of the references cited in the docu­
ment as well as other source materials used in its preparation. 
APPENDIX E is a list of the HPDU Resource Book Consultant Panel. 
Although com p re h e n s i ve in scope, the HPDU Resource Book is meant to be on ly 
one component of an ongoing effort to assist state and local HIV prevention plan­
ners and program managers. These individuals must address the specific issues and 
ch a llenges in their own com mu n i t i e s . O ft e n , s p e c i fic , l o cal inform a t i on will be 
n e e d e d . PA RT 5 provides various sources for further inform a t i on and materi a l s . 
PARTS 1 and 2 also include information on sources of local data on drug use and 
HIV infection. 
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DRUG USE AND ITS EFFECTS

Drug use is a complex health and social problem that affects all segments of 
American society. How to respond to this problem continues to be at the center of 
national and local debates. Further complicating the issue is the rapid rise in HIV 
i n fe c t i on re p o rted over the past decade among drug users and their sex part n e r s 
and children. In addition to understanding drug use and its effects, those involved 
in planning and developing HIV preve n t i on pro g rams must be familiar with the 
nature and extent of local drug use patterns and trends, and must also be sensitive 
to community attitudes and opinions that can influence the design and implemen­
tation of HIV interventions for the population. 
PA RT 1 of the HPDU Resource Book focuses on basic inform a t i on about drug use 
and its effects. Given the importance of drug use in the transmission of HIV, this 
i n f o rm a t i on is intended to make it easier to pri o ri t i ze, d eve l o p, i m p l e m e n t , a n d 
support realistic and targeted HIV prevention programs. 
Sp e c i fi ca lly, PA RT 1 will help HIV preve n t i on planners and pro g ram managers 
increase their knowledge of: 
• major categories of drugs and their effects 
• various patterns of drug use 
• the definition and characteristics of drug use, abuse and dependence 
• key components of the drug treatment system 
• sources of national and local data on drug use 
Types of Drugs Used and Their Eff e c t s 
Major Types of Drugs Linked to HIV Risk 
Drugs are commonly categorized into major types, based on their most prominent 
e f fe c t s . “ O p i a t e s , ” s u ch as hero i n , and “s t i mu l a n t s , ” s u ch as cocaine and cra ck , a re 
two major drug types whose use have been closely linked to HIV risks. For exam-
p l e, c ra ck is linked to HIV tra n s m i s s i on by the risky sexual behaviors associated 
with its use. Another HIV ri s k - related behavior—needle shari n g, or mu l t i p e r s on 
use of syringes—is directly related to how frequently a drug like heroine or cocaine 
is injected, and whether a person has access to sterile injection equipment. Becom­
ing familiar with the unique features of these drugs and their effects will help pri­
o ri t i ze and support effe c t i ve HIV preve n t i on pro g rams that are targeted to those 
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who use them. Exhibit A provides key inform a t i on about opiates and stimu l a n t s , 
including the likelihood of developing dependence on them, the manner in which 
t h ey are used, their phys i cal and behavioral effe c t s , and com m on sym p t oms that 
occur when use stops. H ow eve r, it is important to keep in mind that drug use ex-
p e riences often vary among individuals. C a re should be taken not to genera l i ze 
and assume that all cocaine users, for example, react to cocaine in the same manner. 
The Range of Drug-Using Behaviors 
Drug users com m on ly use more than one dru g. This is often re fe r red to as “p o lydrug” 
u s e . For instance, m a ny injection drug users (IDUs) often use a com b i n a t i on of alcohol, 
m a ri j u a n a , c i g a re t t e s , and cra ck in addition to the drug they inject. H e roin users 
o ften inject a com b i n a t i on of heroin and coca i n e, k n own as a “s p e e d b a ll . ” T h o s e 
who inject cocaine sometimes use heroin to all eviate the agitating effects of cocaine. 
The most common reasons for multiple drug use include: 
• the desire to experience a new or different type of drug-induced effect, such as that 
produced when heroin and cocaine are combined to make a “speedball” 
• the need to “self-medicate,” that is to balance the effects of a particular drug (e.g., using 
a l c ohol to reduce the agitation brought on by the use of a stimulant like methampheta m i n e ) 
• the need to offset the symptoms caused by ending the use of a particular drug, such as 
the nausea and tremors resulting when heroin use is stopped 
• substitution of another drug when the preferred drug of choice is either difficult to 
obtain or too costly 
• the desire to experiment with a variety of drugs 
I n d i v i d u a l s ’ d rug-using behaviors also can vary in intensity and fre q u e n cy. Som e 
individuals may begin to use drugs and then rapidly progress to chronic use, while 
others may start and stop their use with or without the assistance of drug tre a t­
ment.This fluctuation in drug-using behaviors among people is an important con­
cept to consider when pri o ritizing or designing HIV interve n t i on pro g ra m s . Fo r 
e x a m p l e, a person with a long history of ch ronic heroin injection may not benefit 
f rom an HIV interve n t i on that is abstinence-based. I n i t i a lly, this person might 
fare better if offered counseling and education related to needle and syringe disin­
fe c t i on , w ays to access sterile needles and other injection equipm e n t , and re fe r ra l 
to drug treatment. 
M a ny factors con t ribute to these vari a t i ons in drug-using behaviors. For example, 
d rugs such as cra ck may cause som e one with little or no history of prior drug use 
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to quick ly become dependent and begin to experience related social pro b l e m s . 
However, frequency of drug use is not always directly related to the extent of drug-
related problems encountere d . A daily heroin user, for example, m ay be able to 
s u p p o rt his or her habit and maintain a job, while an occa s i onal cocaine user may 
suffer numerous personal problems, including job loss and family disruption. Case 
Example 1.1 provides several personal accounts of various kinds of drug-using be­
haviors and some associated consequences. 
Use of multiple drugs and the range of drug-using behaviors demon s t rate the in-
d i v i d u a l i zed ch a racter of drug use. This dire c t ly affects those who pri o ri t i ze pro-
g rams for drug users and who work with cl i e n t s . Ul t i m a t e ly, p ro g rams for dru g 
t re a t m e n t , HIV preve n t i on , or to support other needs must re s p ond to individual 
drug users’ behaviors and risks. 
Case Example 1.1





“I went to jail for prostitution...trying to get money for my drugs.”

20-year-old male from Seattle 
“Every time I went into treatment, I thought it would be my last time, 
but I always started using again. I just couldn’t help it.” 
44-year-old artist from San Francisco 
“The police came and took away my children and put them in foster homes 
until I went to treatment.” 
25-year-old mother from Nashville 
“My daughter used heroin for ten years without losing her job, and then she 
died of an overdose. Now I’m raising her kids.” 
68-year-old grandmother from Southside Chicago 
“When I was smoking crack, there were no rules. I even stole from my family.” 
17-year-old Miami woman 
“I lost my job, my house, and my marriage after becoming addicted to cocaine.” 
38-year-old accountant from San Juan 
Source:Client interviews submitted by HPDU Resource Book subject matter experts,1995. 
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“If you shoot some hero i n 
you are high, and you 
just kind of sit down and 
mind your own busi­
ness. If you shoot some 
cocaine... you have a 
desire for more, but it’s 
basically something that 
will pass. But with 
rock... the craving for 
more is unbelievable.” 
“Heroin is so intense... 
you can feel it move 
through your body and 
hit your brain.” 
“After I became addicted 
to heroin, I began to use 
it just to not get sick... 
I just couldn’t stand 
going through withdrawal 
again.” 
“The immediate rush 
from cocaine was 
intense. I was powerful. 
But then I crashed and 
all I wanted was some 
more.” 
“I was invincible with 
cocaine... until I came 
down and the depres­
sion hit.” 
Heroin—Characteristics and Effects 
• Made from morphine, which is obtained from the opium poppy. 
• High risk of developing physical and psychological dependence. 
• Can be administered by injection, sniffing (snorting), or smoking. 
• Commonly injected about three times a day (every eight hours). 
• Effects last from three to six hours. 
• Typical behaviors under the influence include sleepiness (“nodding”) after 
injection, sedate behavior, docile appearance and shuffling gait. 
• Acute withdrawal symptoms begin within 8 to 12 hours after last dose. 
• Withdrawal is severe, although generally not life-thre a t e n i n g . 
• Withdrawal symptoms include severe gastrointestinal distress, muscle 
cramping, and other flu-like symptoms. Heroin users call this withdrawal 
being “drug sick.” When these withdrawal symptoms are severe enough, 
individuals addicted to heroin want to obtain and inject the drug as rapidly 
as possible, sometimes without concern for possible HIV risks. 
• High risk of HIV transmission when administered by p reviously used, blood-
contaminated needle and syringe. 
Cocaine—Characteristics and Effects 
• The most potent of the stimulants. 
• High risk of developing physical and psychological dependence. 
• Can be administered by smoking, or “freebasing” (onset of effect: less than 10 
seconds), injection (onset of effect: 15-20 seconds), or snorting (onset of effect: 
2-4 minutes). 
• Effects last from 10 to 40 minutes, depending on purity and route of adminis­
tration. 
• Typical behaviors under the influence include hyperactivity, elation, increased 
energy and alertness, and increased sexual activity. The user may feel invinci­
ble, and is often difficult to deal with and quarrelsome. 
• Withdrawal symptoms occur within several hours after last use and result in 
agitation and depression. 
• High risk of HIV transmission through multiple injections when administered by 
previously used, blood- contaminated needles and syringes, and through 
unprotected, prolonged sexual intercourse. 
• Sold in ready-to-use crystals that, when heated and smoked, cause a “crack-
ling” sound. 
“After my first high on 
c r a c k , I knew I needed 
to find that same feeling 
again.” 
Sources: Ratner, 1993;client 
interviews submitted by 
HPDU Resource Book subject 
matter experts;and interviews 
conducted with drug users in drug 
treatment programs in the 
metropolitan Washington DC 
area,1995. 
Crack—Characteristics and Effects 
• Crack is prepared by heating cocaine, water, and bicarbonate (baking soda). 
This treatment chemically changes cocaine into a smokable form. Cost is lower 
than freebase cocaine (also smoked), making it more accessible. 
• Use is now widespread in some urban and rural areas among both women and 
men. 
• Results in an intense “rush” in a matter of seconds. 
• Effects are short-lived (a few minutes), resulting in repeated use to achieve the 
initial rush again and to avoid severe post-cocaine depression. 
• Typical behaviors under the influence include intense agitation and erratic 
activity, mood swings, confusion and disorientation, facial and body twitching 
(“tweaking”), and preoccupation with obtaining the next dose of crack. 
• Dependence on crack is thought to develop more rapidly than dependence on 
heroin or other forms of cocaine. 
• Crack sale and use can spread rapidly with devastating effects, including an 
increase in related violence, crime, and the exploitation of users, especially 
women. 
• Crack use is associated with increased sexual activity, often performed with lit­
tle regard for HIV risks. As with cocaine use, male sexual performance is often 
affected due to delayed ejaculation, and results in prolonged intercourse with 
increased risk of genital injury and bleeding. 
Major Patterns and Trends in Drug Use 
In addition to an understanding of drug-use behaviors on an individual leve l , a 
t h o rough understanding of the patterns and trends in drug use within com mu n i-
ties will support m o re effe c t i ve appro a ches to HIV preve ntion. These more genera l 
p a t t e rns and trends result from a vari e ty of factors, s u ch as changes in supply a n d 
demand or changes in the drugs t h e m s e lve s . The foll owing examples ill u st ra t e : 
• Changes in Su p p ly and Demand. C ra ck cocaine was essentially unknown until 
the mid-1980s. From the mid-1980s through the early 1990s, h ow eve r, c ra ck was 
i n t roduced into local drug markets of Am e ri can cities and ra p i dly became one of 
the dominant forms of drug use (Miller et al., 1990). 
• Changes in Drug Quality. In the early 1990s, there was an increase in the puri­
ty of heroin marketed in the U.S. The most important consequence of this trend is 
that the higher puri ty has all owed hero i n -
dependent drug users to consume it by 
sniffing (also called “snorting”) instead of in­
jecting (Ray et al., 1996). Low-purity heroin 
u s u a lly is injected because it has a re l a t i ve ly 
limited effect when snorted or smok e d . B e-
cause snorting does not inv o lve syringes and 
avoids the possibility of tra n s fe r ring blood 
d u ring drug injection , it usually reduces the 
risk of HIV tra n s m i s s i on . On the other 
h a n d , i n c reased puri ty has been associated 
with a rise in emergency ro om visits and 
ove rdoses resulting in death. It is import a n t 
to note that experience with earlier hero i n 
“e p i d e m i c s ” suggests that many of the cur-
rent heroin snorters may eve n t u a lly shift to 
injecting hero i n , p a rt i c u l a rly if the puri ty of 
h e roin drops to the levels seen in the early 
1980s. 
In addition to understanding changes in 
d rug supply and quality, p reve n t i on planners 
and program managers need to recognize re­
g i onal and local patterns and trends that af­
fect drug use. For example, a new trend that 
m ay affect drug use and HIV preve n t i on in 
the mid-1990s is the increasing use of am-
Table 1.1: Regional Patterns and Tre n d s 
of Drug Use 
In 1994, the National Institute on Drug Abuse-supported 
Community Epidemiology Work Group (CEWG), report­
ed the following regional patterns and trends related to 
drug use in the U.S.: 
• cocaine use, including crack, remains the most 
common substance on the drug market in 
Atlanta 
• New York City, Newark, Boston, and Chicago 
report that heroin use is either increasing or, at 
least, has stabilized at high levels 
• while most heroin users are over age 30, cities 
including Atlanta, Miami, and Chicago report an 
increase in younger users 
• the current purity of heroin in St. Louis is the 
highest ever seen in the Midwest 
• cocaine remains readily available in Denver and 
its use is increasing in Honolulu 
• increasingly, cocaine abusers in Miami are also 
snorting heroin 
• methamphetamine is the most widely used illicit 
drug in San Diego 
Source:Johnson,Bassin,and Shaw, 1995, vol.II. 
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phetamines in We s t e rn states and the intro d u c t i on of amphetamines into the 
Midwest and So u t h , w h e re amphetamine use was prev i o u s ly uncom m on ( J oh n-
son, Bassin, and Shaw, Inc., 1995, vol. II ). Table 1.1 illustrates some of the varia­
tion in drug use patterns in the United States.This variation reinforces the need to 
incorporate local data into the prevention planning process.1 
Drug Use, Abuse, and Dependence 
As noted prev i o u s ly, d rug use encompasses a wide range of substance-related be­
haviors that have varying effects on the individual and his or her HIV risk expo­
s u re . Understanding the nature of drug use, a b u s e, and dependence can help HI V 
p reve n t i on planners and pro g ram managers better target high-risk drug users and 
s u p p o rt HIV preve n t i on pro g rams that accommodate the re c u r rent and vari a b l e 
n a t u re of the drug use pro b l e m . Su ch an understanding can also provide insight 
into the ways users are viewed and treated by service providers and by the com mu n i ty 
in genera l . Se rvice prov i d e r s ’ o ri e n t a t i on can have a pow e rful impact on how dru g 
users are treated in preve n t i on pro g ra m s , and the com mu n i ty’s view can stron g ly 
a f fect the re s p onse to and acceptance of a pro g ram designed for drug users.2 
In a medical ori e n t a t i on , d rug-using behaviors are viewed as sym p t oms of a ch ron i c 
medical disorder that can be treated but not cured. Drug users are not blamed for 
their use. Ra t h e r, as with other ch ronic diseases, t h ey are helped to manage their 
illness. In this orientation, substance-related disorders are classified into two broad 
ca t e go ries—substance abuse and substance dependence—that form a con t i n u u m . 
Abuse may result in specific re c u r rent personal and social pro b l e m s , while depen­
dence results in an established pattern of con s e q u e n c e s . Exhibit B presents the 
medical criteria by which each of these disorders is recognized and diagnosed.The 
c ri t e ria give a clear idea of the range of behaviors, their potential con s e q u e n c e s , 
and env i ronmental implica t i on s . A ll of these can affect preve n t i on strategies and 
i n t e rve n t i on s . H ow eve r, not eve ryone who uses drugs develops substance-re l a t e d 
d i s o rd e r s . Why this is so is still uncl e a r, although re s e a rchers have identified a 
number of biologica l , p s ych o l o g i ca l , and env i ronmental factors that may have 
a role. 
1. Developing an accurate picture of local drug use is discussed in greater detail later in PART 1 in the section entitled 
“Estimating the Extent of Local Drug Use.” 
2. These orientations and attitudes are discussed more fully in PART 4: PUBLIC POLICY ISSUES. 
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Substance Abuse	 For an individual to be diagnosed with substance abuse, s/he must have experienced 
one (or more) of the following in the same 12-month period: 
• Recurrent substance use resulting in a failure to fulfill major role obligations at 
work, school, or home (e.g., repeated absences, poor work performance, 
neglect of children or household). 
• Recurrent substance use in situations in which it is physically hazardous (e.g., 
driving a car or operating machine while impaired). 
• Recurrent substance-related legal problems (e.g., substance use-related 
arrests). 
• Continued substance use despite having persistent or recurrent social or inter-
personal problems caused by effects of substance (e.g., arguments, physical 
fights). 
Substance For an individual to be diagnosed with substance dependence, s/he must have experi-
Dependence enced three (or more) of the following in the same 12-month period: 
• Tolerance, defined as either: 	a) a need for markedly increased amounts of the 
substance to achieve the desired effect; or b) a markedly reduced effect with 
the continued use of the same amount of the substance. A cocaine user experi­
ences drug tolerance when s/he seeks more cocaine to recapture the “high” 
initially derived from smaller amounts (Ray et al., 1996). 
• Withdrawal, defined as: 	a) the occurrence of a withdrawal syndrome when the 
substance is not used or there is a reduction of use after heavy, prolonged use 
(e.g., with crack, becoming irritable and/or depressed; with heroin, becoming 
shaky and/or nauseous); b) the use of the same or related substance to relieve 
or avoid withdrawal symptoms. 
• The substance is often taken in larger amounts or over a longer period than 
was intended. 
• There is a persistent desire or unsuccessful efforts to cut down or control sub-
stance use. 
• A great deal of time is spent in activities necessary to obtain the substance 
(e.g., visiting multiple doctors, driving long distances), use the substance (e.g., 
chain-smoking), or recover from its effects. 
• Important social, occupational, or re c reational activities are given up or re d u c e d 
because of substance use. 
• The substance use is continued despite knowledge of having a persistent or 
recurrent physical or psychological problem that is likely to have been caused 
by the substance (e.g., continued alcohol consumption despite a known ulcer). 
Source: American Psychiatric Association,1994. 
Substance Dependence as a Chronic, 
Relapsing Disorder 
Drug dependence is con s i d e red ch ro n i c b e cause there is no cure . An integral ele­
ment of this disorder is a common pattern of remission followed by relapse. Many 
of those who are dependent stop using drugs but later resume their use and con­
tinue to have alternating periods of remission and relapse. 
M a ny persons dependent on drugs want to stop or con t rol their substance use. 
Those who are in drug treatment pro g rams or who, on their ow n , a re successfully 
abstaining from drug use are said to be “in remission” or “in recovery.” Recovery 
from drug use is a delicate balancing act. Most initial attempts to stop drug use are 
u n s u c c e s s f u l , and individuals in re c ove ry may relapse one or more times, p a rt i c u-
l a rly early in the treatment pro c e s s . As a result of high relapse rates among those 
in drug treatment, relapse prevention strategies have become an important compo­
nent of many drug treatment programs. These strategies inv o lve helping the patient 
identify personal “ t ri g g e r s”—s i t u a t i on s , l o ca t i on s , or objects—that prompt a desire to 
resume drug use. Helping a person “talk thro u g h” or learn how to manage this cra v i n g 
p rompted by a trigger may be an effe c t i ve technique in reducing relapse potential. 
Substance Abuse and HIV Risk 
Pe r s ons who use, a b u s e, or are dependent on drugs often engage in behaviors, i n­
cluding HIV risk behaviors, that can negative ly affect their health. This may 
caused by the effects of the substance itself. For example, people who use or abuse 
drugs or alcohol sometimes report being so high or intoxicated that they forget to 
use a con d om . O r, risk behavior may result from the desire to avoid withdra w a l 
s ym p t om s . An individual who is dependent on heroin may choose to share a sy­
ringe in order to avoid the painful effects of withdra w a l . In both of these exam-
p l e s , the individuals inv o lved may be well educated about HIV tra n s m i s s i on and 
deeply concerned about the risks of HIV infection and ways to protect themselves. 
Ye t , the effects of the substance ove r ride this knowledge and place them at ri s k . 
E ven given these pow e rful effe c t s , s ome studies show that drug users will ch a n g e 
their behaviors to reduce their risk of HIV and other health pro b l e m s . For exam­
ple, when heroin purity increases, users switch from injecting to snorting the drug. 
One re a s on given for this change is the fear of needl e - a c q u i red HIV infe c t i on 
( Johnson, Bassin, and Shaw, Inc., 1995, vol. I). 
It is important that preve n t i on planners and pro g ram managers understand the 
powerful effects of drug dependence, particularly as they relate to HIV risk behav-
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i o r s , and accept the fact that knowledge alone will not protect a com mu n i ty from 
the tra n s m i s s i on of HI V. This has important implica t i ons for the design, typ e, 
number, and compatibility of programs, and the frequency and number of support 
or “booster” sessions needed to maintain behavior change that lowers HIV risks. It 
also has implica t i ons re g a rding the need to increase the availability of preve n t i on 
s u p p l i e s , s u ch as bleach kits, s t e rile syri n g e s , and con d om s , so that they are easily 
accessed at the times and in the locations where individuals are most vulnerable. 
Drug Treatment 
Drug dependence is identified through behavioral and phys i o l o g i cal sym p t om s 
and best treated by a mu l t i d i s c i p l i n a ry appro a ch . Ou t c omes are determ i n e d , i n 
part, by a number of interrelated factors, including: (1) characteristics of the indi­
viduals seeking treatment, including their level of “readiness for treatment”; (2) the 
t reatment appro a ch used and services prov i d e d ; and (3) elements that affect the 
individual’s adjustment to his or her environment once treatment is completed. No 
single treatment approach is effective for all persons with drug problems. An inte­
g rated system of treatment pro g ra m s , c ontaining a full range of treatment typ e s , 
intensities, and cultural competencies is essential (Selwyn et al., 1995). 
The last decade of ev a l u a t i on re s e a rch on drug treatment has demon s t rated its 
ove ra ll effe c t i veness (Gerstein et al., 1 9 9 0 ; Pi ckens et al., 1 9 9 1 ) . For example, a 
large pre- and post- treatment com p a ri s on study of 649 adult alcoh o l - , c o ca i n e - , 
and opiate-dependent patients admitted to 22 public and private treatment pro-
g rams showed participant improvement in seven are a s : a l c ohol and drug use as 
w e ll as medica l , l e g a l , e m p l oym e n t , f a m i ly / s o c i a l , and psych i a t ric pro b l e m s 
( M c Le llan et al., 1 9 9 4 ) . Other key studies evaluating alcohol treatments (Moos, 
1974; Moos et al., 1990), drug abuse treatments (Hubbard et al., 1989; Simpson et 
a l . , 1 9 8 0 ) , t h e rapeutic com mu n i ty treatment (DeLe on , 1 9 8 4 ) , and methadon e 
maintenance treatments (Anglin et al.,1989; B a ll et al.,1988; Nov i ck et al., 1 9 9 0 ) 
also have shown significant and perv a s i ve changes among substance-dependent 
patients following standard treatments. A review of the data on the effectiveness of 
drug treatment can help prevention planners and program managers decide which 
HIV prevention interventions would best serve drug users and their sex partners. 
Drug Treatment Services 
Some people who have become dependent on drugs are able to stop using on their 
own or with the assistance of family, f ri e n d s , ch u rch , or members of their com mu n i ty. 
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M a ny more, h ow eve r, need help from specialized counseling, s u p p o rt , and/or med­
i cal thera p i e s . Drug abuse treatment pro g rams differ in their ph i l o s o phy, s e t t i n g, d u­
ra t i on , and appro a ch . Most pro g rams use some type of “s e rvice con t i n u u m” b a s e d 
on the concept that tre a t m e n t , like substance-related disorders and re c ove ry, is an 
on going pro c e s s . 
Drug treatment programs provide an important opportunity to conduct HIV pre­
ve n t i on with drug users. Understanding the unique stru c t u re, a p p ro a ch , and ph i­
losophy of drug treatment services within a community allows prevention planners 
and pro g ram managers to support coll a b o ra t i ve efforts with pro g rams that have 
built-in access to drug-users and their sex part n e r s . In addition , d rug tre a t m e n t 
p roviders can become key allies in supporting com mu n i ty-based HIV preve n t i on 
p ro g rams for drug users. Drug users benefit from services that address both HI V 
and drug-related risks. 
Ac c o rding to the Na t i onal Academy of Sciences, an estimated 5.5 mill i on people need 
drug treatment, although it is available for only a fraction of them (Gerstein et al., 
1 9 9 0 ) . The services that are available differ in their appro a ches and com p on e n t s . 
T h ey can be divided into six major ca t e go ries of pro g ra m s : (1) detox i fi ca t i on ; 
(2) inpatient; (3) therapeutic communities; (4) outpatient; (5) methadone mainte­
nance; and (6) self-help. 
Detoxification programs. Detoxification (“detox”) programs are medically 
s u p e rvised pro g rams in which drug users are weaned from their phys i cal dependence 
on drugs, such as heroin, cocaine, and alcohol. Although there are a few outpatient 
d e t ox pro g ra m s , most detox i fi ca t i on occurs at inpatient facilities where a part i c i p a n t’s 
progress can be monitored carefully. 
In most detox pro g ra m s , m e d i ca t i on is used to lessen the seve ri ty of withdra w a l 
s ym p t om s . For users of heroin and other opiates, o ral methadone (a synthetic opiate), 
is used to limit the discom f o rts associated with the abrupt discon t i n u a t i on of a 
drug. The length of stay in a detox program often hinges upon which drug the pa­
tient is addicted to, which detoxification approach is used, and any restrictions es­
tablished by health insurance plans. 
Inpatient programs. Housed in hospitals or specialized treatment facilities away 
from the user’s natural home environment, these programs provide drug users in 
need of intensive treatment with continuous care and supervision. 
Therapeutic communities (TCs). TCs are peer-based, residential treatment 
settings designed to help clients alter, modify, and re-learn behaviors. The length 
of treatment varies from 18 to 36 months. Many therapeutic communities offer a 
wide variety of educational, medical, legal, social, and psychological counseling ser-
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vices, all of which are coordinated under the auspices of a basic self-help model. 
The TC approach is applied in a variety of settings, including community-based 
residences, hospitals, homeless shelters, and prisons. Most TCs have specific rules 
and norms that apply to both clients and staff. Exhibit C on the next page describes 
some basic components of TC programs. 
Outpatient programs. These programs serve about half of all those in treatment 
for drug and alcohol problems. Outpatient care is the least intensive form of treat­
ment, and has fewer restrictions than inpatient or residential programs. This type 
of treatment is most suitable for people who are employed, have a stable and sup­
portive social and family environment, honestly acknowledge their problem with 
drugs, and sincerely desire help in stopping their drug use. Outpatient program ser­
vices range from drop-in centers to individual and group counseling sessions. Some 
outpatient programs provide educational, medical, psychological, and rehabilitative 
services. Patients receiving outpatient treatment must be highly motivated, partic­
ularly if environmental factors or personal relationships are conducive to triggering 
a relapse. 
Methadone maintenance treatment programs. These programs provide 
outpatient services for those addicted to opiates, such as heroin, by offering 
methadone in combination with counseling. Dosages of methadone range from 
approximately 20 milligrams to more than 100 milligrams daily. A daily dose, 
which has a “half-life” of one to two days, stabilizes the patient until it is time to 
receive the next dose. At a sufficiently high dosage, methadone blocks the euphor­
ic “rush” caused by heroin and other opiates, although it has no inhibitory effect on 
stimulants, such as cocaine. 
Methadone maintenance programs have been proven to reduce opiate use, thereby 
enabling users to lead more pro d u c t i ve live s . Some people have re g u l a rly taken 
p a rt in methadone maintenance pro g rams for 10 to 20 years with ve ry good re-
s u l t s . Some pro g rams use methadone as one com p onent of a planned course of 
t reatment in which the methadone dosage is pro g re s s i ve ly reduced to ze ro. C om-
p l e t i on of treatment with methadone usually is foll owed by on - going counseling 
designed to help former users remain abstinent. 
Self-help or “12-Step” programs. The most familiar example of the self-help 
model is Alcoholics Anonymous (AA). The AA model has been adapted by self-
help organizations for drug users such as Narcotics Anonymous (NA) and Cocaine 
Anonymous (CA). Meetings, fellowship, and mutual support are at the core of all 
these self-help groups. In a typical meeting, members gather to discuss their past 
or present problems with alcohol and drugs.They also give testimonials about their 
application of “the 12-step method” in bringing positive changes to their lives. By 
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Basic Components of a 

Therapeutic Community (TC) Program

Community Usually housed in a location separate from other programs and drug-related 
separateness environments. 
Community Environment designed and organized to promote a sense of commonality and 
environment collective activity. 
Community activities	 Treatment and services are provided within the context of the peer community 
and all activities are programmed in gro u p s . 
Peers as community Individuals who reflect the value and teaching of the TC, demonstrate the expect-
members ed behavior, and who are viewed as role models. 
Staff as community Staff are a mix of recovering professionals and other professionals who must be 
members integrated through cross-training in the program and community approach. 
Structured day	 Each day has a formal schedule of therapeutic and educational activities with 
fixed times, routine procedures, and prescribed formats. 
Phase format	 Individual treatment plans are organized into phases that reflect a developmental 
view of the change process; emphasis is on incremental learning at each phase, 
which moves the individual to the next stage of recovery. 
Work as therapy Consistent with the self-help approach, all clients are responsible for the daily 
and education management of the facility. 
Peer encounter A peer group process is used to increase individual awareness of specific atti­
groups tudes or behavioral patterns that need modification. 
Duration of treatment Length of individual treatment depends on stage of recovery. 
TC concepts	 An organized curriculum focused on the TC perspective, particularly its self-help 
re c o v e ry concepts and view of right living. 
Maintenance Development of relationships and a new social network needed to sustain recov­
of recovery ery after treatment. 
Source:DeLeon,1995. 
sharing their stories and hearing others describe their “powerlessness over the dis­
ease of addiction,” participants obtain the support, fellowship, and motivation 
needed to maintain their recovery. 
Self-help meetings provide a mu ch-needed atmosph e re of mutual support from 
others struggling with drug abuse or dependence. Su ch support can be ve ry helpful, 
particularly for those in the early phases of recovery. Participants may attend sever­
al meetings a week, or as often as once or twice each day. The common goal for all 
participants of AA, NA, and CA is total abstinence.Typical meetings i n clude cel­
e b ra t i ons of the “a n n i ve r s a ri e s ” of those who have been “s o b e r” or “clean and 
s e re n e” for intervals of a mon t h , six mon t h s , a ye a r, and each annive r s a ry therea ft e r. 
A A , NA , and CA are member-opera t e d , n on p rofit organiza t i on s . The organiza­
tions themselves arrange for a place to conduct meetings, distribute literature, and 
p rovide the stru c t u re for the meeting. Although the 12-step pro g rams themselve s 
are not considered “formal” drug treatment programs, they are often major factors 
in helping drug users control their use of drugs. 
HIV Prevention and Drug Treatment Programs 
Typ i ca lly, d rug treatment pro g rams are not con s i d e red preve n t i on pro g ra m s — 
t reatment is usually applied when pri m a ry preve n t i on fails. In the case of dru g 
abuse treatment however, there is real potential for treatment to achieve primary 
HIV/AIDS preve n t i on go a l s , g i ven the close association between drug use and 
HIV infe c t i on . By effe c t i ve ly treating drug use, d i rect and indirect risks of HI V 
infection can be reduced. 
Data from the past ten years have cl e a rly established an association between part i c-
i p a t i on in treatment and lower risk of HIV infection. For example, an examination 
of self-re p o rted risk behaviors of IDUs in treatment and out of treatment has 
s h own significa n t ly lower rates of risk behaviors (e.g. , d rug injection , n e e dle shari n g ) 
p racticed by drug users who are in treatment (Abdul-Quader et al., 1 9 8 7 ; B a ll et 
a l . , 1 9 9 1 ; C a p l e h o rn et al., 1 9 9 5 ) . These self-re p o rted behavioral diffe rences are 
c onsistent with studies of HIV incidence/prevalence and treatment part i c i p a t i on , 
which have shown that participation in treatment programs that use opiate substi­
t u t i on (usually methadone) is associated with lower sero p o s i t i v i ty rates (Metzger 
et al., 1993; Moss et al., 1994; Serpelloni et al., 1994). 
In addition to being an effe c t i ve HIV preve n t i on pro g ra m , d rug treatment pro-
grams provide an ideal opportunity to reach drug users and their sex partners with 
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a variety of HIV prevention interventions over a period of time. As one of the few 
o r g a n i zed social institutions with access to drug users at risk of HIV infe c t i on , 
t reatment pro g rams have in many ways become com mu n i ty-based “staging are a s ” 
for risk re d u c t i on interve n t i ons directed at IDUs (Metzger, 1 9 9 7 ) . E ven though 
d rug users in treatment re p resent on ly a minori ty of active drug users, t h e re is a 
g rowing awareness that individuals in treatment provide access to a mu ch larger 
c om mu n i ty of drug users who are not in tre a t m e n t . This is due to the fact that 
d rug use often takes place in small groups or within social netw o rks of drug users.3 
Several studies have found that drug users currently in treatment are effective peer 
c ontacts who can conduct street outre a ch and disseminate preve n t i on inform a t i on 
and materials to their social netw o rks of active drug users (Birkel at al., 1 9 9 3 ; 
Latkin et a l . , 1 9 9 6 ) . 
T h e re has been mu ch debate, h ow eve r, as to the nature of HIV preve n t i on pro-
g rams within drug treatment pro g ra m s . M a ny drug treatment pro g ram adminis­
t rators believe that it is the pro g ra m’s re s p on s i b i l i ty to educate clients about how 
to protect themselves from HIV infection, including how to disinfect needles and 
s yringes in the likelihood that the client may relapse during or after tre a t m e n t . 
Others argue that risk reduction without abstinence violates the core principles of 
drug-free treatment and recovery.4 
Drug treatment program administrators and staff can be valuable sources of exper­
tise and support to preve n t i on planners and pro g ram managers. Building these 
links requires a sensitivity to the various approaches and perspectives of those who 
w o rk within the drug treatment sys t e m . E xchanging ideas and ph i l o s o phies with 
drug treatment service providers can help pave the way for a coordinated, stream-
lined, and cooperative approach to HIV prevention community-wide. 
Estimating the Extent 
of Local Drug Use 
Thus far, PA RT 1 has given an ove rv i ew of various types of dru g s , the range of 
d rug-using behaviors, the general patterns and trends of drug use, and an under-
3. The social contexts of drug use are discussed more fully in PART 2: DRUG USE, SEXUAL BEHAVIOR, AND HIV 
RISK. 
4. Issues related to the debate over HIV prevention efforts within drug treatment programs are further discussed in 
PART 4: PUBLIC POLICY ISSUES. 
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standing of drug dependence and drug tre a t m e n t . This provides important back-
g round for developing HIV preve n t i on pro g rams for drug users at the local leve l . 
In order to develop effective community programs, however, planners and p ro g ra m 
managers need to have an accurate understanding of local drug-using behaviors, 
drug-use environments, affected populations, and local patterns and trends. 
This information may be difficult to obtain. Traditional survey methods and other 
t e chniques that may be used to estimate local drug use have distinct limitation s . 
For example, s ome people may not admit 
to using drugs or will understate their 
d rug use because drug use is illegal and 
s o c i a lly unacceptable. In addition , ch ronic 
d rug users often are not re a ched by tra­
d i t i onal com mu n i ty surveys. Difficulties 
in a c c u ra t e ly estimating the number of 
people who inject specific dru g s , s u ch as 
h e ro i n , cocaine, and amphetamines, are 
further compounded because IDUs may 
use several drugs in combination or may 
v a ry their drug-using behaviors over time 
by switching from one drug or method of 
use to another (e.g. , injecting to snort i n g ) . 
B e cause of the difficulties in obtaining 
exact inform a t i on on the extent and pat-
t e rn s of drug use in a given community, 
it is important to gather information on 
drug use from a variety of sources and 
c ombine them to obtain general estimates 
of the extent and patterns of drug use in 
the com mu n i ty. Table 1.2 summari ze s 
potential local sources of inform a t i on 
on drug use trends and pattern s . I n 
c om b i n a t i on , t h ey can increase preve n-
t i on planners’ and pro g ram managers’ 
understanding of the drug use situation 
in their com mu n i ty, w h i ch in turn , w i ll 
enhance their ability to support more 
e f fe c t i ve HIV preve n t i on pro g rams for 
drug users. 
Table 1.2: Local Resources for Inform a t i o n 
on Drug Use Trends and Pattern s 
The following resources may be available to provide 
local information on drug use trends and patterns: 
Government Agencies 
• state, city, and county drug treatment and 
prevention agencies 
• state Boards of Education 
• criminal justice system 
• govern o r ’s and mayor’s task forces on drug abuse 
Research Institutions 
• university research projects on drug use 
• hospital-based research projects on drug use 
Community / Neighborhood Programs Serving 
Drug Users 
• outreach projects to drug users and youths 
• public health clinics 
• drug abuse treatment providers 
Libraries 
• literature searches of local drug use reports, 
surveys, and/or relevant newspaper articles 
National Institute on Drug Abuse ( N I D A ) -
s u p p o rted Community Epidemiology Work Gro u p 
(if available in your state) 
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Each of these sources will present its own opportunities and challenges. When ap­
p ro a ching gove rnment agencies, s u ch as drug treatment and preve n t i on agencies, 
b o a rds of educa t i on , or the criminal justice sys t e m , for example, it is best initially 
to contact staff who oversee inform a t i on and data management for the agency. 
These agencies may have other useful data in addition to data on drug-use tre n d s 
and pattern s , and the inform a t i on/data management staff will likely be in a go o d 
p o s i t i on to bring them to the attention of preve n t i on planners. The criminal jus­
tice system may have data on the number of drug-related arrests, what drugs were 
c on fi s cated in arre s t s , and high-use neighborhoods and population s . State board s 
of educa t i on con t ribute inform a t i on to the CDC - s u p p o rted Youth Risk Behavior 
Survey, which collects some drug-use data on a sample of 9-12th grade students. 
Preve n t i on planners also can seek re l evant data from the com mu n i ty drug tre a t­
ment programs or public health clinics, with the understanding that their data col­
l e c t i on systems are often limited. These data coll e c t i on systems vary con s i d e ra b ly 
as to their re p o rting re q u i rements and staff ca p a c i ty to summari ze data in an ag­
gregate way. A priority for many prevention programs and clinics is to gather data 
on service delivery to report to their funders rather than to gather data on patterns 
and trends of drug use among their targeted population . When re l evant data are 
not available from pro g rams serving drug users, planners can conduct stru c t u re d 
interviews with a representative sample of professional providers. 
Research institutions, often university or hospital-based, are another source of rel­
evant data. R e s e a rch projects related to drug use often are located in depart m e n t s 
s u ch as public health, p s ych i a t ry, p s ych o l o gy, s o c i o l o gy, a n t h ro p o l o gy, or social 
w o rk . If the institution has a re s e a rch depart m e n t , staff there often can re s p on d 
initially or through direct data inquiries to other departments. 
Preve n t i on planners also should use public libra ries in seeking re l evant local data 
and information. Literature searches on drug use can often identify reports or sur­
veys that have been conducted. In addition, a search of newspaper files can identify 
articles on drug use and drug use environments. 
Another valuable source of information on drug uses is the Community Epidemi­
o l o gy Wo rk Group (CEWG ) , a Na t i onal Institute on Drug Abuse (NIDA ) - s u p-
p o rted netw o rk of re s e a rchers from 20 major metropolitan areas of the U.S., 
C a n a d a , and Mexico. The CEWG provides current descri p t i ve and analyt i cal in-
f o rm a t i on re g a rding the nature and patterns of drug abuse, emerging tre n d s , a n d 
ch a ra c t e ristics of vulnerable population s .5 Table 1.3 lists the 20 major metro p o l i-
tan areas surveyed by the CEWG: 
5. PART 5: RESOURCES provides contact information for the CEWG. 
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Table 1.3:

M e t ropolitan Areas Surveyed by CEWG

The following 20 major metropolitan areas are covered by the data-gathering activities of the 










































Finally, planners should not underestimate the value of gaining information about 
t rends and patterns of drug use from drug users themselve s . K ey informant inter-
v i ews and focus groups with active drug users or those in treatment can yield in-
formation about current practices, drugs of choice, and their availability. These in-
t e rv i ews will also provide planners and managers with a more holistic 
understanding of the lives of drug users. These interv i ews should be arra n g e d 
through staff who work in programs for active and inactive users. 
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Key Questions for HIV Prevention

Planners and Program Managers

The following key questions related to PART 1 may be helpful in guiding preven­
tion planners and program managers to obtain information on how to design, im­
plement, and set priorities among programs for drug users and their sex partners. 
■ H ow would you assess the local com mu n i ty’s attitude tow a rd drug use? 
■	Who are the major drug treatment providers in your community 
and what kinds of services do they provide? 
■	Do local or state-funded drug treatment programs provide HIV 
prevention education for their clients and, if so, what do these 
programs consist of? 
■	Have local or state drug use surveys or other types of research been 
conducted within your community to determine the nature and 
extent of local drug use? 
■	How might the goals of local drug treatment providers reinforce or 
conflict with those of HIV prevention efforts? 
■	How might drug treatment providers be involved in the HIV 
Prevention Community Planning process? 
■	How might state and local corrections systems agency representa­
tives be involved in the HIV Prevention Community Planning 
process? 
■	How might state and local alcohol and drug agency representatives 
be involved in the HIV Prevention Community Planning process? 
■	Is a member of the Community Epidemiology Work Group 
(CEWG) conducting research in your area? 
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DRUG USE, SEXUAL BEHAVIOR, 
AND HIV RISK 
Recent estimates suggest that the HIV/AIDS epidemic in the U.S. is being driven 
by subepidemics in three gro u p s : (1) injection drug users and their sex part n e r s 
and ch i l d re n ; (2) heterosexual women who use cra ck ; and (3) young and minori ty 
men who have sex with men (Holmberg, 1996). Of these three subepidemics, two 
a re dire c t ly associated with drug use and underscore the importance of drug use 
and sexual behaviors to the spread of HIV. In addition, there is some evidence that 
the third subepidemic also is associated with drug use. Am ong MSM, n on - i n j e c-
t i on drug use (e.g. , c u r rent or past heavy alcohol use; c u r rent use of stimu l a n t s , 
hallucinogens, and inhalants) (Woody et al., 1996) has been shown to be associat­
ed with higher-risk sexual behavior. 
Drug users face many opportunities for HIV exposure, infection, and transmission 
as a result of their drug-using practices and sexual behaviors. In the past, HIV pre­
vention efforts often focused on either the drug-related or the sex-related risk be­
haviors of individuals, neglecting both the interre l a t i onships among these behav­
iors and the social context in which they occur. The association betw e e n 
Table 2.1:

High-Risk Practices and Behaviors Among Drug Users

Injection Drug-use Practices* 
Type of drug injected 
• speedball (heroin and cocaine combined; highest correlation with HIV transmission) 
• heroin 
• cocaine (frequency of injection) 
Sharing of equipment 
• direct sharing of syringe 
• indirect sharing 
Sharing water, cooker, or cotton 
Using used syringe plunger to stir 
drug solution 
Backloading, frontloading 
Recycling used cottons to extract 
residual drugs 
Using unclean rinse water to mix with drug 
Using dirty syringe to draw up water or mea­
sure shared drugs 
Returning a portion of the drug solution to the 
cooker from a used syringe 
Sharing unknowingly (IDU partner or spouse 
loans out works to another IDU) 
• using crack as well as injecting dru g s 
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n on - i n j e c t i on drug use, s u ch as cra ck coca i n e, and sexually related risk behaviors 
has also been ignore d . Now, h ow eve r, those inv o lved in efforts to contain the 
s p read of HIV infe c t i on in drug users ack n owledge a pressing need to focus on 
both drug-related (injection and non-injection) and sexually related risk behaviors. 
PA RT 2 builds on the general inform a t i on on drug use patterns and behaviors 
presented in PART 1 by focusing on the interface of HIV, drug use, and sexual be-
h a v i o r s , and by describing the HIV risks incurred by drug-using population s . I t 
p rovides inform a t i on to help HIV preve n t i on planners and pro g ram managers 
take into account the multiple risks associated with drug use as well as the social 
conditions that uniquely influence the frequency and level of such risks. 
Sp e c i fica lly, PA RT 2 will help HIV preve n t i on planners and pro g ram managers 
increase their knowledge of: 
• drug-using practices, sexual behaviors, and the social context of drug 
use, all of which influence HIV infection risk 
• special groups of drug users who are most heavily affected by HIV 
• national, state, and local HIV/AIDS data available to help identify 
trends in transmission of HIV among drug users 
Table 2.1:  continued

Non-injection Drug Practices 
Multiple sexual risk behaviors (see below) 
Sexual Behaviors 
Unprotected sex 
• receptive anal intercourse 
• insertive anal intercourse 
• vaginal intercourse 
• oral sex 
Multiple partners

Trades of sex, money, and drugs

Lack of treatment for STDs (especially ulcerative lesions)

*NOTE:These practices are defined and described more fully later in PART 2 in the section entitled “Direct and Indirect 
Transmission of HIV Risk Through Sharing of Injection Equipment” and in the BOX on “Drug Use Practices and Risk for HIV 
Transmission.” 
Drug Use, Sexual Behavior, and HIV Risk 2-3 
HIV Behavioral Risks 
Among Drug Users 
Drug users face multiple opportunities for HIV exposure through their drug use, 
s e x u a l , and social behaviors. Understanding these behaviors will all ow preve n t i on 
planners and managers to identify reliable inform a t i on related to the behaviors, 
c u r rent populations who are at high risk for HIV infe c t i on , and populations who are 
most in need of preve n t i on interve n t i on s . Table 2.1 lists these practices and behaviors. 
Injection Drug Use Practices 
Injection drug users are the second largest subgroup of persons with AIDS in this 
c o u n t ry (CDC , 1 9 9 6 ) . Seve ral factors con t ribute to the IDU’s level of ri s k . T h e s e 
i n clude the type of drug injected, f re q u e n cy of injection , a v a i l a b i l i ty of sterile injecting 
e q u i pm e n t , method of pre p a ring the drug for injection , and the loca t i on ch o s e n 
for the pro c e s s . B e cause each one of these behaviors also presents an opport u n i ty 
for interve n t i on , it is essential to understand the full con s t e ll a t i on of specific injection 
d rug-using behaviors if planning groups are to support successful interve n t i on s . 
For example, if IDUs inject with sterile syringes and do not share equipment, their 
risk of drug-related HIV infection is low. However, IDUs who use bleach to clean 




Figure 2.1: Equipment Used to 
Spoon 
Cup Prepare and Inject Drugs 
in the drug solution . The foll owing section 
p rovides a general ove rv i ew of HIV tra n s m i ssion 
risks associated with drug use, a discussion of 
the processes of pro c u ri n g, m i x i n g, and injecting 
d ru g s , and a discussion of high-risk sexual 
b ehaviors common among drug users. 
D i rect and Indire c t 
Transmission of HIV Thro u g h 
Sharing of Injection Equipment 
Injecting a drug like cocaine or heroin re q u i re s 
several pieces of equipment that are commonly 
re fe r red to as a “set of work s . ” Fi g u re 2.1 dis­
plays some of the most frequently used compo­
nents for pre p a ring and injecting dru g s . E x h i b i t 
D discusses these components in detail. 
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Drug Use Practices and 

Risk for HIV Transmission

Using a Drug Runner	 IDUs often pool their money and make a single drug purchase in an effort to off-
set the cost of heroin or cocaine and to avoid the risk of arrest and/or imprison­
ment in buying these drugs. A drug “runner” who purchases drugs for a group 
of users may become a direct or indirect link for the transmission of HIV to dif­
ferent groups of IDUs. Runners may travel to outside communities or unfamiliar 
contact groups to negotiate a drug purchase. On these buying “runs,” they may 
also take part in risky activities, such as testing (“tasting”) drugs, using bor­
rowed injection equipment, or having casual sex with those they come into con-
tact with. 
If drug buyers pay the runner with a portion of the drugs bought, the runner may 
subsequently inject with other members of the group once the drug has been 
distributed and prepared. The runner may become infected through this process 
and, in turn, infect others within this own network of IDUs and sex partners. If 
already infected with HIV, runners may transmit the virus through syringe shar­
ing or sexual activity with members of different groups. 
Using Contaminated Injection drugs are usually sold in dry powder form, which must be mixed with 
Syringes and Drug water and sometimes heated before being injected. This is typically done in a 
spoon or a bottle cap, called the “cooker.” The drug and 
water solution is then drawn into a syringe through a filter 
or a “cotton,” which prevents small particles in the solution 
from clogging the syringe. 
P reparation Equipment 
IDUs usually inject the drug into a vein in their arm or hand. 
The arm veins of long-time users often are damaged from 
repeated injections; when this is the case, veins in other parts of their body are 
used. Before injecting, the IDU must first determine whether the needle has been 
inserted into a vein. To do so, he or she pulls back the syringe plunger to see if 
blood enters the syringe. This is called “registering.” 
If blood registers in the syringe, the needle is in a vein. Registering contaminates 
the entire syringe: needle, hub, barrel, and plunger (Normand et al., 1995). 
Once the user inserts the needle into a suitable vein, the drug is 
injected directly into it. To ensure injecting all of the drug, the IDU 
may pull the plunger back several times, drawing blood into the 
syringe each time, and then re-injecting it into the vein. This technique, called 
“booting,” results in a higher volume of residual blood in the syringe (Normand 
et al., 1995). 
HIV survives in the residual blood in used syringes, even if the syringe has been 
rinsed with water. This was demonstrated in a 1990 study, in which used needles 
were tested for HIV. Of the needles with visible blood, 20 percent tested seropos­
itive; of those with no visible blood, just over five percent were seropositive 
(Chitwood et al., 1990). A follow-up study in 1992 found that over half of the 
syringes with visible blood were HIV positive (McCoy et al., 1994). 
After injecting the drug, the user rinses the syringe with water to prevent the 
clotting of any blood remaining in the syringe. Not only does this not disinfect 
the syringe of HIV or hepatitis viruses, it also contaminates the 
rinse water. Drug injection may take place in locations with little 
access to water, so rinse water may be infrequently changed, and 
therefore, become increasingly contaminated with each use. 
“Moreover, rinse water is commonly used not only for rinsing, but 
also for the mixing of the drug solution to be injected....It is the 
injection of this contaminated water that poses the greatest threat 
for HIV transmission, especially in the case of cocaine injection, 
because cocaine is water soluble and does not always require 
heating in a cooker to be dissolved” (Normand et al., 1995, p. 27). 
The injection of cocaine presents greater risk to the IDU than injection of other 
drugs or of heroin alone. Cocaine injectors require more injections per day, mul­
tiplying the number of opportunities for HIV exposure (depending on injection 
practices) over those faced by heroin users. The injection of speedball also has 
been highly correlated with HIV infection (Battjes et al., 1994). In one study, 
speedball users were one-and-a-half times more likely to be seropositive than 
were those injecting heroin (Koblin et al.,1990). Another study found that the 
techniques used for loading syringes with speedball doubled the risk for HIV 
infection for the IDU (Inciardi et al., 1991). 
T h rough the shared use of drug equipm e n t , HIV can be transmitted from an in­
fected IDU to an uninfected person either “directly” or “indirectly.” Transmission 
may occur directly when someone injects a drug with a syringe that another person 
has used and contaminated with HI V. I n d i rect tra n s m i s s i on happens when the 
drug solution in a syringe is contaminated in the process of mixing or distribution. 
Direct sharing 
Even with the advent of AIDS, the use of drug injection equipment by more than 
one person (mu l t i p e r s on use, or “s h a ri n g”) continues to be practiced among injection 
drug users (Koblin et al., 1990; Mandell et al., 1994; Battjes et al., 1994). Sharing 
s yringes occurs among IDU partners and people who re g u l a rly inject drugs to­
gether (drug netw o rks) (Hart e l , 1 9 9 4 ; 
Wi lliams et al., 1 9 9 5 ) . An onym o u s , 
sequential sharing also can occur at 
“shooting galleries,”1 where syringes are 
rented out to one person after another 
without being disinfected (Murphy et 
a l , 1 9 9 1 ) .2 Other factors also influ e n c e 
whether or not injection equipment will 
be shared by IDUs (see Table 2.2). 
Not all those who inject drugs do so 
i n t ra ve n o u s ly, h ow eve r. For example, 
injecting a drug underneath the skin 
(“skin popping”) is a method commonly 
employed by those just beginning to ex-
p e riment with drug injection (Inciard i 
et al., 1 9 9 1 ; Ka p l a n , 1 9 8 3 ) . Nov i c e s 
m ay incorre c t ly harbor the notion that 
d rug dependence as well as HIV tra n s-
m i s s i on cannot occur by this pra c t i c e . 
Beginners ra re ly have their own inject­
ing equipm e n t , so they fre q u e n t ly share 
another IDU’s syringe. 
Table 2.2: 
Factors in Sharing Injection Equipment 
Sharing drug equipment is a function of a number of 
interrelated factors, including: 
• demographic factors of users (e.g., age, gender, 
length of time using drugs, and drug treatment 
history) 
• the availability of drug injection equipment in the 
community 
• perception of the risk of arrest as a result of car­
rying injection equipment 
• perception of risk of infection from HIV and other 
infectious diseases 
• the settings in which injection occurs 
• membership in a network of injection drug users 
• the type of drug or drugs used 
• the frequency of injection 
Source: Normand et al.,1995 
1 .“ Shooting gall e ri e s ”a re defined and described later in this PA RT in the section entitled “ Social Contexts that Increase HI V 
R i s k . ” 
2. Research on the history of drug injection in New York City has indicated that there has been a large- scale decline in the 
direct sharing of contaminated needles. This has been associated with the use of syringe exchange programs and with the 
fact that many users have switched to “snorting” heroin (Des Jarlais et al., 1994). 
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Table 2.3:

I n d i rect Sharing Practices

HIV can be transmitted indirectly among injection drug users by use of previously blood-contami­
nated equipment in any of the following sharing practices. None of these practices involves direct 
re-use of a syringe for drug injection by another user. 
• “Backloading,” in which drug solution is transferred from one previously blood-conta­
minated syringe to another. In this case, the plunger is removed from the syringe into 
which the drug will be transferred. The drug mixture is then squirted into the back of the 
syringe. 
• “Frontloading,” in which the drug solution is transferred from one previously blood-
contaminated syringe to another by removing the needle on the syringe receiving the 
solution, and then squirting the drug into the syringe’s hub or barrel. This is now rela­
tively uncommon, since most insulin syringes used by IDUs do not have removable nee­
dles. 
• Squirting the drug solution from a previously blood-contaminated syringe into the 
drug mixing “cooker” or “spoon” and then drawing it into another syringe. 
• Using the plunger from a previously blood-contaminated syringe to mix the drug with 
water. 
Indirect sharing 
The risks of HIV exposure with indirect sharing arise from the processes of 
p re p a ring the drug for injection and dividing it among seve ral users. A fter pur­
chasing dru g s , one user in the group may use his or her syringe to draw up ri n s e 
water to mix with the drug. A plunger may be used to stir the solution as it heats, 
and the drug may be distributed by using the measurement markers on a syri n g e . 
Drug users are at risk of HIV transmission if the water or the syringe used for dis­
t ri b u t i on has been contaminated with HI V- i n fected blood. Table 2.3 shows the 
indirect sharing practices that may occur with injection drug use. 
M a ny IDUs are unaware of the risk of transmitting HIV through sharing pra c­
tices. In one study, only 7 percent of the IDUs interviewed were aware of the risks 
of indirect shari n g, even though more than 70 percent of the injectors observe d 
w e re curre n t ly inv o lved or had already participated in an AIDS interve n t i on 
(Koester et al., 1994). 
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Table 2.3: continued

• Drawing up the drug through a cotton filter that has been contaminated with 
HIV-infected blood. 
• Returning the drug solution from a previously blood-contaminated syringe to the 
shared cooker or directly to another syringe (this occurs when the user draws up more 
than his or her allotted share of the drug). 
• “ B e a t i n g ” a used cotton (or several cottons) to retrieve any drug remaining in the cotton. 
• “Kick out a taste” by putting a part of the drug/water solution from a previously 
blood-contaminated syringe back into the cooker or into another IDU’s syringe so that 
another or several other IDUs can get some of the drug. 
• Rinsing a used, blood-contaminated syringe in water that other IDUs also use to 
rinse their own syringes or to dissolve drugs. 
• Draw up the water for dissolving the drug by using another injectors used, inade­
quately disinfected syringe. 
Source:Koester et al.,1994. 
High-Risk Sexual Behavior Among IDUs 
Along with the knowledge of practices and risk behaviors related to drug injection, 
p reve n t i on planners and managers need to take into con s i d e ra t i on the sexual ri s k 
behaviors of drug users.These include unprotected anal, vaginal, or oral sex; multi­
ple part n e r s ; t rades of mon ey, d ru g s , and sex; and lack of treatment for STDs, e s­
pecially those with ulcerative lesions. 
Tra d i t i on a lly, most HIV preve n t i on efforts for IDUs have focused pri m a ri ly on 
l ow e ring risk of HIV tra n s m i s s i on by changing drug injection pra c t i c e s . Less at-
t e n t i on , h ow eve r, has been paid to low e ring the sexual risks of HIV tra n s m i s s i on 
a m ong IDUs . In one recent survey of IDUs , at least half re p o rted that they were 
not sure that con d oms are effe c t i ve in preventing sexual tra n s m i s s i on of HIV and 
less than on e - t h i rd re p o rted using con d oms (Rhodes et al., 1 9 9 0 ) . Seve ral studies 
h a ve found a strong corre l a t i on between IDUs ’ u n s a fe sexual behaviors and their 
risky injection practices, suggesting that IDUs who engage in one unsafe behavior 
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Water Filter 
Crack Pipe 
Figure 2.2: Typ i cal Eq u i p­
ment Used to Sm oke Cra ck 
a re more likely to engage in others (Sch i lling et al., 1 9 9 1 ; 
Vanichseni et al., 1993; Paone et al., 1995). All studies of risk 
re d u c t i on interve n t i ons for IDUs that com p a red changes in 
i n j e c t i on risk behavior with changes in sexual risk behavior 
found greater changes in injection risk behavior (Friedman et al., 
1 9 9 3 ) . Ove ra ll , c on d oms have been found to be used more 
c on s i s t e n t ly by IDUs in “ca s u a l” sexual re l a t i onships than in 
“p ri m a ry ” sexual re l a t i onships and with non-injecting sex part­
ners than with injecting sex partners (Friedman et al., 1994). 
Purchase, Preparation, 
and Use of Crack 
Powd e red coca i n e, w a t e r, and baking soda are heated, f o rm­
ing a waxy substance known as “c ra ck . ” C ra ck is ch e a p e r 
than other illicit dru g s , costing som ew h e re between $5 and 
$10 for a small bag of cra ck “ro ck s . ” Typ i ca lly, a simple glass 
pipe is filled with one or two “ro ck s ” and then lit. As the 
c ra ck melts, it vapori zes and makes a cra ckling sound. T h e 
user then inhales the vapor. A water pipe is often used to fil­
ter impurities and cool the hot vapor. Fi g u re 2.2 shows tw o 
types of pipes commonly used to smoke crack. 
The fact that crack is relatively inexpensive, easy to use, and easy to hide makes it 
e x t re m e ly popular. H ow eve r, c ra ck has to be used fre q u e n t ly and re p e a t e dly since 
its effects are short - l i ve d . As with other forms of coca i n e, users can quick ly be-
c ome cra ck - d e p e n d e n t . M a ny cra ck abusers use the substance again and again 
until their mon ey is gon e . C ra ck users may spend from $50-$500 during a thre e -
to four-day binge, known as a “mission,” in which they consume up to 50 rocks of 
crack each day. During these binges, crack users often do not eat or sleep. 
High-Risk Sexual Behavior Among Crack Users 
C ra ck use is associated with high-risk sexual activities as a result of the exch a n g e 
of sex for cra ck or mon ey to buy cra ck . The circumstances under which cra ck is 
purchased, prepared, and used can influence the level of these risks. When a crack 
user is dependent on sex exchange to purchase or use crack, for example, the level 
of risk for HIV infe c t i on increases significa n t ly. Data on the “intersecting epi­
demics” of crack and HIV are now emerging and help to shed light on these com-
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plex behaviors. Case Example 2.1 describes one recent study that explored this 
linkage in inner-city young adults. 
Crack use and the sexual risks of HIV transmission 
Considering cocaine’s inhibitory effect on sexual functioning, it is still not clear 
w hy there is such a close association between cra ck use and increased sexual activity. 
Some theories suggest that it is the disinhibiting effect of drug use or the compul­
sion to use crack that prompts the sexual activity. 
Case Example 2.1 
Intersecting Epidemics: Crack Use and 
Sexual Risks for HIV Infection 
Young adults ages 18-29 were recruited from inner-city neighborhoods in New York, 
Miami, and San Francisco. The study examined 1,967 participants who were regular 
smokers or non-smokers of crack cocaine but who had never injected drugs. Overall, 
15.7 percent of the crack smokers were positive for HIV antibodies, compared with 
5.2 percent of non-smokers. HIV prevalence was highest among women who used 
crack in New York (29.6 p e rcent) and Miami (23.0 percent). In San Francisco, sero­
prevalence was higher among male crack users, but still substantially lower than all 
East Coast users and non-users. 
Crack smokers of both sexes were more likely than non-smokers to re p o rt high-risk 
sexual practices and a history of STDs. Female crack users were 28 times more likely 
to have engaged in recent, unprotected sex than were non-users. Crack smoking 
appears to lead to the transmission of HIV through its association with high-risk sexu­
al practices. Women who use crack and engage in high-risk sexual practices were 
found to be at nearly equal risk to that of men who have sex with men. 
Edlin et al.,1994. 
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T h ree types of sexual exchanges are com m on ly associated with cra ck use (Ra t n e r, 1 9 9 3 ) : 
• Casual exchange: a sexual exchange among crack-using acquaintances within a 
social setting. 
• Sex-for-money-for-crack-exchange: a commercial exchange in which crack-u s i n g 
p rostitutes expect mon ey but will also accept cra ck for use during the sexual 
exchange or as a “bonus.” 
• Sex-for-crack-or-money-exchange: a sexual exchange made out of desperation by 
those whose lives are dominated by the compulsion to use crack. 
A ll three of these types of exchanges present risks of HIV tra n s m i s s i on , a l t h o u g h 
to varying degre e s .3 Since con d om use is ra re in these circ u m s t a n c e s , w omen are 
exposed to the potentially infectious semen of all their male partners, who in turn, 
are also exposed to the semen of the women’s previous male partners. In addition, 
men who abuse cra ck often have diffic u l ty ejaculating, w h i ch leads to pro l on g e d 
sexual intercourse and possible breaks and tears in the genital skin and mu c o s a l 
m e m b ranes (Ra t n e r, 1 9 9 3 ) . These breaks provide opportunities for exposure to 
p o t e n t i a lly infectious genital secre t i on s , b l o o d , and semen. C h ronic cra ck users 
also can burn their lips and tongue while using hot crack pipes, increasing the risk 
of HIV tra n s m i s s i on during oral sex, an activity fre q u e n t ly perf o rmed by both 
male and female crack users during sexual exchanges for crack or money. 
The com b i n a t i on of a strong com p u l s i on to use and the power imbalance that occurs 
during an exchange of sex for drugs or money presents many challenges to preven­
t i on planners and pro g ram managers who develop and conduct HIV preve n t i on 
p ro g rams for cra ck users. In part i c u l a r, p reve n t i on pro g rams need to be designed 
to reach women crack users who exchange sex for drugs. 
Social Contexts That Increase HIV Risk 
As discussed, s p e c i fic behaviors place drug users at risk for HIV infe c t i on . Howev­
e r, these behaviors occur b e tween people and often take place in d i f f ering settings 
and under differing social conditions. Drug use often takes place in small groups that 
meet in apart m e n t s , h om e s , or residential hotel ro om s . St i ll others use drugs at 
“party houses,” consisting of a variety of physical settings where individuals gather 
to use dru g s . Examining the settings and social netw o rks in which drug users in-
t e ract and influence each other can help pro g ram planners and managers under-
stand the social contexts that place drug users at high risk of HIV and can help 
them select and design more focused and effective HIV prevention interventions. 
3 . The section on women in “Impact of HIV Am ong Special Groups of Drug Us e r s , ” later in this PA RT, discusses this issue i n 
further detail. 
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Injection drug use settings 
Some drug-use social settings increase the potential for sharing con t a m i n a t e d 
e q u i pment or for practicing unsafe sex, and thus influence the risk of HIV tra n s-
m i s s i on . For example, one of the strongest predictors of HIV sero c onve r s i on 
among IDUs is injecting in outdoor settings or abandoned buildings (Friedman et 
a l , 1 9 9 5 ) . In c i t i e s , the most re c o g n i zed social settings where IDUs gather are 
“shooting gall e ri e s . ” Shooting gall e ri e s , also known as “s a fe houses” or “g e t - o f f 
houses,” can be situated in back rooms, basements, dark hallways, or empty rooms 
of abandoned buildings in sections of cities where drug use rates are high (Inciardi 
et al., 1993). 
Ne i g h b o rhood heroin and/or cocaine dealers may operate shooting gall e ries as a 
s e rvice to customers — providing users, at the cost of just a few doll a r s , with a nearby 
l o ca t i on to safe ly “s h o o t - u p. ” M o re oft e n , h ow eve r, g a ll e ry operators are dru g 
users who provide a service for a small fee or a “ t a s t e” (sample) of som e one else’s 
drugs. For a fee, IDUs rent a set of works and relax while “getting off.” After using 
the syringe and needle, the user generally returns them to a central storage place in 
the gall e ry where they are held until som e one else rents them. These works also 
m ay be passed to another user in the gall e ry, w h i ch may inv o lve an exchange of 
money, drugs, or sex (Inciardi et al., 1993). 
For many IDUs, the use of shooting galleries is commonplace. For users who have 
no works of their own or their friends or “running part n e r s ” h a ve no work s , t h e n 
g a ll e ries are their logical re c o u r s e . This is also true for those who purchase dru g s 
far from home. In addition, some IDUs prefer local galleries because of the oppor­
tunities they provide to socialize with other users. (Inciardi et al., 1993). 
Crack houses 
“ C ra ck houses” a re another drug use setting that poses a significant potential ri s k 
for HI V. C ra ck houses are places where users gather not on ly to purchase and 
s m oke cra ck , but also to exchange sex for cra ck or for mon ey to buy cra ck , or to 
provide money or drugs for sex (Inciardi et al., 1993). They may also be a place to 
m a n u f a c t u re or package cra ck . C ra ck houses can be located in private houses or 
a p a rt m e n t s , a b a n d oned ca r s , a vacant building, or a com m e rcial establishment. 
Depending on the geogra ph i cal re g i on , c ra ck houses are also known as “hit houses,” 
“smoke houses,” and “resorts.” 
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As with shooting galleries, some crack houses charge users admission fees. For ad-
d i t i onal fe e s , c ra ck houses may provide cra ck - s m oking equipm e n t , the cra ck itself 
as well as other dru g s , ro oms in which to have sex, and access to sex work e r s . 
Crack houses are more likely to be the scene of sex, stealing, bizarre behavior, beg­
ging and/or violence than are shooting gall e ri e s . Individuals who manage cra ck 
houses often re c ruit ch ronic cra ck users, p a rt i c u l a rly wom e n , to whom they pro-
vide c ra ck and sometimes food and shelter, in exchange for the women prov i d i n g 
s e x ual services to male customers (Ratner, 1993). 
Other settings 
Shooting gall e ries and cra ck houses are not the on ly settings where risky sexual 
p ractices and drug use are linked. For instance, the availability of drugs at social 
and recreational settings, such as bars, massage parlors, social clubs, or through es­
cort services also is frequently linked to risky sexual behavior. 
No matter what drugs are used, h ow eve r, the key com p onent to social settings is 
the number of drug users in the setting. When social settings bring together mul­
tiple individuals who then either inject drugs in a way that transfers HIV-infected 
blood among them, or have high-risk sex, HIV tra n s m i s s i on can more re a d i ly 
o c c u r. Although popular culture dra m a t i zes the risks of tra n s m i s s i on in shooting 
g a ll e ries and cra ck houses, a ny gathering of people who use dru g s , whether in an 
apartment or a street corner creates the risk of transmission. 
Social networks 
Social networks are characterized by groups of individuals who are linked by vari­
ous relationships and common bonds.These networks may comprise people whose 
common link may be friendship, kinship, short-term acquaintances, or anonymous 
re l a t i on s h i p s . Social netw o rks among drug users may vary, depending upon the 
type of drug used and how it is used, the size of the group, the degree in which the 
group is open to new members, the level of stability of the group, and the kind of 
social activity that occurs in the group (Needle et al., 1995). 
Types of social networks. Networks generally have been characterized as “open” 
or “closed” systems (Trotter et al., 1995). In “closed networks,” drug use takes place 
in private residences mainly among individuals who know one another. In these 
kinds of netw o rk s , it is uncom m on for users to cross social, c u l t u ra l , e c on omic or 
g e o g ra phic boundari e s , t h e reby keeping HIV tra n s m i s s i on re l a t i ve ly con fin e d 
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within the netw o rk . “Kinship netw o rk s ” a re one type of netw o rk where members 
have close kinship or family-based ties. 
In “open netw o rk s , ” HIV may be more easily spread to a greater pool of individuals 
since the boundaries are not as tight as those in closed netw o rk s . Case Example 2 . 2 
d e s c ribes a type of open netw o rk , ca lled an “acquaintance netw o rk , ” in which memb e r 
t u rn over is frequent and multiple drug and sex exchanges occur on a regular basis. 
Case Example 2.2

Social network webs. Large netw o rks often are composed of smaller “w e b s ” o f 
individuals who may engage in risky drug use and sexual behavior (Trotter et al., 
1 9 9 5 ) . Some of these webs are con s i d e red “HIV risk contact netw o rk s ” w h o s e 
members are at high risk of HIV infe c t i on because of the extent and nature of 
their con n e c t i ons with HI V- p o s i t i ve people in their own web or in con n e c t i n g 
w e b s . If the personal netw o rks of HI V- p o s i t i ve individuals are small and are not 
connected to larger webs where there are more interactions, the risk of HIV trans-
mission may be less pronounced. 
Fa m i l i a ri ty with existing social netw o rks within a com mu n i ty can help determ i n e 
the most effe c t i ve channels of com mu n i ca t i on among netw o rk members. For ex-
ample, it may be useful to identify the key “gatekeepers” or “brokers” within a net-
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w o rk , who act as the main link to the netw o rk ’s membership. I n t e rve n t i ons de-
signed to re a ch netw o rk gatekeepers can help alter risk behaviors within the net-
work (Friedman, 1995). 
Impact of HIV Among Special Groups 
of Drug Users 
As shown in the previous section, a user’s drug practices and sexual behaviors, and 
the social context in which he or she uses drugs can all significantly influence that 
p e r s on’s HIV ri s k . In addition , these practices and behaviors appear to be part ly 
dependent on the drug users membership in one or more specific groups in which 
HIV risk is magnifie d . These groups are : w omen who are drug users, p a rtners of 
d rug users, or who trade sex; men who have sex with men and bisexual men; t h e 
mentally ill; the homeless; and incarcerated and paroled individuals. 
Studies conducted on the prevalence of HIV among drug users highlight the im­
portance of directing prevention efforts to these special groups. For example, a re-
cent report by the Institute of Medicine cites studies showing that HIV prevalence 
is higher among IDUs who are minority, female, and under 30 years old than that 
a m ong other population groups (Friedman et al., 1 9 8 7 ; No rmand et al., 1 9 9 5 ; 
S choenbaum et al., 1 9 8 9 ) . By taking a close look at these special groups and the 
c i rcumstances that place members at high ri s k , p ro g ram planners and managers 
will be able to select and design more relevant and effective HIV prevention inter­
ventions. 
Women 
Data from a number of sources suggest that women should be a population of par­
ticular concern. For example, AIDS surveillance data show that an increasing pro­
p o rt i on of AIDS cases is being diagnosed among wom e n . HIV sero p rev a l e n c e 
studies complement these data by showing the increasing prevalence of HIV in­
fe c t i on in seve ral subsets of women in part i c u l a r. These include minori ty wom e n 
and women who are at risk for HIV infe c t i on because of their own drug use or 
that of their partners (No rmand et al., 1 9 9 5 ) . R e s e a rch is on ly just beginning to 
help preve n t i on planners understand the unique needs of these women and the 
circumstances that lead to their being at risk for HIV infection. 
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Women who inject drugs 
Although the estimated ratio of male to female IDUs is 3 to 1, it is important to 
note that female IDUs face special ri s k s . One study, w h i ch examined a sample of 
w omen in drug tre a t m e n t , s h owed that these women had a faster tra n s i t i on from 
drug use initiation to abuse and dependence and greater severity of dependence as 
compared to their male counterparts (Anglin et al., 1987; Hser et al., 1987). Other 
re s e a rch shows that female IDUs are more likely than their male counterp a rts to 
engage in high-risk sex with multiple partners for mon ey or dru g s , s h a re needl e s , 
and have unprotected sex with an IDU partner (Hartel, 1994). 
The substance abuse litera t u re has shown that there are diffe ring experiences for 
men and women in the drug culture (Reed, 1 9 8 5 ; Pa on e, 1 9 9 5 ) . For example, 
compared with male IDUs, female IDUs are less likely to have social support net-
w o rk s , w h i ch have been shown to be pro t e c t i ve (Reed,1985; Fi n k e l s t e i n , 1 9 9 4 ) . 
Women appear to experience a heightened level of stigma associated with dru g 
u s e, w h i ch , when intern a l i ze d , o ften produces feelings of shame and guilt (Reed, 
1985). Their social support system, which traditionally places a heavy focus on at-
t a chment and affil i a t i on with others, is often damaged by drug use because such 
use is genera lly accompanied by social isolation (Fi n k e l s t e i n , 1 9 9 4 ) . One re c e n t 
study found that the pro t e c t i ve behaviors practiced by disenfra n chised wom e n 
w e re dependent on their level of self-esteem and the degree to which they per-
c e i ved life as con t ro llable and meaningful (Nyamathi et al., 1 9 9 4 ) . H ow eve r, t h e 
social env i ronments in which female IDUs live often do not con t ribute to their 
self-esteem or feelings of power in their surro u n d i n g s . High rates of unemploy­
m e n t , unstable housing, and homelessness are com m on among these wom e n . 
Some female injectors also experience phys i cal and sexual abuse, ch a ra c t e ri zed by 
drug-related violence and illegal activities (Worth et al.,1989). 
For seve ral re a s on s , sexual tra n s m i s s i on of HIV from IDUs to their sex part n e r s 
m ay present a greater risk for women than for men. Although both male and fe­
male IDUs are likely to have IDU part n e r s , this possibility is part i c u l a rly high 
among women (Mandell et al., 1994). One study showed that 75 to 90 percent of 
female IDUs have a male injection - d rug-using part n e r, c om p a red with 20 to 50 
percent of male users who have female drug-using partners (Donoghoe, 1992). 
Female IDUs who are sex partners of male IDUs also use sex as a way to obtain 
drugs (Donoghoe, 1992). According to one study, approximately 25 percent of fe­
male IDUs trade sex for either mon ey or drugs (Sa xon et al.1991). The risk of 
HIV infe c t i on is increased when they also share needles with their sex part n e r s . 
I n j e c t i on - d rug-using women may be less likely to use con d oms with their sex 
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partners than non-injecting women who have IDU sex partners (Cohen, 1991). In 
addition, the use of condoms by female IDUs with sex partners varies according to 
the type of sex partner (ca s u a l , p ri m a ry, p a rtners with which the IDU exch a n g e s 
m on ey or dru g s ) . Am ong women participating in needle exchange pro g ra m s , 6 0 
percent who exchanged sex for money or drugs, 50 percent who had sex with casu­
al part n e r s , and 32 percent who had sex with pri m a ry partners re p o rted “a lw ays ” 
using a condom (Paone et al.,1995). 
R e s e a rch has shown also that a strong predictor for HIV sero c onve r s i on amon g 
female IDUs is engaging in wom a n - t o - w oman sex. It is likely that the re a s on for 
high sero c onve r s i on rates for these female IDUs is that the people with whom 
t h ey inject drugs are more likely than other IDUs to be infe c t e d . Female IDUs 
who have sex with women are more likely than other female IDUs to share nee­
dles or syringes with male IDUs who have sex with men (Friedman et al., 1995). 
Female sex partners of IDUs 
Ac c o rding to the Na t i onal Research Council, female sex partners of IDUs have 
been difficult to study and re a ch with preve n t i on pro g rams (Miller et al., 1 9 9 0 ) . 
These women are often difficult to identify, since they ra re ly belong to any unify­
ing social group and may have very unstable living conditions. 
Many female partners of IDUs may not be aware of their partner’s injection prac­
tices or may be unw i lling or unable to ack n owledge this behavior. Women may 
fear the confrontation that might occur if drug use practices are openly addressed. 
Without re c o g n i t i on or ack n owledgment of their part n e r s ’ risky pra c t i c e s , t h e s e 
w omen may perc e i ve their risk as unre a l i s t i ca lly low and have little re a s on or op­
portunity to use condoms. 
Female crack users 
The association between cra ck use and HIV infe c t i on is significa n t ly stron g e r 
a m ong women than among men (Edlin et al., 1 9 9 4 ) . Women who smoke cra ck 
f re q u e n t ly engage in sex work and often have a history of genital ulcer disease, 
making them more vulnerable to the acquisition or tra n s m i s s i on of HI V. Fe m a l e 
c ra ck users who exchange sex for drugs or mon ey to buy drugs also may not be 
able to negotiate con d om use with their sex part n e r s . Females who smoke cra ck 
and barter sex genera lly have degrading sexual experiences in which they are the 
s u b o rdinate partner and subject to abuse (Ra t n e r, 1 9 9 3 ) . HIV preve n t i on pro-
grams for these women must take into account this social dynamic. 
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Female sex workers 
A study of 1,396 female sex workers in six U.S. cities found an HIV sero p rev a­
lence of 12 percent, ranging from zero to nearly 50 percent, depending on the city 
and the level of injection drug use (CDC, 1987). Street sex workers are likely to be 
dependent on drugs and alcohol and there f o re more vulnerable to HIV infe c t i on 
( A l e x a n d e r, 1 9 9 2 ) . M a ny are poor or homeless and have a history of child abuse. 
Female injection drug users who trade sex for mon ey or drugs are more likely to 
share needles than female injectors who do not engage in sex trading, and are less 
likely to use new needles or to clean old ones (Kail et al., 1995). 
The circumstances of subordination and powerlessness in which many sex workers 
l i ve increase their vulnera b i l i ty to HIV infe c t i on . For example, if business is slow, 
if they are desperate for money to buy drugs, or if a client offers substantial money, 
a sex worker may agree to unprotected sex. Violent clients may force unsafe sex. In 
m a ny cities, police con fis cate con d oms when they arrest or stop sex work e r s , a n d 
they may have difficulty getting replacements. (CAPS, 1996). 
Regardless of whether a female drug user is an injector or non-injector, a sex trader 
or com m e rcial sex work e r, the power imbalance they may experience with men 
may make it difficult for women to change their sexual behaviors. Prevention plan­
ners and pro g ram managers should be sensitive to the unique issues experi e n c e d 
by such women and support and develop pro g rams that adequately address the 
multiple obstacles faced by women at risk for HIV infection. 
Men Who Have Sex with Men (MSM) 
and Bisexual Men 
Relatively little HIV/AIDS research has focused on male IDUs who have sex with 
men or who are bisexual. AIDS case data indicate that men in this dual risk group 
a re at substantially increased risk for AIDS com p a red with those re p o rting either 
risk behavior alon e . Ac c o rding to CDC this subpopulation of IDUs com p rises 6 
p e rcent of all AIDS ca s e s , 10 percent of AIDS cases occurring in MSM, and 21 
p e rcent of AIDS cases occurring in IDUs (CDC , 1 9 9 6 ) . One analysis of MSM 
and bisexual men participating in the San Francisco Men’s Health Study found 
that this subpopulation was more likely to report high-risk sexual activity at study 
e n t ry than were non-IDU MSM and bisexual men (St a ll et al., 1 9 8 9 ) . An o t h e r 
s t u d y, w h i ch looked at male sex workers in San Fra n c i s c o, s h ows the significa n t 
risk for these men by documenting high rates of injection and needle shari n g 
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a m ong hustlers and ca ll men in com munal settings such as shooting gall e ries and 
sex clubs (Wa l d o rf, 1 9 9 4 ) . In addition , the increased use by MSM IDUs of 
methamphetamine, which induce heightened sexual needs, has increased their risk 
for HIV through both needle sharing and high-risk sexual behavior. 
The Homeless and Mentally Ill 
T h e re are significant ove rlaps among ch ronic mental ill n e s s , substance abuse, u n-
safe sexual behavior, and homelessness. For example, surveys and exploratory stud­
ies of dru g - related behavior con s i s t e n t ly indicate that the prevalence of injection 
d rug use increases as housing becomes more unstable (NIDA , 1 9 9 0 ) . As many as 
30 percent of homeless adults may be substance abusers (Schutt et al., 1 9 9 2 ) . R e-
ported rates of alcohol problems average 50 percent, with evidence that homeless, 
a l c ohol-dependent adults display more seve re forms of alcoholism (Fi s cher et al., 
1991; Schutt et al., 1992). 
Overall, homeless adults have higher rates of HIV seroprevalence than do the gen­
eral population. This is especially true in areas of high HIV prevalence. Data from 
two New Yo rk City psych i a t ric hospitals found about a five percent sero p o s i t i v i ty 
rate among hom e l e s s , m e n t a lly ill patients, c om p a red with a rate for the genera l 
p o p u l a t i on in New Yo rk City of less than three percent (Cournos et al., 1 9 9 1 ) . 
One sample of non-hospitalized homeless psychiatric patients in a New York City 
homeless shelter for males showed that almost one-fifth were HIV positive (Suss­
er et al., 1 9 9 3 ) . In Miami, 9.8 percent to 14.3 percent of homeless persons enter­
ing clinics were seropositive (Greer et al., 1989). 
A survey of homeless adults entering a store f ront medical clinic found that ove r 
tw o - t h i rds were at risk for HIV infe c t i on from various sourc e s , i n cluding unpro­
tected sex with multiple part n e r s , i n j e c t i on drug use, sex with an IDU part n e r, o r 
e xchanges of unprotected sex for mon ey or dru g s . Almost half re p o rted at least 
two risk factors combined, and one-fourth reported three or more risk factors (St. 
La wrence et al., 1 9 9 5 ) . A l ong with facing multiple risks for HI V, m a ny hom e l e s s 
people find it hard to form safe and stable intimate re l a t i onships because of their 
d rug use, mental ill n e s s , v i o l e n c e, or transient living situation s . For example, a 
study of homeless women found that almost all had been exposed to battery, a n d 
over half to rape. (Fisher et al., 1995). 
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Incarcerated Persons and Parolees 
Drug offenses account for the single largest number of fe d e ral crimes for which 
people are inca rc e rated (Po l on s k y, 1 9 9 4 ) . In 1991, almost 80 percent of state 
p ri s on inmates re p o rted using illicit drugs at some time (DO J, 1 9 9 3 ) . High ra t e s 
of HIV infection occur in this population, with female inmates, inmates age 25 or 
yo u n g e r, and Afri can Am e ri can and Hispanic inmates having the highest rates of 
i n fe c t i on (Po l on s k y, 1 9 9 4 ) . As re p o rted by the Na t i onal Institute of Justice in 
1 9 9 4 , the AIDS incidence rate for people in corre c t i onal facilities (aggre g a t e d 
a c ross all facilities) was 518 per 100,000, up from 392 per 100,000 in 1992-93, a s 
c om p a red to 41 per 100,000 in the general population of the U.S. ( DO J, 1 9 9 4 ) . 
Additional data show that the overall rate of confirmed AIDS among the nation’s 
prison population (0.52 percent) was more than seven times the rate in the general 
p o p u l a t i on (0.07 percent) (DO J, 1 9 9 6 ) . In 1991, on ly one percent of fe d e ral in-
mates who had moderate to seve re drug abuse problems had re c e i ved appro p ri a t e 
t re a t m e n t ; for those who did complete tre a t m e n t , t h e re were no aft e rca re serv i c e s 
in place to help them remain dru g - f ree when re e n t e ring the com mu n i ty (U.S. 
House of Representatives, 1991). HIV prevention planners and program managers 
need to work with the judicial and correctional systems, including the drug courts 
that exist in some cities, to support and plan programs for HIV risk reduction and 
drug-free living for paroled and released inmates and for correctional staff. 
Determining the Extent of HIV 
Infection Among Drug Users 
Thus far, PA RT 2 has given an ove rv i ew of drug-using pra c t i c e s , the high-ri s k 
sexual behaviors of drug users, and the social context of drug use. It also has dis­
cussed several specific population groups who are heavily affected by the HIV epi­
d e m i c . This provides important back g round for HIV preve n t i on planners and 
p ro g ram managers, who will be pri o ri t i z i n g, d e s i g n i n g, and implementing HI V 
prevention programs in their communities. 
With this back g round in mind, one of the first things that preve n t i on planners 
and pro g ram managers will need to do when developing an interve n t i on pro g ra m 
is to develop a profile of the extent of HIV infection among the drug users in their 
c om mu n i ty. Some of the data needed to develop such a pro file can be obtained 
f rom HIV/AIDS surve i llance and re p o rting sys t e m s . These data, w h i ch are avail-
able to local planners and pro g ram managers through their health depart m e n t s , 
p rovide inform a t i on on the number and ch a ra c t e ristics of persons diagnosed with 
AIDS or re c e n t ly infected with HI V, and about the mode of exposure to HI V. 
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Table 2.4: Key Data Sources for 
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Local drug use surveillance











Hepatitis B and hepatitis C surveillance

Note: For more information,consult CDC’s Suggested 
Guidelines for Developing an Epidemiologic P rofile for 
HIV Prevention Community Planning and Chapter 4 of 
the Handbook for HIV Prevention Community Planning. 
(For ordering information,see Part 5: RESOURCES.) 
This inform a t i on will help to incre a s e 
the understanding of the extent of drug 
use among persons infected with HI V 
as well as the patterns of drug use and 
HIV risk in certain parts of the U.S. 
State and local health departments have 
epidemiologists on staff who can help 
planning groups and pro g ram mana­
gers understand these data and their 
strengths and limitations. Table 2.4 lists 
s ome major data sourc e s , a number of 
which are discussed on the page 2-23. 
In addition , t h e re are other sources of 
l o cal data that may be useful to planners. 
Some of these sources have been des i g n e d 
to supplement national HI V / A I D S sur­
ve i llance data, and provide inform ation on 
the scope of the epidemic attri b u table t o 
injection drug use. For example, seve ra l 
l o cal HIV/AIDS surve i llance pro g ra m s 
and a number of special studies have 
begun to re p o rt data on the association 
b e tween HIV exposure and the use of 
n on - i n j e c t i on dru g s , s u ch as cra ck 
(Chirgwin et al., 1 9 9 1 ; C h i a s s on et al., 
1 9 9 1 ; Diaz et al., 1 9 9 3 ; Diaz et al., 
1 9 9 4 ; E dlin et al., 1 9 9 4 ; E ll e rb ro ck et 
al., 1995; Sugarman et al., 1995). 
Sources of Data 
Fo ll owing are brief descri p t i ons of spe­
c i fic sources of nation a l , s t a t e, and loca l 
data that may be useful to planning 
g roups and pro g ram managers as they 
c ome to understand the HIV and dru g 
use pro file of their com munities and 
as they pre p a re to select and develop 
i n t e rve n t i on s . D e fin i t i ons of key term i­
nology can be found in Exhibit E. 
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AIDS surveillance 
Almost all persons with AIDS who re c e i ve medical attention are re p o rted to the 
n a t i onal AIDS surve i llance sys t e m , making these data re p re s e n t a t i ve of person s 
with AIDS. Of all AIDS cases re p o rted to CDC in 1995, just over 35 percent were 
associated with injection - d rug use (CDC , 1 9 9 6 ) . Am ong those with IDU-associated 
AIDS, just over half were heterosexual males, 20 percent were female, and 13 per-
cent were men who have sex with men. The rest were male and female hetero s e x u a l 
p a rtners of IDUs (11 perc e n t ) , and ch i l d ren whose mothers were either IDUs or 
sex partners of IDUs (1 percent). Because of the completeness and representative­
ness of AIDS surveillance data, emerging trends in characteristics of HIV-infected 
p e r s ons can be detected by analysis of AIDS case surve i llance data. H ow eve r, b e-
cause AIDS surve i llance re p resents those persons with advanced HIV disease, 
early detection of trends among subgroups may not be possible. Also, surveillance 
of AIDS cases may fail to detect cases in some subgroups, such as lesbians, because 
questions about sexual orientation among females may not be asked or answered. 
HIV-infection surveillance 
As of November 1996, confidential HIV infection reporting for adults and adoles­
cents by name is re q u i red by 26 states and for ch i l d ren by 29 states. HIV re p o rting is 
an adjunct to AIDS surveillance. HIV-reporting data provide a minimum estimate 
of the number of persons known to be infected with HIV in states with confiden­
tial HIV infe c t i on re p o rt i n g. These data may be used to anticipate trends amon g 
particular groups, such as adolescents. 
These data are representative only of HIV-infected persons who are confidentially 
tested for HIV in the states where HIV re p o rting is re q u i re d . HI V- i n fe c t i on re-
p o rting data are not re p re s e n t a t i ve of HI V- i n fected persons who have not been 
t e s t e d , who have been tested anonym o u s ly, or who live in states or terri t o ri e s 
where HIV reporting is not required. 
Clinic-based seroprevalence surveys 
Clinic-based data compiled by CDC provide important inform a t i on about HI V 
seroprevalence among injection drug users.These data also provide a valuable win-
d ow on the drug-use practices in local areas and how these practices differ from 
a rea to are a . For example, s e ro p revalence surveys conducted in local drug tre a t­
ment centers (DTCs) over the past seve ral years provide inform a t i on on person s 
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Anonymous HIV testing	 HIV test conducted without identifiers so that a person’s name cannot be linked 
with a test result. 
Confidential HIV testing	 HIV test linked to a person’s name, which is kept confidential under state/local 
laws assuring confidentiality to prevent potential for disclosure or discrimination 
and to protect the patient’s rights to privacy. 
Incidence	 The number of new cases of a disease or condition that occur in a specified pop­
ulation during a specified period of time. Often incidence is expressed annually, 
e.g., the number of AIDS cases diagnosed in the United States in 1995. HIV inci­
dence is the best measure of the need for, and the effectiveness of, primary pre­
vention programs. Incidence studies measure ongoing HIV transmission, and 
thus the current dynamics of the HIV epidemic. However, they are complicated to 
conduct and require that persons be tested repeatedly to determine if and when 
they become infected. Incidence studies are not practical, nor would they be 
widely acceptable, in most locations. 
Incidence rate	 The number of new cases that occur in a specified population during a specified 
period of time divided by the population at risk; often expressed as annual inci­
dence per 100,000 population. 
Prevalence	 The number of persons in a specified population living with a disease or condi­
tion at a specific time. Estimates of HIV prevalence allow planners to identify the 
populations from which future AIDS cases will arise. HIV prevalence estimates 
provide a more complete picture of the magnitude of the HIV epidemic than 
does the prevalence of AIDS, which represents only those persons with 
advanced HIV disease, or than do HIV infection reporting data, which represent 
only those persons who choose to be confidentially tested for HIV. 
Prevalence ratio	 The number of persons in a specified population living with a disease or condi­
tion at a specific point in or period of time divided by the population at risk, 
sometimes expressed as a percentage. 
Serologic Pertaining to the serum, the clear portion of the blood. 
Seroprevalence	 The number of persons in a specified population who have serologic evidence of 
a disease at a specific point in or period of time. 
Serosurveillance	 Ongoing, systematic collection, analysis, interpretation, and timely dissemination 
of serologic data. The Survey of Childbearing Women, which measures the sero­
prevalence of HIV infection among women giving birth to live-born infants by 
testing infants for maternal antibody to HIV, is an example of serosurveillance. 
Surveillance 	 The ongoing, systematic collection, analysis, interpretation, and timely dissemi­
nation of outcome-specific data for purposes of prevention and control of dis­
ease. Example include surveillance for AIDS, viral hepatitis, salmonellosis, and 
tuberculosis. 
NOTE : Please see Appendix C: G LO S S A RY, for definitions of m o re HIV/AIDS-rel a ted terms used in this book . 
who enter participating DTCs and who re p o rt injecting illicit drugs during the 
previous year (CDC, 1994a). Seroprevalence among IDUs entering DTCs was the 
s e c ond highest of any group surveyed in CDC’s Na t i onal Se ro s u rve i llance Pro-
g ra m . In 1991-1992, the HIV sero p revalence among IDUs ranged by DTC from 
less than one percent to more than 50 percent. 
From 1991 through 1992, 39 STD clinics in which sero p revalence surveys were 
c onducted re p o rted at least 50 injection drug users (the minimum number re-
q u i red for calculating sero p rev a l e n c e ) . Median sero p revalence among injection 
drug users attending these STD clinics was around six percent. A number of find­
ings from the surveys of these DTCs (CDC , 1994b) show how data from a na­
t i onal re p o rting system can be used to plan, d e s i g n , and implement interve n t i on s 
that are appropriate to local communities: 
Geographic diff e rences. HIV sero p revalence among IDUs differs dra m a t i ca lly 
a c c o rding to loca t i on . D TCs in metropolitan areas along the Atlantic Coast and 
Pu e rto Rico showed the highest median HIV sero p rev a l e n c e, ranging from just 
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under 5 percent to around 40 perc e n t . The median HIV sero p revalence in DTC s 
in the Midwest ranged from 3 percent to 17 percent, and from less than 1 percent 
to around 7 percent in the West. Figure 2.3 displays the HIV prevalence reported 
in 34 metropolitan areas among IDUs entering DTCs (CDC, 1994a). 
Although the re a s ons for these geogra phic diffe rences are unknow n , s eve ral plau­
sible hypotheses have been advanced. Fi r s t , i n j e c t i on drug use (and the potential 
for HIV tra n s m i s s i on) will occur most fre q u e n t ly near channels of drug distri b u-
t i on . Se c on d , like gon o r rhea and syph i l i s , the dru g - related tra n s m i s s i on of HI V 
may be a “core group” phenomena whereby the occurrence of “a disease is clustered 
g e o g ra ph i ca lly and sociodemogra ph i ca lly in distinct population subgro u p s . T h e 
extent to which those in the core group have sexual [or injecting] partners outside 
the group determines STD [or HIV] distribution” (Marx 1991, p.93).4 
Fi n a lly, it has been suggested that the mode of tra n s m i s s i on influences geogra ph i c 
d i s t ri b u t i on of HIV prev a l e n c e . The fact that some MSM have tra veled widely and 
l i ve all around the country accounts for the geogra phic similari ty of HIV prev a l e n c e 
in the homosexual population . On the other hand, the fact that IDUs are less 
m obile and tend to stay in certain parts of the country might account for the 
g e og ra phic diffe rences among HIV prevalence in this population (Hu et al., 1 9 9 4 ) . 
Racial and ethnic differences. In all geographic regions, the median HIV sero­
p revalence by DTC was substantially higher among Afri can Am e ri cans than 
a m ong whites. HIV sero p revalence was genera lly higher among Hispanics than 
a m ong whites, a diffe rence largely due to the higher sero p revalence among His-
panics in the Northeast. 
Gender diff e rences. Evidence from the DTCs showed that sero p revalence ra t e s 
among men and women were generally similar. In a different seroprevalence study 
c onducted from 1988 to 1993, h ow eve r, s e ro p revalence was similar among men 
and women except in the So u t h , w h e re the sero p revalence among women was al­
most twice that among men (Prevots et al., 1996). 
HIV sero p revalence among IDUs entering DTCs increased before 1989 and has 
s t a b i l i ze d , although marked geogra phic vari a t i ons remain (CDC , 1 9 9 4 a ) . Prev o t s 
et al. support these findings, and suggest that, based on “estimates of historical in-
4 .C o re gro u p s , also known as “social netw o rk s , ”w e re discussed in more detail in the section on “ Social Contexts that Increase 
HIV Risk” p rev i o u s ly in PA RT 2, and are also discussed in PA RT 3: S OCIAL AND BEH AV I O RAL INTERV EN TI O N S, 
in the section on “Interventions Using the Social-Level Approach to Behavior Change.” 
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fe c t i on rates...the peak years of HIV incidence among injection drug users in the 
United States were 1983-1986” (Prevots et al., 1996, p.739). 
B e cause IDUs entering DTCs may not be re p re s e n t a t i ve of all IDUs , these data 
should be interpreted with caution, and other sources of information used, such as 
studies conducted among stre e t - re c ruited IDUs (Deren et al., 1 9 9 5 ; Friedman et 
a l . , 1 9 9 5 ) . Non e t h e l e s s , D TC sero p revalence data interp reted along with data on HI V 
s e ro p revalence among IDUs attending STD clinics may provide a more c om p l e t e 
picture of the potential for HIV acquisition or transmission in a given community. 
Supplement to HIV/AIDS Surveillance 
C DC coll a b o rates with 11 state and local health departments in a project ca ll e d 
the Supplement to HIV/AIDS Su rve i llance (SHAS). The data generated from 
this project are important because they represent localized drug use that is specifi­
ca lly related to HIV sero p o s i t i v i ty in that com mu n i ty. These data also are impor­
tant because they include inform a t i on on non - i n j e c t i on drug use. Other state and 
l o cal health departments may want to explore how they can develop loca lly re l e­
vant data sources in collaboration with the CDC/SHAS process.5 
In the SHAS pro j e c t , i n t e rv i ew data are collected from a cross section of person s 
aged 18 years or older with AIDS (or HIV infection in HIV-reporting states) who 
a re medica lly able to complete interv i ew s . Am ong 1,142 persons re p o rted with 
HIV infection or AIDS who also reported injection drug use, 71 percent reported 
injecting more than one dru g. Ove ra ll , 35 percent of IDUs interv i ewed re p o rt e d 
c o caine as their pri m a ry drug injected, f o ll owed by heroin (28 perc e n t ) , s p e e d b a ll 
(17 perc e n t ) , and amphetamines (16 perc e n t ) . The pri m a ry drug injected vari e d 
n o t a b ly by state or city of residence (see Table 2.5). For example, h e roin was re-
ported as the primary drug injected by nearly all IDUs interviewed in Detroit and 
by almost half of IDUs interviewed in Connecticut, but by one-quarter or fewer of 
I D Us interv i ewed in all other are a s . (Diaz et al., 1994).SHAS data suggest that, 
ove ra ll , c o caine has been the most popular drug for injection among IDUs with 
HIV/AIDS, and that cocaine also has been positively associated with the practice 
of needle sharing (Diaz et al., 1994; Mandell et al., 1994). 
SHAS data also suggest that some IDUs may serve as a bridge between the inject­
ing com mu n i ty, in which the prevalence of HIV infe c t i on is high, and the cra ck -
using com mu n i ty, in which the prevalence of high-risk sexual behavior is high 
5 . The CDC section of PA RT 5: RES O U RC ES ,p rovides inform a t i on on how to explore ways of developing loca lly relevant 
data sources in collaboration with the CDC/SHAS process. 
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Table 2.5: Primary Drug Injected by Persons With HIV/AIDS 
Who Have Ever Injected Drugs, by State or City of Residencea 
DRUG TYPE, % 
No. Cocaine Heroin Speedball Amphetamine Other b 
Florida 263 37 11c 46c 3c 3 
Denver 157 46 19 2c 31c 3 
Detroit 145 1c 94c 4c 1 1 
Atlanta 119 56c 20 9 9 5 
Arizona 112 44 15 9 25 7 
Los Angeles 90 25 25 14 23 13c 
Connecticut 89 30 48c 22 0 0 
Washington 85 24 12 4c 56c 3 
South Carolina 42 64 12 10 14 0 
Delaware 40 55 23 12 8 3 
Total sample 1142 35 28 17 16 3 
Note. Percentages are based on row totals. 
aExcludes New Mexico because only five persons interviewed reported injection drug use;these five persons are 
similarly excluded from the total. 
bIncludes PCP/LSD, barbiturates,steroids,and other nonspecific or unknown drugs. 
cP < .oo5 based on multiple (10) comparisons with the average proportion of persons injecting a specified drug. 
Source: Diaz et al., 1994 
* This table is reprinted with the permission of the American Journal of Public Health, copyright 1994. 
(Diaz et al., 1 9 9 4 ) . In Houston and Dayt on / C o l u m b u s , O h i o, 75 percent and 70 
p e rcent of IDUs , re s p e c t i ve ly, s m oked cra ck in addition to injecting dru g s 
(Williams et al., 1995). 
Other sources of data 
Additional data about the drug-using population may be available from local drug 
t reatment and mental health pro fe s s i onals and STD cl i n i c s , as well as from loca l 
s u rveys of drug use and risk behavior funded by a range of fe d e ral agencies, i n-
6. More information on these and other local sources of drug use and risk behavior, such as the SHAS project, the 
Behavioral Risk Factor Surveillance System, or the Youth Risk Behavior Surveillance System, can be found in CDC’s 
Suggested Guidelines for Developing an Epidemiologic Profile for HIV Prevention Community Planning and the 
Handbook for HIV Prevention Community Planning. Information on how to obtain both of these documents can be 
found in PART 5: RESOURCES. 
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cluding CDC , the Na t i onal Institute on Drug Abuse (NIDA ) , and the Na t i on a l 
Institute on Mental Health (NIMH).6 Since the drug-using population relies on 
the mental health and drug treatment system for serv i c e s , re p re s e n t a t i ves from 
l o cal agencies providing these services can con t ribute mu ch to local preve n t i on 
planning and pro g ram deve l o pm e n t . Drug treatment and STD clinics offer op­
portunities to collect data as well as to provide HIV and STD prevention services 
to the drug user. With proper assurances of pro t e c t i on of con fid e n t i a l i ty, h e a l t h 
professionals can work together to identify populations vulnerable to infection, fa­
cilitate contact with, and provide cross referral for those populations.7 
It should be noted, h ow eve r, that the availability of agency data for preve n t i on 
planners may vary considerably, based on reporting requirements and staff capacity 
to summari ze these data in an aggregate way. Although data may be available, f o r 
e x a m p l e, on the percentage of drug users in an agency’s funded pro g ra m s , t h e re 
m ay not be data on the types of drugs used by this population . A l t e rn i t a ve ly, d a t a 
m ay be available from a mental health service agency on the percentage of 
clients/patients who are dual-diagnosed (e.g. , mental illness and ch e m i cal depen­
d e n cy ) , but not be available on how many of these clients/patients are hom e l e s s . 
When certain data a re not available for planning purp o s e s , it is best to con d u c t 
s t ru c t u red interv i ews with a re p re s e n t a t i ve sample of re l evant pro fe s s i on a l 
providers to retrieve the information. 
Surrogate markers 
Su r rogate markers of HIV risk behavior can be another valuable indicator of the 
potential for HIV tra n s m i s s i on within a com mu n i ty. One example of a surro g a t e 
m a rker is teenage pre g n a n cy ra t e s , w h i ch indicate unprotected sexual interc o u r s e 
and, therefore, HIV risk behavior. Another marker is rates of sexually transmitted 
diseases (STDs) acquired through unprotected sexual intercourse. Because sexually 
transmitted disease rates are a reliable indicator of high-risk behavior, groups with 
high rates of STDs are at increased risk for the spread of HIV infection once it has 
been introduced into the group. 
Rates of infection with hepatitis B virus (HBV) and hepatitis C virus (HCV) may 
s ometimes be used as surrogate markers because HIV can be transmitted by the 
same drug injection practices that transmit HBV and HCV. Like HI V, these in-
7. PART 4: PUBLIC POLICY ISSUES discusses in more detail issues surrounding the preservation of confidentiality for 
drug users. 
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fe c t i ons also can be transmitted sexually and peri n a t a lly. B e cause the incidence of 
H BV, and pro b a b ly HCV, is com m on ly higher than that of HIV infe c t i on (Bor­
tolotti et al., 1 9 8 2 ; Chamot et al., 1 9 9 2 ; C DC , 1 9 9 1 ) , studies of HBV and HCV 
i n fe c t i ons have been suggested as a method of evaluating some HIV preve n t i on 
programs (Committee on Social and Behavioral Sciences, 1992). 
Since syph i l i s , gon o r rh e a , ch l a m yd i a , hepatitis B, and hepatitis C are re p o rt a b l e 
d i s e a s e s , l o ca lly re p o rted data on these diseases may be used by HIV preve n t i on 
planners and program managers as an indirect way to determine the prevalence of 
high-risk behaviors in the local population and the potential for HIV spread, once 
it is introduced into the population. However, incidence of these infections is seri­
ously under-reported, especially hepatitis B and C, because the majority of persons 
infected with HBV and HCV do not have symptoms. 
Preve n t i on planners and pro g ram managers should be aware, h ow eve r, that hepatitis 
B ( H BV) cannot alw ays be used as a reliable surrogate marker for HIV tra n s m i s s i on . 
HIV transmission not only depends on individuals engaging in risk behaviors, but 
also on the prevalence of HIV in the community. Thus, although the prevalence of 
HBV among drug users is generally high, HBV would not be considered a reliable 
surrogate for HIV prevalence in a community where the prevalence of HIV is low, 
even if HBV prevalence among drug users in that community were high. Current 
re s e a rch on the re l a t i onship between HBV and HIV sero c onve r s i on has demon­
s t rated that trends of incident HBV infe c t i on do not para llel trends of incident 
HIV infe c t i on in a population of IDUs foll owed over time. At an individual leve l 
of analys i s , h ow eve r, incident HBV infe c t i on is a predictor of incident HIV infe c t i on 
among male but not female IDUs (Levine et al., 1996). 
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Key Questions for HIV Prevention

Planners and Program Managers

The following key questions related to PART 2 may help prevention planners and 
p ro g ram managers select and implement more effe c t i ve pro g rams for drug users 
and their sex partners: 
■ What kind of information is available from national, state, and 
local sources (e.g., health departments, academic institutions) on 
HIV seroprevalence, surrogate markers, drug use, and risk behav­
iors among drug users? 
■ What data do we have about HIV in IDUs? In crack users? 
What are the strengths and limitations of the information? 
■ What do we know about HIV risk behaviors and drug use in pop­
ulations at risk, including women, particularly those who 
exchange sex for drugs and money, MSM and bisexual men, the 
homeless/mentally ill, or incarcerated or paroled individuals? 
■ What are the social settings and networks that may increase HIV 
risk among drug users in the community? 
■ Are shooting galleries and/or crack houses common in the com­
munity or do users more commonly gather in private settings (e.g., 
cars)? 
■ Who among the drug user community are the key points for com­
munication with other drug users? 
■ How can we initiate locally relevant data gathering in collaboration 
with other local, state, and national organizations, or as part of 
other ongoing surveys and studies? 
■ Who should be involved in gathering and reviewing available 
information and determining program priorities? 
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SOCIAL AND BEHAV I O R A L 
I N T E RV E N T I O N S 
PA RT 3 of the HPDU Resource Book addresses the use of social and behaviora l 
t h e o ry in selecting and developing effe c t i ve HIV preve n t i on interve n t i ons with 
d rug-using population s . In addition , it provides an ove rv i ew of the ch a ra c t e ri s t i c s 
of effe c t i ve interve n t i ons and highlights selected studies and re s o u rce materi a l s 
that focus on effectiveness. 
PART 3 is intended to help HIV prevention planners and program managers gain 
a better understanding of the foundations of scientifica lly-based interve n t i on s . 
These interve n t i ons can effe c t i ve ly modify the drug-using and sexual behaviors 
that place drug users at increased risk of HIV infection. 
Sp e c i fica lly, PA RT 3 will increase HIV preve n t i on planners’ and pro g ram man­
agers’ understanding of: 
• social and behavioral theories and theoretical factors related to specified target popula­
tions and their risk behaviors 
• the process of systematically deciding on intervention features during the planning and 
intervention design process 
• the characteristics of effective interventions 
• the results of existing evaluation research on successful interventions for drug users 
and their partners 
In each ca s e, PA RT 3 will provide examples ill u s t rating the points and descri b e 
a d d i t i onal re s o u rces that planners can access to determine appro p riate HIV pre­
vention interventions for their priority target populations. 
Theories of Behavior Change

The Role of Theory in Planning Interventions 

Early in the epidemic, prevention planners assumed that a greater awareness of the 
factors inv o lved in HIV tra n s m i s s i on would more likely result in the adoption of 
HIV preve n t i on behaviors. It is now known that HIV preve n t i on efforts ca n n o t 
re ly solely on providing risk inform a t i on . Other factors also must be addre s s e d . 
Theory can help identify these additional social, psychological, and cultural factors 
and can help planners decide which factors need to be addressed for which population s . 
3-2 Social and Behavioral Interventions 
Social and behavioral science theory helps clarify the reasons why people behave as 
they do, and it gives planners a framework for the goals and components of an in­
tervention. This is particularly true in situations where planners have little empiri­
cal inform a t i on from evaluated HIV preve n t i on interve n t i ons to indicate which 
approaches are likely to be effective. 
The more that is known about the factors that influence whether or not a person 
w i ll engage in a behavior, the more successful preve n t i on planners and pro g ra m 
managers can be at selecting an interve n t i on that effe c t i ve ly influences that behavior. 
Social and behavioral theory, and testing this theory in HIV preve n t i on interve n t i on s , 
can help identify more specifica lly the factors that pro g rams need to address to 
f acilitate behavior change. 
In fact, p reve n t i on planners and pro g ram managers re g u l a rly use behavioral theory. 
Because HIV is largely transmitted through behavior — sexual and drug-using — 
planners and managers know that they must promote behavior ch a n g e . T h ey are 
familiar with at-risk populations in their communities, and often have an intuitive 
understanding of what ch a ra c t e ristics and circumstances of their target population s 
i n fluence their risk behaviors. By using social and behavioral theory and re s e a rch , 
planners and managers can ve rify mu ch of their pra c t i cal experi e n c e, ch a ll e n g e 
c e rtain assumption s , a n d , ove ra ll , h a ve a firmer scientific foundation for selecting 
and designing effe c t i ve interve n t i on s . In short , the use of behavioral science ca n 
help i m p rove pro g ra m s , i n c rease effe c t i ve n e s s , and save valuable time, re s o u rc e s , a n d 
lives. 
Some Important Theories and Approaches 
T h e o re t i cal appro a ches identify diffe rent sets of factors to explain HIV risk be­
havior ch a n g e . This section rev i ews seve ral theore t i cal appro a ches that are com­
monly used to explain and influence behavior and behavior change related to HIV 
p reve n t i on . These theories lay out factors thought to influence behavior and be­
havior ch a n g e, p rinciples about how these factors are re l a t e d , and methods for 
measuring these factors. 
Major behavior change theories 
Of the many diffe rent theories of human behavior, t h ree have been used fre q u e n tly 
in behavioral and social science re s e a rch on the preve n t i on of HIV infe c t i on .The Health 
Belief Model (Rosenstock et al., 1994) from health educa t i on focuses on four key 
health beliefs that are necessary to produce a readiness to act. The Theory of R e a-
Social and Behavioral Interventions 3-3 
s oned Ac t i on (Fishbein et al., 1989) is a social psych o l o g i cal appro a ch dealing with t h e 
re l a t i onships among beliefs , a t t i t u d e s , i n t e n t i on s , and behaviors. Social C o g n i t i ve 
T h e o ry (Bandura , 1994) is rooted in cognitive learning theory and cl i n i cal psych o l o gy. 
Fortunately for program planners and managers attempting to select among inter­
ventions, there is a significant overlap and consistency among these theories. Eight 
basic or com m on factors have been identified as points of consensus among the 
theorists (Fishbein, et al, 1993). These eight factors, which were summarized in a 
National Commission on AIDS 1993 report (see Table 3.1), have been shown em­
pirically to account for or explain most of the variation in the ways that individuals 
act out a given behavior. An effe c t i ve interve n t i on will influence one or more of 
these common factors. 
Table 3.1:

Eight Common Theoretical Factors

Factor 






Perceived Social Norms 
Barriers 
The Individual 
at Risk Must 
Believe the advantages of performing the 
behavior (the benefits) exceed the disadvan­
tages 
Have formed a strong positive intention or 
commitment to perform a behavior 
Possess the skills to perform a behavior 
Be confident that he/she can perform a 
behavior 
Believe that the performance of a behavior 
will more likely produce a positive than a 
negative emotional response 
Believe that the performance of a behavior 
is consistent with his/her self-image 
Perceive greater social pressure to perform 
a behavior than not to perform it 
Experience fewer environmental constraints 
to perform a behavior than not to perform it 
Source: National Commission on AIDS,1993. 
3-4 Social and Behavioral Interventions 
The stages of behavior change approach 
A l ong with addressing the factors that influence behavior, p reve n t i on planners and pro-
g ram managers may want to use a model that proposes that behavior change occurs in 
stages (Pro chaska et al., 1 9 9 2 ) .C a lled the Tra n s t h e o re t i cal Model, this appro a ch assumes 
that individuals start with no intention to ch a n g e, f o rm weak intention s ,s t rengthen these 
i n t e n t i on s , t ry the behavior incon s i s t e n t ly at fir s t , and then fin a lly adopt the new behav­
iors as a routine part of their live s . The model also accounts for those individuals who 
s u c c e s s f u lly pro g ress through all five stages of behavior ch a n g e, but who may relapse back 
to previous stages and engage in harmful behaviors again. Table 3.2 describes the five 
stages of ch a n g e . Ac c o rding to this model, designing an effe c t i ve interve n t i on is a matter 
of determining where an individual is on the continuum of behavior change and ch o o s­
ing an interve n t i on that moves him or her to a subsequent, m o re advanced stage. 
The eight com m on theore t i cal factors rev i ewed earlier and stages of behavior 
model change work well together because the various theore t i cal factors can be 
used to move persons from stage to stage in their behavior change. For example, to 
motivate individuals at the pre - c on t e m p l a t i on stage to form intentions to ch a n g e 
b e h a v i o r, an interve n t i on might first create a perc e p t i on of risk in order to alert 
them to the potential danger of not ch a n g i n g. For individuals at the pre p a ra t i on 
stage who have formed an intention to change behavior, an intervention might try 
to increase their con fidence or, “s e l f - e f fica cy, ” in perf o rming a safe or safer behavior. 
Table 3.2:








Individuals in this stage have no intention to change behavior in 
the foreseeable future, are unaware of the risk, or deny the con-
sequences of risk behavior. 
Individuals are aware that a problem exists, are seriously think­
ing about overcoming it, but have not yet made a commitment 
to action. 
Individuals intend to take action in the near future and may have 
taken some inconsistent action in the recent past. 
Individuals modify their behavior, experiences, or environment 
to overcome their problems; the behavior change is relatively 
recent. 
Individuals work to prevent relapse and maintain the behavior 
change over an extended period of time. 
Source: Prochaska et al.,1992 
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Social-level approaches 
As reviewed in PART 2, risk behaviors among drug users occur between individu­
als and are influenced by the larger social context of social netw o rk s , f a m i ly and 
friends, the immediate community, and the society as a whole. Although some in­
dividuals inject or use drugs by themselve s , others use drugs in small groups in 
s p e c i fic phys i cal or social settings. The settings in which sexual activity and dru g 
risk-taking occur can be closely related to users’ social environment and participa­
tion in social networks. 
Social- and community-level approaches to behavior and behavior change address 
the behavioral risk of individuals in the context of their personal networks and so­
cial env i ron m e n t s . Although there is no existing synthesis of social-level theori e s , the 
Institute of Medicine convened a workshop in 1995 to begin to look at the re s e a rch 
and pro g ram con t ri b u t i ons of a broad set of appro a ches and models (IOM, 1 9 9 5 ) .Ta b l e 
3.3 bri e fly describes four social-level appro a ches that emerged from the work s h o p. 
Table 3.3:





Social Movement / Community 
Mobilization Theory 
Social Network Theory 
Source: IOM, 1995 
Focuses on the processes by which an idea 
or practice is spread throughout a social 
system from person to person by way of 
particular channels of communication. 
Considers how naturally occurring leaders 
within groups can be encouraged to exhibit 
and communicate about an innovation or 
practice to their peers and the people they 
influence. 
Describes how a culture’s institutions, expe­
riences, or characteristics can be changed 
by social movements begun by members of 
that culture. 
Focuses on the relationships or interactions 
between two or more people or the linkages 
among people in a given group. 
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Harm reduction approach 
Another widely discussed concept, the “harm reduction approach,” focuses on 
IDUs and their behaviors related to sharing injection equipment. Harm reduction 
acknowledges that drug users vary in their readiness and ability to abstain from 
drug use totally (Des Jarlais et al., 1993).This approach suggests that, based on the 
ways in which HIV is transmitted, some ways of engaging in drug use may be less 
prone to viral transmission than are others. Advocates of harm reduction propose 
multiple complementary solutions that operate simultaneously, including drug 
abuse treatment, non-injection of drugs, and providing sterile injection equipment 
and/or materials to disinfect used equipment.1 
Using Theory to Plan and 
Design Effective Interventions 
To help preve n t i on planners and pro g ram managers to ach i eve a more pra c t i ca l 
understanding of the use of behavioral theory, the following section provides con-
c rete examples of how the theore t i cal appro a ches can form the basis for effe c t i ve 
b e h a v i o ral interve n t i on s . In addition , Appendix B of the HPDU Resource Book 
summarizes resources that address behavioral research and the underlying theoret­
i cal basis for behavioral interve n t i ons with drug-using population s . R ev i ew i n g 
these re s o u rces will give preve n t i on planners and pro g ram managers a more com­
p re h e n s i ve understanding of how to assess and design more effe c t i ve interve ntions. 
The AIDS Community Demonstration Projects 
Exhibit F illustrates how various theoretical approaches to behavior change can be 
used to design effective interventions for drug users. The CDC-funded AIDS 
C om mu n i ty Demon s t ra t i on Projects ( AC D P ) w e re com mu n i ty - l evel HI V 
p revention programs targeting several ethnically diverse, high-risk, hard-to-reach 
populations, including drug users (CDC, 1996). Using a common research and 
i n t e rve n t i on pro t o c o l , re s e a rchers in five cities designed and implemented a theory -
based community intervention that incorporated elements of the Health Belief 
Model, the Social Cognitive Theory, and the Theory of Reasoned Action. More 
specifically, the theoretical premise of the intervention assumed that four factors 
may influence an individual ’s intentions and behaviors: 
• the indiv i d u a l’s perception that he/she is personally susceptible to ac q u i ring HIV disease 
• the indiv i d u a l’s attitude toward perf o rming a low-risk behavior (e. g. , c o n s i s tent condom 
1. The harm reduction approach is discussed in more detail in PART 4: PUBLIC POLICY ISSUES. 
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or bl e ach use), w h i ch is dependent on his/her bel i efs about the positive and nega t ive con-
sequences of e n gaging in the low-risk behavior (ex p e c ted outcomes) 
• the individual ’s perception that the community and peer norms toward low-risk 
behaviors are positively changing and thus support his/her effort to change (perceived 
social norms) 
• the individual ’s belief that he/she can effectively perform low-risk behaviors under a 
variety of circumstances (self-efficacy) 
In addition , the theore t i cal fra m ew o rk of ACDP included the Tra n s t h e o re t i ca l 
Model by recognizing that the individuals in the intervention would be at differe n t 
stages of behavior change and thus would re q u i re diffe rent interve n t i on appro a ch e s . 
In laying out the theore t i cal fra m ew o rk for the interve n t i on s , the planners ack n ow l-
edged the importance of barriers to behavior ch a n g e, or env i ronmental con s t ra i n t s . 
That is, for example, people might not be able to act on their intentions if con d om s 
and sterile injection equipment were not available, re a d i ly accessible, or afford a b l e . 
Interventions using the social-level approach to behavior change 
As rev i ewed earl i e r, s o c i a l - l evel appro a ches include diffusion theory, l e a d e r s h i p -
focused models, social network theory, and social movement/community m o b i l i za­
t i on theory. Seve ral interve n t i ons for drug-using populations have used pri n c i p l e s 
of diffusion theory in which material or new practices are spread to the members 
of a social system through person - t o - p e r s on ch a n n e l s . For example, one outre a ch 
program in San Francisco used a word-of-mouth educational program for drug in­
jectors that promoted the use of bleach to decontaminate syri n g e s . The pro g ra m 
grew to include the distribution of bleach by outreach workers, who facilitated the 
dissemination and acceptance of the innovation (Institute of Medicine, 1995). 
Leadership models encourage natura lly occurring group “l e a d e r s ” to model and 
talk about a new practice to their peers. Since the practice may depart from the 
group’s established social norms, these models often rely on making risk-reduction 
strategies socially acceptable, or normative, within the target population. The Na­
t i onal AIDS Demon s t ra t i on Research/AIDS Targeted Ou t re a ch Model 
( NA D R / ATO M ) p rojects used this behavioral theory in the natura lly occurri n g 
social structure of injecting drug users. In one of the projects, ex-addicts, under the 
s u p e rv i s i on of trained ethnogra ph e r s , c onducted outre a ch to injection drug users 
not in treatment. Specific efforts were made to enroll influential persons (“indige­
nous leaders”) within drug-using netw o rks into the pro j e c t , and have them act to 
influence other injection drug users to practice safer injection (Wiebel et al., 1996; 
Wiebel, 1993). 
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Factors Influencing Distribution of small media material (newsletters, brochures, pamphlets, flyers or 
Individual Behavior baseball cards) that included: 
Perceived susceptibility to • Role model stories or authentic stories in target group language that described 
acquiring HIV disease a person’s motivation for considering or initiating behavior change, the type of 
change begun, how barriers to change were overcome, and that reinforced 
Perceived positive and positive consequences of change 
negative outcomes 
• AIDS information 
Perceived supportive com­
munity and peer norms • Instructions on the effective use of condoms or bleach to clean needles 
Perceived self-efficacy • Biographies of community members participating in the project 
• Notices of community events 
• Information on other health and social services (e.g., food provision, mammo­
gram screening, drug and alcohol treatment) 
Environmental Constraints Provision of free condoms and bleach 
Stages of Behavior Change	 Distribution of role model stories in the community that were designed to 
address the stage of behavior change of the target group (community members’ 
stage of change was assessed before development and distribution of role 
model stories) 
Social-Level Approaches Use of peer volunteers from the local community who were trained to reinforce 
(e.g. Diffusion Theory acceptance of, and attention to, the intervention messages, as well as attempts 
and Leadership Models) to change behavior 
Social network theory focuses on the social networks of drug users as a unit of in-
t e rve n t i on to reduce risky behaviors and infe c t i on leve l s .2 K n owledge of existing 
social netw o rks within a com mu n i ty can help determine the most effe c t i ve ch a n n e l s 
of communication among network members and identify key “gatekeepers” to act 
as a main link to the netw o rk ’s membership. One example of the use of social netw o rk 
t h e o ry is an HIV preve n t i on interve n t i on in Baltimore, in which injection dru g 
users were asked to re c ruit members of their netw o rks to attend a mu l t i - s e s s i on 
w o rkshop on HIV preve n t i on and to take part in a group discussion and decision 
on how the interve n t i on would address the issues of HIV and AIDS. T h ey also 
discussed ways that the interve n t i on could support individual members’ d e c i s i on s 
to alter their risk behaviors (Latkin et al., 1995). 
Social move m e n t / c om mu n i ty mobiliza t i on theory describes how social move m e n t s 
initiated by members of the com mu n i ty change that com mu n i ty’s re p re s e n t a t i on s , 
i ns t i t u t i on s , or experi e n c e s . This is an important stra t e gy because local inv o lvement is 
needed to implement changes necessary for improving the health of the com mu n i ty. 
This theory was used in one of the NADR projects that promoted “s e l f - o r g a n i za t i on” 
a m ong injecting drug users. Ou t re a ch workers re c ruited IDUs and assisted them to 
d evelop self-help groups to address HIV tra n s m i s s i on and other issues of import a n c e 
to them. Pa rticipants held regular group meetings to discuss how they could ch a n g e 
peer norms about injection and sexual risk behaviors (Friedman et al., 1 9 9 3 ) . T h i s 
t h e o ry was also used in an interve n t i on in Baltimore that built on the power and 
i nfluence of a com mu n i ty-based publica t i on . For a number of ye a r s , St reet Vo i c e, a 
drug-users’ organization composed primarily of African Americans, has published 
a s t reet new s l e t t e r. The newsletter was used as an interve n t i on ve h i cle to discuss 
HI V- related issues and changes in local treatment pro g rams or welfare ru l e s , and to 
s h a re art i cles in which users talked about their lives (Institute of Medicine, 1 9 9 5 ) . 
Interventions that use the harm reduction approach 
Syringe exchange is the standard harm re d u c t i on method for preventing HIV infe c-
t i on among IDUs . In these pro g ra m s , I D Us can exchange their used needles and 
s yringes for new, s t e rile injection equipment at no cost. By collecting the used injection 
e q u i pm e n t , s yringe exchange pro g ram managers also provide for safe disposal of 
p ot e n t i a lly HI V- c ontaminated equipm e n t . B e cause the exchange is conducted in 
pers on , the pro g ram can also deliver other services to IDUs . Syringe exchange pro-
g rams typ i ca lly provide AIDS educa t i on and counseling, d i s t ribute con d oms (to pre-
vent sexual tra n s m i s s i on of HI V) , make re fe r rals to drug abuse treatment and other 
m e d i cal and social serv i c e s , and distribute bleach for disinfecting injection equipm e n t 
and/or alcohol swabs to reduce the likelihood of IDUs developing abscesses and other 
i n fe c t i on s .T h ey vary in their loca t i on (fixed versus “rov i n g” s i t e s ) , hours of opera t i on , 
2. Social networks are described in greater detail in PART 2: DRUG USE, SEXUAL BEHAVIOR, AND HIV RISK, in 
the section entitled “Social Contexts that Increase HIV Risk.” 
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and the number of syringes all owed for exch a n g e . It is estimated that over 100 syri n g e 
e xchange pro g rams have been implemented nationwide (V l a h ov, 1 9 9 7 ) . 
Designing HIV Prevention Interv e n t i o n s

Once preve n t i on planners and pro g ram managers decide that an interve n t i on is nec­
e s s a ry to meet identified com mu n i ty preve n t i on needs, the specific fe a t u res of the 
i n t e rve n t i ons must be determ i n e d . It is not sufficient to simply re fer to “d i s t ri b u t i on 
of con d oms and bleach” in describing a planned interve n t i on . M o re specific inform a­
t i on is needed on where, to whom , by whom , over what period of time, and under 
what circumstances an interve n t i on will be delive re d . Sp e c i f ying the key fe a t u res of 
the interve n t i on is useful for a number of re a s on s . Fi r s t , it all ows preve n t i on planners 
to more cl e a rly com mu n i cate the types of pri o ri ty interve n t i ons that they are re c om-
mending to preve n t i on service prov i d e r s , and it helps providers more cl e a rly design 
i n t e rve n t i ons and implement them as planned. Thinking through the details also 
helps providers apply elements of behavioral and social science re s e a rch and theory 
w h e re useful in designing specific interve n t i on s . 
Making decisions about the key fe a t u res and describing the pro g ram in this way ca n 
also be stra t e g i ca lly useful if a pro g ram intends to get support , or continue to get sup-
p o rt , f rom outside funders and the com mu n i ty. Fi n a lly, a systematic descri p t i on 
e n c o u rages a thorough implementation of the interve n t i on , a ll ows for re p l i ca t i on of 
the interve n t i on for other groups or com mu n i t i e s , and provides a stru c t u re to design 
and ca r ry out process and outcome ev a l u a t i on s . 
Deciding on the Features of Interventions 
I n t e rve n t i ons for drug-using populations genera lly fall into one of three major 
ca t ego ri e s : c o u n s e l i n g, t e s t i n g, re fe r ra l , and partner notifica t i on (CTRPN); h e a l t h 
e d uca t i on / risk re d u c t i on (HE/RR ) ; and health com mu n i ca t i on/public inform a­
t i on (HC/PI ) . E a rlier materials developed by CDC for com mu n i ty planning 
g roups described a taxon omy or cl a s s i fica t i on system based on these ca t e go ri e s .3 
This taxon omy can help planners and managers develop a com m on term i n o l o gy 
and diffe re ntiate types of interve n t i on s . Exhibit G builds on this taxon omy and pre­
sents inform a t i on on the key fe a t u res of interve n t i ons that preve n t i on planners and 
p ro g ram managers need to con s i d e r. It is organized around four basic question s : 
• Who is being targeted? • Wh ere is the intervention being del ivered? 
• What is the proposed intervention? • How is the intervention being del ivered? 
3.	 See What Intervention Studies Say About Effective n e s s , A Resource for HIV Prevention Community Planning Gro u p s A ED, 1 9 9 5 . 
Information on how to obtain this document can be found in PART 5: RESOURCES. 
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General risk behaviors and 
stage of behavior change 
Description 
Describe the racial/ethnic background of the target group(s). 
Describe other demographic characteristics of the target group(s), such as ado­
lescent vs. adult, in-school vs. out-of-school, homeless, mentally ill, female vs. 
male, MSM, sex industry workers, inmates, parolees, immigrants. 
Describe the section or neighborhood of the city where the target group(s) are 
located. 
Describe the general risk behaviors of the target group(s), such as sexual behav­
iors, injecting drug use, crack use, and their general readiness for behavior 
change (see Table 3.2: Stages of Behavior Change). 




Factors expected to affect 
risk behavior(s) 
Services, materials, and 
information 
Description 
Describe whether the intervention will be delivered at the individual, couples, 
group, street and/or community, or general public level. 
Describe what risk behaviors the intervention expects to change and the direc­
tion of this change (e.g., increased cleaning of injection equipment, reduced 
number of needle-sharing partners, increased use of condoms). 
Describe theoretical factors that will need to be addressed to affect the behav­
ioral objectives of the intervention, such as addressing the target group’s inten­
tions, skills, perceived self-efficacy, and supportive community and peer norms, 
and the barriers and expected outcomes (see Table 3.1: Eight Common 
Theoretical Factors). 
Describe the services, materials, and other information that will be delivered in 
the interventions, such as HIV counseling and testing, case management, peer 
outreach, skills training, condoms, bleach kits, and/or educational pamphlets. 










Describe whether the intervention will be delivered in a school, prison, hospital, 
STD clinic, drug treatment program, or other institutional setting. 
Describe whether the intervention will be delivered in the streets or corner of a 
street in a high drug-use area, a crack house, park areas where MSM cruise, or 
another informal settings where high-risk behaviors are performed. 
Describe whether the intervention will be delivered in a community-based orga­
nization, store front, mobile van, bar, or another community setting or settings 
(e.g., such as the multiple community settings of a media intervention). 
How is the intervention being delivered? 
Feature Description 
Persons delivering Describe whether the intervention will be delivered by peers, community volun­
intervention teers, health professionals, or other types of individuals. 
Visibility of the interv e n t i o n Describe how the target group(s) for the intervention will learn about its services, 
to the target group(s) 
Frequency/ duration 
Scale and significance 
Contextual factors 
Extent of coordination 
such as through various types of media in the community or through formal or 
informal outreach on the street or with related agencies. 
Describe whether the frequency of the intervention will be one-time only, period­
ic, or ongoing, and whether the duration of the intervention will be minutes, 
hours, days, weeks, and/or years. 
Describe how many members of the target group(s) will be reached by the inter­
vention and, if possible, whether this size is sufficient to make a measurable con­
tribution to influencing the epidemic. 
Describe any contextual factors that will influence how the intervention is deliv­
ered, such as the type or level of drug use, the physiologic or mental state of the 
target group(s), and the competing needs for food, shelter, health care, employ­
ment, and protection from violence. 
Describe the extent of coordination between the intervention and services of 
other agencies in the area and what the effect of other HIV prevention interven­
tions will be on the implementation of the proposed intervention. 
Who will receive the interv e n t i o n ? 
Prevention planners and program managers need to understand and describe who 
w i ll re c e i ve the interve n t i on . This includes addressing certain key fe a t u res of the 
target gro u p, s u ch as their racial/ethnic back g ro u n d ; their other d e fining ch a ra c-
t e ri s tics ( e . g. , g e n d e r, a g e, ove rlap with other at-risk populations such as dru g 
users who are MSM, homeless, mentally ill, sex industry workers, immigrants, or 
prison inmates or parolees); their geographical location (e.g., section or neighbor-
hood in the com mu n i ty ) ; and their g e n e ral risk for HIV infe c ti o n ( e . g. , u n p ro t e c t e d 
sex with many part n e r s , i n j e c t i on drug use, c ra ck use). A target group can also be 
d e s c ribed in terms of its general readiness for behavior ch a n g e, or its stage of 
behavior change. The stage of change could refer to the stage of drug use behavior 
( e . g. , i n i t i a t i on , m a i n t e n a n c e, risk re d u c t i on , relapse) or stage of behavior ch a n g e 
as described in Table 3.2 (i.e., p re c on t e m p l a t i on , c on t e m p l a t i on , p re p a ra t i on , 
action, maintenance). 
What is the proposed intervention? 
Planners and pro g ram managers need to address key fe a t u res of the interve n t i on 
itself. This includes the level at which the intervention will be targeted, which may 
be at the individual, c o u p l e, g roup/social netw o rk , c om mu n i ty, or general public 
l eve l . For example, c o u n s e l i n g, t e s t i n g, and re fe r ral interve n t i ons for the dru g -
using population most often target individual drug users. Health educa t i on and 
risk re d u c t i on efforts genera lly target drug users’ social netw o rks or the com mu n i ty. 
It is important to cl e a rly specify the b e h av i o ral objecti ve s of the interve n t i on . 
Which drug-using and sexual risk behaviors are targeted for change? For injection 
d rug-using population s , these behaviors might include the fre q u e n cy of injection , 
s h a ring of injection equipm e n t , n e e dle shari n g, type of drug injected, mode of 
drug use, type of sexual activities and partners, and number of sex partners. Behav­
i o ral objectives for non-injectors might include high-risk sexual activities associated 
with the exchange of sex for crack or money to buy crack. 
What factors are ex pected to affect the risk behav i o r s of the target population ? 
Some interventions attempt to improve skills at cleaning equipment or using con-
d om s . Others address barriers to obtaining clean needles and con d om s . B e ca u s e 
risk taking occurs in the context of social re l a t i on s h i p s , factors such as perc e i ve d 
peer and com mu n i ty norms are import a n t . B e h a v i o ral and social science theori e s 
will inform and enrich the decisions about how to influence risk behaviors. 
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Interventions also provide different services,materials,or information. A program 
manager will need to determine the types of activities, written documents, a n d 
other materials to deliver to ach i eve interve n t i on outcom e s . These can incl u d e 
HIV counseling and testing, p a rtner notifica t i on , client case management, S T D 
and TB treatment, referrals for drug treatment or other health and social services, 
HIV/AIDS education workshops or video presentations, support groups, and dis­
t ri b u t i on of written educa t i onal materials or injection equipm e n t . H e re again, 
consideration may be given to where the individual, group, network, or community 
is on the continuum of change for a particular behavior. 
Where is the intervention being delivered? 
The settings and loca t i ons where behavioral interve n t i ons are delive red for dru g 
users vary con s i d e ra b ly. Some interve n t i ons are delive red in i n s ti tu tional setti n g s , 
s u ch as STD cl i n i c s , c om mu n i ty-based organiza t i on s , s t o re fron t s , health vans, o r 
other more formal settings. Other interventions are street-based, where drug users 
hang out or use drugs (e.g. , s t reet corn e r s , shooting gall e ri e s , c ra ck houses). St i ll 
others are com mu n i ty - w i d e, for example, a media campaign that delivers the pre­
vention messages in multiple locations in the community. Some interventions may 
even use mu l tiple setti n g s , s u ch as a pro g ram that does both street outre a ch and 
conducts other services in an institutional setting. The delivery setting is a key fea­
ture of intervention design. 
How is the intervention being delivered? 
This question covers a range of important implementation decisions. One key fea­
ture related to this issue is the person(s) delivering the intervention or the individ­
uals re s p onsible for the delive ry of specific serv i c e s , i n f o rm a t i on , or materi a l s . 
These could include peers, indigenous workers from the com mu n i ty, c om mu n i ty 
volunteers, and health professionals or paraprofessionals. Research has shown that 
respected peers in the drug users’ social netw o rk or com mu n i ty are often effe c t i ve 
d e l i ve rers of services (Wiebel et al., 1 9 9 6 ; Des Jarlais et al., 1 9 9 3 ) . This is part ly 
due to the illicit behaviors engaged in by drug users and their distrust toward “out­
s i d e r s ” and institutional authori ty fig u re s , e q u i pm e n t , and police and corre c t i on a l 
officer confiscation of condoms from inmates and sex workers). 
Another key fe a t u re related to how the interve n t i on will be delive red is the v i s i b i l i ty 
of the interve n ti o n to the target gro u p. In order for an interve n t i on to affect the target 
g ro u p, the group must be aware of its existence and have an appre c i a t i on of how the 
i n t e rve n t i on services can address its needs. This can be accomplished through mu l­
tiple methods, s u ch as the use of local media (ra d i o, n ew s p a p e r s ) , o u t re a ch to o t h e r 
services agencies that serve the target gro u p, and outre a ch dire c t ly to the population . 
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The frequency and duration of the intervention are key to program delivery. Pro-
g rams can be either one-time on ly, p e riodic (e.g. , once a week for five weeks), o r 
on go i n g. T h ey can be as short as a few minutes or as long as hours or days . 
Programs for drug users have used different time periods and levels of intensity in 
o rder to re s p ond to the varied life s tyles and circumstances of drug users. O n e -
t i m e, s h o rt outre a ch interve n t i ons are often conducted with drug users on the 
street. Periodic, moderately intensive HE/RR interventions often are conducted in 
c om mu n i ty-based organiza t i on env i ron m e n t s . O n go i n g, m o re intensive interve n t i on s 
with drug users have been implemented in long-term treatment programs. 
To demon s t rate the potential impact of a proposed interve n t i on , p reve n t i on 
p l a nn e rs and pro g ram managers need to describe its s cale and significa n c e . T h i s 
i ncludes the number of target group members the interve n t i on intends to re a ch , 
and, if possible, whether or not the projected target group size will be sufficient to 
make a measurable impact on the epidemic. 
Contextual factors may need to be considered in the delivery of an intervention to 
a particular population . Wo rk with drug-using populations in particular re q u i re s 
a w a reness of important contextual issues, s u ch as type of drug used; health pro b l e m s 
and health status of the target population ; the competing needs for food, s h e l t e r, 
health care, employment, and protection from violence; HIV serostatus/prevalence 
of those in their netw o rk , i n cluding sexual and needl e - s h a ring part n e r s ; a n d 
legal/institutional issues that affect availability and access to services, information, 
and materials (e.g. , l o cal laws and policy issues related to needle exch a n g e, ove r -
the-counter sale of syri n g e s , p o s s e s s i on of sterile needles and equipm e n t , and police 
and correctional officer confiscation of condoms from inmates and sex workers). 
Finally, an important feature in intervention planning and delivery is the extent of 
c o o rd i n a ti o n b e tween the interve n t i on and the services of other agencies in the 
area. Drug users have multiple needs, depending on their physiological and mental 
states and personal resources. To strengthen the delivery of needed services and to 
avoid duplica t i on of effort , HIV preve n t i on pro g rams should be well coord i n a t e d 
with other agencies that can respond to these multiple needs and be aware of how 
other HIV prevention services in the area can effect program implementation. 
Exhibit H ill u s t rates how preve n t i on planners in the Na t i onal Institute on Dru g 
Abuse addressed these key features when planning the HIV Counseling and Edu­
ca t i on Interve n t i on Model, an interve n t i on designed and developed to influ e n c e 
the risk behaviors of drug users and their partners (Coyle, 1993). 
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Factors Affecting Risk 
Behaviors 





Visibility of Intervention 
Frequency/Duration 
Scale and Significance 
Contextual Factors 
Extent of Coordination 
Description 
Counseling, Testing, Referral, and Partner Notification

Out-of-treatment, adult, injection drug users and their sex partners; most were

African American and Latino, and located in a specific neighborhood of a city;





Decreased drug-use and sexual risk behaviors

Knowledge of HIV and AIDS transmission

Perceived vulnerability to acquiring HIV

Perceived self-efficacy with correct condom use

Perceived outcomes of behavior change

Accessibility of condoms and bleach

Perceived peer and community norms





Free condoms and bleach

Written materials about HIV transmission and HIV-related facilities and services





Medically trained staff member (for HIV screening)

Outreach staff of both sexes who reflected the makeup of the neighborhood dis­





Two 20-30 minute sessions over two to three weeks (moderate intensity)

Approximately 1,000 of the estimated 5,000 target group members were reached

Services delivered were partly dependent on the context of the client’s HIV sta­

tus; seronegative participants received education, counseling, and referrals;





Formal and informal coordination and referral contracts developed with eight

other service agencies in the targeted neighborhood 





The purpose of this section is to provide HIV preve n t i on planners and pro g ra m 
managers with results of evaluation research on the general characteristics of effec­
t i ve HIV preve n t i on pro g rams and, m o re specifica lly, on interve n t i ons that have 
been shown to be effe c t i ve at reducing sexual and drug-use risk behaviors amon g 
d rug-using population s . A mounting body of scientific evidence generated from 
evaluation research has shown that lasting changes in risky behavior can occur as a 
result of well-designed interventions. 
General Characteristics of Effective 
Prevention Programs 
Behavioral science research has been used to design effective prevention programs 
in areas such as teen pregnancy, smoking cessation, and substance abuse, as well as 
in HIV prevention.The results of this research, including that of HIV researchers, 
( H o l t g ra ve et al., 1 9 9 5 ; Choi et al., 1 9 9 4 ; K e lly, 1 9 9 2 ; St ryker et al., 1 9 9 5 ; J a n z 
et al, 1996) has helped identify some general ch a ra c t e ristics of effe c t i ve HIV 
p reve nt i on p ro g rams to consider during pro g ram design. The more ch a ra c t e ri s t i c s 
an interve n t i on integrates into a pro g ra m , the stronger the chance for effe c t i ve n e s s . 
Exhibit I on the facing page presents these characteristics. 
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Effective HIV Prevention Programs

Behavioral research • are designed according to the results of a comprehen­
has identified these sive needs assessment, including an identification of 
target group members’ level of motivation to change
characteristics of risk behaviors 
effective programs: 
• are affordable and easy to access by the target popu­
lation served and are able to respond to other 
expressed needs of the community 
• are culturally competent, relevant to the targeted pop­
ulation (i.e., consistent with norms, attitudes, beliefs 
and attitudes), and include members of the target 
population in program planning and implementation 
• have clearly defined target group(s), interventions and 
program components, and objectives 
• focus on behavioral skills, which include how to carry 
out low-risk, safer behaviors as well as how to avoid 
and cope with high-risk situations 
• do not provide messages that are judgmental, moral­
istic, or attempt to instill fear 
• have ample duration and intensity to achieve lasting 
behavior change, and provide support and skills nec­
essary to cope with lapses and setbacks in maintain­
ing safe behaviors 
• address the social and community norms of the target 
population so that program participants receive con­
sistent messages and reinforcement for the pre-
scribed behavior change 
• are offered to the target group as part of a continuum 
of health care (e.g., drug and alcohol treatment, STD 
treatment, family planning, other health services) 
• address other basic needs of the targeted population 
(e.g., housing, food) in order for HIV prevention to be 
considered a priority 
• are regularly monitored to assure implementation is 
according to plan and that outcomes are being met 
Studies That Evaluate the Effectiveness of HIV 
Prevention Interventions for Drug Users 
In addition to findings about the general ch a ra c t e ristics of effe c t i ve pro g ra m s , a 
body of re s e a rch exists that examines the effe c t i veness of specific interve n t i on s 
conducted with drug users and their partners.This section provides an overview of 
selected ev a l u a t i on studies from the peer-rev i ewed litera t u re and more genera l 
res o u rce materials (book s , m on o g ra ph s , j o u rnal art i cles) chosen for their focus on 
e f fe c t i veness and their usefulness to com mu n i ty planners and pro g ram managers. 
More complete descriptions of the materials are contained in Appendices A and B 
of this document. 
Appendix A contains summaries of 13 evaluation studies of interventions selected 
f rom the peer-rev i ewed journal litera t u re . E a ch has been summari zed using a 
s t a nd a rd Evaluation Study Su m m a ry Fo rm designed to address the needs of pre­
ve n t i on planners. Nine of the summaries are also included in the document, What 
I n tervention Studies Say About Effective n e s s : A Resource for HIV Prevention Community 
Planning Gro u p s ( A ED, 1 9 9 6 ) . Four more have been added to take advantage of 
n ew findings and ensure a vari e ty of settings and drug-using population s . T h e s e 
s u m m a ries do not re p resent all studies on interve n t i on effe c t i veness with dru g 
u s e r s . Ra t h e r, t h ey are intended to provide a range of current and quality re s e a rch 
re l evant to the needs of HIV preve n t i on planners and pro g ram managers. 
On the foll owing page, Table 3.4 provides a guide to the Evaluation Study Su m-
m a ries included in Appendix A. The table lists the citation , target population s , 
and type of intervention for each article included. 
Appendix B contains descriptions of additional resources with a focus on effective-
n e s s , i n cluding book s , b o ok ch a p t e r s , m on o g ra ph s , and journal art i cl e s . T h e s e 
m at e rials offer a broad range of com p re h e n s i ve inform a t i on on interve n t i ons for 
drug users and their partners. For example, one book discusses the effectiveness of 
a range of interve n t i ons conducted with drug users and their sex part n e r s 
( So re n s e n , 1 9 9 1 ) . A chapter in another book addresses interve n t i ons con d u c t e d 
with drug users in natural settings (as opposed to drug treatment settings) and 
their effe c t i veness (Wa t t e r s , in DiClemente et al., 1 9 9 4 ) . A second chapter 
discusses the effe c t i veness of interve n t i ons for sex partners of HI V- i n fected or 
high-risk individuals, with special attention given to partner notification and HIV 
antibody testing and counseling pro g rams (Pa d i a n , in DiClemente et al., 1 9 9 4 ) . 
Another important re s o u rce is the Na t i onal Research Council’s Con g re s s i on a lly -
c om m i s s i oned national study on the effe c t i veness of needle exchange and bleach 
distribution programs (Normand et al., 1995). 
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Table 3.4:

Guide to Evaluation Study Summaries

Article Citation Target Population Type of Intervention 
Calsyn et al., 1992 Male IDUs Institutional-based (outpatient 
drug abuse treatment), condom 
distribution and instruction 
Des Jarlais et al., 1992	 Adult intranasal heroin Group-level, peer-mediated coun­
users seling 
El-Bassel et al., 1995 Adult women with history Institutional-based (prison), 
of drug use group-level, non-peer mediated 
counseling 
Latkin et al., 1996 Networks of IDUs	 Group-level, peer-mediated train­
ing 
Malow et al., 1994 Male African American Institutional-based (inpatient drug 
IDUs and cocaine users abuse treatment), group-level 
counseling, non-peer mediated 
training 
Nyamathi et al., 1994	 Hispanic women who are Group-level counseling, peer-
homeless and drug-using mediated training 
Reitmeijer et al., 1996 IDUs	 Community-level, peer and non-
peer street and community out-
reach 
St. Lawrence et al., 1995 Substance dependent Group-level, non-peer mediated 
adolescents skill training 
Schilling et al., 1991 African American and Group-level counseling, non-peer 
Hispanic female drug mediated in methadone mainte-
users nance program 
Siegal et al., 1995 Out-of-treatment, HIV Individual and group-level coun-
seronegative IDUs seling, non-peer mediated 
Sorensen et al., 1994 Adult IDUs Community and street outreach, 
group-level, non-peer mediated 
counseling in outpatient treat-
ment program 
Stephens et al., 1991 Out-of-treatment IDUs	 Individual-level counseling, non-
peer mediated 
Watters et al., 1994 Active IDUs 
syringe exchange 
Community and street outreach, 
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Key Questions for HIV Prevention

Planners and Program Managers

The foll owing key questions may help HIV Preve n t i on Com mu n i ty Pl a n n i n g 
G roups and pro g ram managers select or design a more effe c t i ve preve n t i on pro-
gram for drug users and their sex partners: 
■ Did you consider the theoretical basis for the proposed interven­
tion? Which theoretical approaches and factors did you use in 
selecting or developing the intervention? 
■ What are the key features of the intervention selected? Are you 
able to answer the four basic questions in Exhibit B? 
■ Did you consider the general characteristics of effective HIV pre­
vention programs in selecting or developing the intervention? 
Which did you use in the proposed intervention? 
■ Did you look for and find research on the effectiveness of inter­
ventions for target populations similar to group(s) you are target­
ing? If available, did you use the results in selecting or designing a 
proposed intervention? 
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Long-standing con flicts in society’s attitudes and beliefs related to drug use and 
sexual behavior heavily influence the policy and pro g ram env i ronment in which 
HIV preve n t i on pro g rams are delive re d . Du ring the 20th century, gove rn m e n t ’s 
dominant approach to drug use has been one of reducing access through interdic­
t i on and inca rc e ra t i on . In developing HIV preve n t i on effort s , planners and pro-
g ram managers must balance the need for pro g rams that are effe c t i ve in re d u c i n g 
the spread of HIV with initiatives that are tolerated and supported by the commu­
n i ty at large, that provide for con fid e n t i a l i ty, and that con f o rm to fe d e ra l , s t a t e, 
and local regulations and practices. 
PA RT 4 of the HPDU Resource Book is intended to help preve n t i on planners and 
p ro g ram managers appreciate the com p l e x i ty of the policy debates surro u n d i n g 
HIV preve n t i on for drug users and their sex partners by highlighting some of the 
issues that they may face in their com mu n i t i e s . Sp e c i fica lly, PA RT 4 will help 
HIV prevention planners and program managers increase their knowledge of: 
• the impact of community attitudes and belie fs on the design and delivery of HIV 
prevention programs for drug users and their sex partners 
• the influence of laws, regulations, and practices on HIV prevention efforts 
• how agency policies and practices influence the nature of HIV prevention among drug 
users within a community 
Community Attitudes and Beliefs 
Beliefs About Drug Use 
Drug use is generally viewed as bad for individuals and for society. Over the last 20 
years, criminal penalties for the sale and possession of drugs have increased as part 
of what political leaders refer to as the “war on drugs.” The growing intolerance of
d rug use and fear of drug users have been accompanied by an incre a s i n g ly heated 
debate about pro g rams that provide treatment and other health ca re services for 
d rug users. The appro a ches taken with HIV preve n t i on activities are often a cen­
tral element of that debate. 
People may agree that there is a need for HIV preve n t i on activities, but disagre e 
about their goals and methods. They also may disagree about who should have the 
final authority in choosing which prevention methods to use.The core of most de-
bate about preve n t i on methods is whether an “abstinence-based appro a ch” or a 
“risk-reduction approach” is most effective. 
4-2 Public Policy Issues 
Abstinence-based appro a ches to HIV preve n t i on stress methods such as admis­
sion to a drug treatment pro g ram to help individuals. A b s t i n e n c e -based approaches 
oppose interventions such as bleach distribution, syringe exchange, and increasing 
access to over-the-counter sale of syri n g e s , since these methods are not dire c t ly 
linked to stopping drug use and may appear to encourage drug use. 
Risk re d u c t i on (also re fe r red to as “h a rm re d u c t i on”) appro a ches emph a s i ze that 
most drug users are unable or unw i lling to stop drug use immediately and com­
p l e t e ly; that there are limited drug treatment pro g ram “s l o t s ” a v a i l a b l e ; that many 
d rug users cannot stop drug use even when they are enro lled in drug treatment 
p ro g ra m s ; and that many of the drug users who are able to stop using drugs may 
relapse. Risk reduction approaches emphasize a variety of interventions with drug 
u s e r s , p a rt i c u l a rly those who continue to use. These interve n t i ons include prov i d i n g 
access to sterile syringes through over-the-counter sale from ph a rmacies and 
syringe exchange programs; stressing never sharing syringes, water, or drug prepa­
ration equipment; emphasizing bleach disinfection for drug users who do not have 
s t e rile syri n g e s ; p roviding alcohol swabs to clean injection sites to reduce the occ u rre n c e 
of abscesses; and offe ring hepatitis B and other vaccinations to active drug users. 
Views on the best approaches to deal with HIV prevention among IDUs vary dra­
m a t i ca lly at both the com mu n i ty and national leve l . Case Example 4.1 highlights 
some viewpoints on the appropriateness of HIV prevention activities. 
Case Example 4.1 
Public Policy Issues 4-3 
The Importance of Community Attitudes 
Regarding HIV Prevention Interventions 
The HIV epidemic has had a dispro p o rt i onate impact on certain com mu n i t i e s , 
p a rt i c u l a rly minori ty com mu n i t i e s . In some com mu n i t i e s , s u ch as yo u t h , t h e 
ra p i dly growing impact of HIV infe c t i on portends an important future public 
health con c e rn . A broad range of HIV preve n t i on efforts have been launched to 
re s p ond to this situation , and com munities have diffe red in their re a c t i on s . E ve n 
within com mu n i t i e s , o p i n i ons and support can vary widely. For example, s om e 
A f ri can Am e ri can leaders believe that HIV has been delibera t e ly introduced into 
the Afri can Am e ri can com mu n i ty as a form of racial genocide and are suspicious 
of gove rnment preve n t i on efforts (T h omas et al., 1 9 9 3 ) . At the same time, o t h e r s 
support a full range of HIV prevention measures.This section of PART 4 provides 
two examples of differing attitudes toward HIV prevention efforts. They illustrate 
for preve n t i on planners and pro g ram managers the fundamental importance of 
understanding the com mu n i ty’s attitudes tow a rd HIV preve n t i on if successful in­
terventions are to be implemented. 
A study on syringe exchange in the U.S. and Canada conducted by the Institute 
for Health Policy Studies at the University of California, San Francisco, identified 
four major reasons for opposition expressed by African Americans to HIV risk re­
duction programs: (1) failure to provide adequate drug treatment; (2) failure by ad­
vocates of syringe exchange programs to meet with community leaders; (3) lack of 
re c o g n i t i on by those who advocate syringe exchange of the negative effects of the 
existing drug market and of drug use on com munities of color; and (4) failure to 
explain how syringe exchange can help, in the long term , to curb the impact of 
drug use (Lurie et al., 1993). 
In spite of skepticism expressed by some Afri can Am e ri can leaders, m a ny others 
support a full range of HIV prevention measures. For instance, African American 
mayors in New York, Baltimore, New Haven, and Washington, DC, have publicly 
expressed their support for HIV risk reduction programs that incorporate access to 
s t e rile injection equipment (Lu rie et al., 1 9 9 3 ) . Joining in this support for HI V 
risk reduction efforts are a number of African American-operated HIV prevention 
a g e n c i e s , i n cl u d i n g, for example, the Black Coalition on AIDS in San Fra n c i s c o. 
Some religious leaders who initially supported on ly abstinence-oriented interve n­
tions have changed their position in the face of the ever-increasing number of peo­
ple of color affected by HIV. 
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An African American Leader Speaks Out

An African American Leader Speaks Out 

in Defense of HIV Risk Reduction 
“I’m one who spoke out very harshly against the distribution of condoms 
and the distribution of needles, saying that it’s cooperation with evil....If it’s 
going to save lives and it’s going to allow for an arresting of this disease in 
our community so that people who have heart attacks and other ailments 
can get into the emergency rooms and be treated, then I think that these 
measures are not bad measures and lots of us are going to have to think 
real hard about how we oppose things that could stop this disease. In dras­
tic times, you have to take drastic actions. My prayer is that our drastic 
actions will do enough quickly enough because too many people, homo-
sexual, heterosexual, rich, poor, educated, non-educated, male and female 
are dying....” 
Reverend Calvin Butts, Harlem, New York 
Source: Lurie et al.,1993. 
The second ill u s t ra t i on shows the importance of com mu n i ty attitudes re g a rding HI V

p reve n t i on pro g rams for adolescents. I nvestigators now re p o rt that the ave rage age of

those diagnosed with AIDS has declined each ye a r, and that an increasing number of

adolescents are becoming infected with HIV (Rosenberg, 1 9 9 4 ) . C om p re h e n s i ve

studies have also made it clear that drug use plays an important role in HIV infe c t i on

a m ong adolescents. In fact, 23 percent of all cases of adolescents diagnosed with

AIDS are directly attributable to injection drug use or to sex with individuals who

inject drugs (CDC, 1995). NIDA’s Monitoring the Future survey, an annual study

of the prevalence of drug use among U.S. a d o l e s c e n t s , i n d i cates that drug use amon g

8 t h , 1 0 t h , and 12th graders increased in

1 9 9 4 , c ontinuing the growth seen in Case Example 4.2

1 9 9 3 . Although the sharpest rises in dru g

use were for mari j u a n a , other subs t a n c e s ,

s u ch as coca i n e, s h owed significant

inc reases as well ( J oh n s on et al., 1 9 9 5 ) .

The debate over what is an appro p ri a t e

a p p ro a ch to HIV preve n t i on amon g

adolescents is heated. C om mu n i ty sup-

p o rt for or opposition to educa t i onal

p ro g rams about human sexuality and

about drugs can be a cri t i cal element in the

success or failure of an HIV preve n t i on

i n t e rve n t i on . Case Example 4.2 ill u s t ra t e s

the power of community opposition.
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In other communities, however, parents and school officials have expressed strong 
s u p p o rt for a com p re h e n s i ve appro a ch to sex educa t i on for youth that incl u d e s 
equipping young people with knowledge and decision-making skill s . In som e 
communities, this includes support for efforts to make condoms available through 
s ch o o l - b a s e d , s ch o o l - w i d e, or district-wide health pro g ra m s . Table 4.1 lists a 
number of cities where con d oms are now available through school-based pro g ra m s . 
Table 4.1: Cities with School-Based Health Centers Offering

Condom Availability Pro g r a m s

The Advocates for Youth (formerly the Center for Population Options, Washington, DC) estimate 
that condoms are now available to sexually active students in more than 100 school-based health 
clinics in the following communities: 
Little Rock, AR Chicago, IL Jackson, MS Portland, OR 
Culver City, CA Boston, MA Portsmouth, NH Philadelphia, PA 
Los Angeles, CA Cambridge, MA Espanola, NM Dallas, TX 
Miami, FL Baltimore, MD Taos, NM Houston, TX 
Quincy, FL Readfield, ME New York, NY 
Source: Blair et al.,1994. 
In addition to understanding com mu n i ty attitudes tow a rd HIV preve n t i on pro g ra m s 
for adolescents, p reve n t i on planners and pro g ram managers need to have a thoro u g h 
k n owledge of the laws and re g u l a t i on s re g a rding HIV preve n t i on activities for adoles­
c e n t s . These include the need for parental consent to administer medical ca re to minors 
e xcept for those deemed “e m a n c i p a t e d” by the court s . These youth have been legally re-
leased from the superv i s i on of their pare n t s . H ow eve r, in eve ry state there are now laws 
that permit minors to give their own consent for certain health s e rv i c e s , w h i ch may in­
clude those related to STDs and other infectious diseases. Those states that con s i d e r 
HIV or AIDS either an infectious or sexually transmitted disease often permit adoles­
cents to provide their own consent for receiving HIV preve n t i on counseling and testing. 
Laws, Regulations, and Practices 
As seen above with adolescents, the nature and scope of HIV prevention initiatives 
for drug users are shaped by various laws and re g u l a t i on s . This section examines 
some of the more important laws and regulations for prevention planners and pro-
g ram managers to consider when planning HIV preve n t i on pro g ra m s , i n cl u d i n g 
p re s c ri p t i on and para ph e rnalia laws, re g u l a t i ons protecting the con fid e n t i a l i ty of 
clients in drug treatment, and HIV and AIDS reporting requirements. 
4-6 Public Policy Issues 
Prescription and Paraphernalia Laws 
These laws have been enacted pri m a ri ly to discourage illicit drug use. T h ey impose 
s eve re re s t ri c t i ons on the purchase and possession of equipment used to administer 
d ru g s . 
• Pr e s c ri p tion laws re q u i re that a person wishing to purchase syringes must have a valid 
m e d i cal pre s c ri p t i on for syri n g e s . In addition , s ome states re q u i re that syringe pur­
chasers show identifica t i on and provide their name, a d d re s s , and other identifyi n g 
i n f o rm a t i on . Pre s c ri p t i on laws are now in force in nine states and the District of 
C o l u m b i a , as well as Pu e rto Rico. A number of counties within states also have pre-
s c ri p t i on laws. In the states in which these laws are in effe c t , physicians are all owed to 
p re s c ribe hyp o d e rmic equipment on ly for medical purp o s e s , and ph a rmacists mu s t 
keep re c o rds of the sale of all syringes and needl e s . 
• Pa ra p h e rnalia laws in 45 states make it illegal to distribute or possess equipm e n t 
intended for injecting, s m ok i n g, or otherwise consuming illegal substances. 
These and other laws, s u ch as “d ru g - f ree zon e s ” that prohibit persons convicted of a 
d ru g - related crime from entering certain loca t i ons during certain times of the day, 
a re con s i d e red by many advocates of HIV risk re d u c t i on to be major barriers to ob­
taining and ca r rying sterile syri n g e s . Ac c o rding to a re p o rt on syringe exchange by 
the Institute for Health Po l i cy St u d i e s , U n i ve r s i ty of Californ i a , San Fra n c i s c o, t h e s e 
laws con t ribute to continued syringe sharing re p o rted among IDUs (Lu rie et al., 
1 9 9 3 ) . M a ny groups have ca lled for the repeal of these laws, i n cluding the Na t i on a l 
C om m i s s i on on AIDS and the Na t i onal Research Council (Na t i onal Com m i s s i on 
on AIDS, 1 9 9 1 ; No rm a n d , et al., 1 9 9 5 ) , as well as the recent NIH Consensus De­
ve l o pment Con fe rence (NIH , 1997) and many com munities have changed their 
l a w s . Case Example 4.3 provides a descri p t i on of changes made in Con n e c t i c u t’s 
l a w s . H ow eve r, access to sterile syringes continues to ev oke debate as states and 
c om munities rev i ew their policies in light of drug con t rol and HIV preve n t i on effort s . 
Case Example 4.3 
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Attitudes and Practices of Law Enforcement 
Officers and Pharmacists 
Both law enforcement officials and ph a rmacists are con s i d e red key “g a t e k e e p e r s ” 
who can influence the ability of drug users to obtain and possess sterile syri n g e s . 
B e cause of their roles and re s p onsibilities in enforcing pre s c ri p t i on and para ph e r­
nalia laws, law enforcement officials and pharmacists often come into conflict with 
a d v o cates of syringe exchange and other similar strategies to reduce the risk of 
HIV tra n s m i s s i on among drug users. At the same time, t h ey are among the pro­
fe s s i onals and com mu n i ty leaders who can make valuable con t ri b u t i ons to the 
planning and implementation of com mu n i ty-wide HIV preve n t i on efforts for 
I D Us . E f fe c t i ve com mu n i ty-based HIV preve n t i on pro g rams re q u i re their on go­
ing support and participation. 
Law enforcement officials 
In general, law enforcement officials are considered to be “tough on drugs.” In ad­
dition to recognizing that many risk reduction measures, such as syringe exchange 
p ro g ra m s , a re in violation of pre s c ri p t i on and para ph e rnalia laws, m a ny believe 
that these types of pro g rams will result in: (1) a rise in the number of needles in 
circulation in a community; (2) an increase in crime and in other drug-related so­
cial ills; (3) an increase in the number of police officers receiving needle sticks; and 
(4) a decrease in the amount of attention devoted to addressing the underlyi n g 
causes of addiction . Case Example 4.4 demon s t rates the important role that the 
attitudes and behaviors of law enforcement personnel play in the use of sterile sy­
ringes by IDUs. 
Case Example 4.4 
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Pharmacists 
Pharmacists function as gatekeepers for IDUs to obtain syringes because they are a 
principal source of sterile syringes. For example, in Connecticut after the 1992 law 
change permitting the sale of up to 10 syringes without a medical pre s c ri p t i on , 
over 80 percent of pharmacies sold nonprescription syringes and drug users report­
ed significant increases in their purchase of syringes from a ph a rm a cy. In states 
that have prescription laws, pharmacists have to be alert for falsified prescriptions. 
In some, pharmacists who knowingly sell syringes to customers for the purpose of 
injecting illicit drugs can have their licenses suspended. 
I n c onsistencies in practices among ph a rmacists are documented even in states 
where no prescription laws exist. In a 1991 study, for example, less than 15 percent 
of ph a rmacists surveyed in a southern state re p o rted that they sold any syri n g e s 
(Compton et al., 1992). The remainder said they sold syringes only to those with a 
p re s c ri p t i on , even though one was not re q u i re d . M a ny ph a rmacists re p o rted re-
q u i ring each customer purchasing a syringe to sign for it as an indica t i on that the 
intended use was for legitimate medical re a s on s . Ph a rm a c i s t s ’ d i s c re t i on over the 
sale of syringes may affect equal access among IDUs , even where laws do not 
specifically prohibit sales, as shown in Case Example 4.5. 
Case Example 4.5

The Am e ri can Ph a rm a c e u t i cal Association has offic i a lly endorsed syringe exchange as a 
viable part of any com p re h e n s i ve appro a ch to HIV preve n t i on that includes outre a ch , 
c o u n s e l i n g, t re a t m e n t , and com mu n i ty inv o lvement in pro g ram design (No rmand et al., 
1 9 9 5 ) . The Association believes ph a rmacists are in a unique position to make a signifi­
cant con t ri b u t i on to HIV preve n t i on efforts by providing access to sterile syri n g e s . 
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This position is not universal how eve r, and debates re g a rding the appro p ri a t e n e s s 
of various HIV risk re d u c t i on strategies occur. Du ring a 1995 panel workshop on 
syringe exchange and bleach distribution programs sponsored by the National Re-
s e a rch Council and the Institute of Medicine, the Na t i onal Association of Chain 
Drug St o res (composed of ph a rm a cy retailers) and the Na t i onal Ph a rm a c e u t i ca l 
A s s o c i a t i on (composed of pro fe s s i onal ph a rmacists) expressed con c e rn ove r : 
(1) disposal of used needles and syringes; (2) liability for occupational exposure of 
workers; (3) adherence to federal rules and regulations; (4) personal discretion; and 
(5) the high cost of complying with state and federal regulations (Normand et al., 
1995). 
Confidentiality and Mandatory Reporting 
A number of federal, state, and local laws have been enacted to protect the confi­
dentiality of those receiving treatment for drug abuse, HIV, sexually transmitted 
diseases (STDs), and general medical or mental health pro b l e m s . H ow eve r, m e d i ca l 
care providers are required by law to report to their state public health departments 
all cases of individuals diagnosed with AIDS, some STDs, tuberculosis, and other 
infectious diseases. All 50 states now require reporting of AIDS cases by name to 
the public health depart m e n t , and 26 states re q u i re named re p o rting of those testing 
positive for HIV antibodies (CDC, 1995). Reporting drug use, however, is a dif­
ferent matter. 
Confidentiality of Drug Abuse Treatment 
Patient Information 
In an effort to encourage participation in drug treatment programs, federal regula­
t i ons that protect the identities of persons in alcohol and drug treatment were 
e nacted in the early 1970s, implemented in 1975, and revised in 1987 by the 
D e p a rtment of Health and Human Se rvices (Title 42, Pa rt 2, Code of Fe d e ra l 
R e g u l a t i on s ) . R e c e n t ly, C on g ress re a f firmed and re o r g a n i zed the original statutes 
by merging them into Title 22 of the Public Health Service Act. This law ensures 
that strict fe d e ral con fid e n t i a l i ty standards are in place for clients in tre a t m e n t . I t 
also prohibits the disclosure, except under limited conditions (see Table 4.2), of in-
formation about patients by programs receiving federal assistance that allows them 
to provide tre a t m e n t , c o u n s e l i n g, a s s e s s m e n t , and re fe r ral services for people with 
drug problems. 
All state and local laws that address the confidentiality of patients in drug treat­
ment are superseded by this federal confidentiality law, unless state laws are more 
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re s t ri c t i ve . Although there are exc e p t i on s , 
even a court order is insufficient for 
d i sclosing inform a t i on without pri o r 
notification of the program and the 
client. Drug treatment programs that 
o f fer on-site HIV antibody testing, 
therefore, may seem to face a dilemma 
of complying with required HIV/AIDS 
re p o rting and limiting discl o s u re of 
i n - f o rm a t i on about clients in dru g 
treatm e n t . H ow eve r, this does not neces­
s a ri ly have to be the case. The law does 
not specifically prohibit the release of 
information about a cl i e n t’s HI V / A I D S 
s t a t u s , even though the release of infor­
m a t i on that would dire c t ly or indire c t ly 
identify an individual as a drug tre a t m e n t 
client is re s t ri c t e d . Table 4.2 lists 
those circumstances where disclosure 
of information about a patient’s drug 
treatment is permitted. 
Table 4.2:  Circumstances Perm i t t i n g 
D i s c l o s u re of Drug Treatment 
Patient Inform a t i o n 
The General Rule: The program may not disclose 
any information about any patient. 
Exceptions in Which Information 
May be Disclosed: 
• internal communications 
• disclosure that contains no patient identifying 
information 
• proper patient consent 
• Qualified Service Organization Agreement 
• medical emergency 
• research/audit/evaluation 
• court order 
• crime on program premises or against program 
personnel 
• need to report suspected child abuse and neglect 
Source: Legal Action Center. 
Confidentiality and Protection against 
Discrimination of People Living with HIV/AIDS 
Since the early years of the AIDS epidemic, the social stigma and the threat of 
discrimination against persons with AIDS has been clearly recognized. Because of 
this discrimination, many states have passed special laws to protect against the un­
w a r ranted release of inform a t i on about a person’s HIV status. These laws are in-
tended to promote fair treatment and make it more likely that persons at risk will 
accept HIV testing and early intervention. 
In addition to these laws, broad protections against discrimination are provided by 
the 1990 Am e ri cans with Disabilities Act (ADA ) . The ADA prohibits discri m i­
n a t i on in housing, public access, and employment against people who have or are 
p e rc e i ved to have a disability. Under the act, those who are infected with HIV or 
diagnosed with AIDS are considered “people with disabilities.” 
The ADA re q u i res drug treatment providers to make “re a s onable accom m o d a­
t i on s ” to ensure that individuals with HIV/AIDS can participate in and benefit 
f rom treatment serv i c e s . Su ch accom m o d a t i ons include arranging home adminis­
t ra t i on of methadon e, reducing the number of re q u i red weekly therapeutic ses-
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s i on s , and making special living arrangements in a residential setting in order to 
curb opportunities for exposure to infectious disease. In addition, the act makes it 
illegal to require HIV testing as a condition for admission to drug treatment. 
Agency Policies and Practices 
The policies and practices of agencies serving drug users vary in re l a t i on to HI V 
p reve n t i on . For instance, d rug treatment pro g rams may be con c e rned that HI V 
e d u ca t i on will undermine their messages about abstaining from drug use. Si m i l a rly 
c o r re c t i onal officers may be appre h e n s i ve about discussing safer sex or syri n g e 
d i si n fe c t i on since sexual behavior and drug use are prohibited within corre c t i on a l 
i n s t i t u t i on s . These con flicting views often result in discon t i n u i ty of preve n t i on 
s e rvices needed for drug users. HIV preve n t i on planners and pro g ram managers 
must re c o g n i ze that pro g rams linking various service agencies need to be coord i­
nated to ensure a com p re h e n s i ve and consistent appro a ch to HIV preve n t i on 
a m ong drug users. This section takes a closer look at some of the dynamics associated 
with differences among agency policies and practices. 
Abstinence-Based Drug Treatment Programs 
and HIV Risk Reduction 
The purpose of most drug treatment pro g rams is to help clients stop all drug use. 
G i ven that go a l , m a ny drug treatment pro g rams have diffic u l ty providing their 
clients with dru g - related ri s k - re d u c t i on educa t i on and advice. Te lling drug users 
t h a t , if they re l a p s e, t h ey should use sterile syringes to mix and pre p a re drugs and 
n ever use a cooker or cotton after another drug user may appear to be tempting the 
re c ove ring user to re s t a rt drug use. This con flict may exist even though the staff of 
the drug treatment pro g ram ack n owledge that relapse is a real risk for cl i e n t s . 
For some treatment pro g ra m s , e d u cating clients on how to prevent the sexual 
transmission of HIV may seem unrelated to, or even in conflict with, their mission 
to help the person recover from drug dependence. This is particularly true if a pro-
g ram subscribes to the ph i l o s o phy that individuals in the early stages of re c ove ry 
should refrain from forming sexually-intimate relationships. 
Abstinence-based treatment pro g rams encourage clients to disclose what may be 
very personal information about their drug use and its consequences as a means to 
maintain their recovery. However, conflicts regarding confidentiality and the right 
to privacy may arise for clients who are HIV-infected. At the very outset of treat­
ment, clients in such programs need to be fully apprised of the program’s philoso­
phy and expectations as well as be made aware of the measures that are in place to 
safeguard their rights regarding such personal matters as HIV status. 
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AIDS Service Organizations 
Although early in the epidemic, 
many AIDS Service Organiza- Case Example 4.6

t i ons (ASOs) focused their effort s

on gay and bisexual men, a l a r g e

number now conduct com p re-

h e n s i ve preve n t i on pro g rams f o r

i n j e c t i on and non - i n j e c t i on dru g

u s e r s . These include a range of

a c t i v i t i e s , f rom on e - on - on e

counseling to street outre a ch ,





ASOs with HIV preve n t i on

p ro g rams may be an exc e ll e n t

s o u rce of inform a t i on about

h i g h - risk drug users. These

org a n i za t i ons may be able to sup-

p l e m e n t existing epidemiologic

data with qualitative inform a t i on

based on re s e a rch con d u c t e d

d u ring the design of pro g ra m s .

ASO p e r s on n e l also may be able

to provide insights about dru g

related behavior gained from

m a ny hours of direct observ a t i on .

M a ny ASOs have adopted ri s k

reduction or “recovery readiness”

programs that focus on reducing

the individual drug user’s risk of

c on t racting HIV rather than on

re q u i ring immediate part i c i p a­

t i on in drug treatment pro g ra m s . This appro a ch re c o g n i zes the diffic u l ty inherent in

abstaining from drug use and the lack , in many com mu n i t i e s , of adequate tre a t­

ment facilities. Case Example 4.6 describes one such appro a ch , the Gay Men’s

Health Crisis (GMHC) “Steps Toward Change” program.

1.	 For information about ASOs that provide these services in specific communities, contact the CDC’s National AIDS 
Clearinghouse. PART 5: RESOURCES contains contact information for the Clearinghouse. 
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The Criminal Justice System 
The HIV/AIDS epidemic has had important implications for the criminal justice 
system, particularly in the northeast and other areas with high HIV seroprevalence 
a m ong drug users. Ye t , within the con fines of the criminal justice sys t e m , t ra d i­
tional policies prohibiting sexual activity and drug use make it difficult for correc­
tions staff to establish HIV prevention programs. 
Despite these con s t ra i n t s , h ow eve r, m a ny have succeeded in developing con s t ru c­
tive and dynamic HIV prevention programs. These programs serve not only those 
who are inca rc e ra t e d , but also those who soon will be released into society. M a ny 
of these programs actively discuss safer sex practices, as well as procedures for dis­
infecting drug injection equipment. According to the National Institute of Justice, 
86 percent of all U.S. fe d e ral and state pri s on sys t e m s , and 58 percent of all 
c i ty / c o u n ty corre c t i onal systems provided instructor-led AIDS educa t i on for in-
mates over the course of the previous year (DO J, 1 9 9 4 ) . C u r re n t ly, c on d oms are 
made available to inmates in the following six correctional systems: District of Co­
l u m b i a , M i s s i s s i p p i , Ve rm on t , New Yo rk City, San Fra n c i s c o, and Ph i l a d e l ph i a . 
Seve ral examples of coll a b o ra t i ve efforts to develop and implement HIV preve n t i on 
p ro g rams within corre c t i onal systems are described in Exhibit J. 
Improving Cooperation Among Programs 
Serving Drug Users 
Drug injectors and persons using cra ck cocaine account for a major pro p o rt i on of 
the HIV and AIDS cases in many parts of the United St a t e s , p a rt i c u l a rly the 
No rt h e a s t , So u t h , and Pu e rto Rico ( J oh n s on , B a s s i n , and Sh a w, v o l . I , 1 9 9 5 ) . I f 
the spread of HIV among drug users, their sex partners and ch i l d ren is to be 
slowed, the organizations providing HIV prevention, drug treatment, medical and 
social services to drug users must cooperate. 
Substantial barriers prevent agencies from working together, h ow eve r. For exam-
p l e, substantial diffe rences in ph i l o s o phy and organiza t i onal culture among dru g 
t re a t m e n t , health depart m e n t , and com mu n i ty-based pro g rams often exist. In ad­
dition, the laws and regulations established to protect HIV-infected people in drug 
treatment from stigma and discrimination may make it more difficult for the orga­
nizations attempting to help these individuals to obtain or share basic information 
about the clients. 
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Georgia	 In collaboration with the state correctional authori­
ties, the Georgia Division of Public Health, now pro­
vides a four-session HIV prevention education pro-
gram for inmates in 20 state prisons. The program 
includes overviews of: AIDS and HIV; substance 
abuse, addiction and HIV (including a demonstration 
on bleach disinfection of injection equipment); and 
methods to reduce the risk of sexual transmission of 
HIV and other STDs. Program faculty include com­
munity health educators who are in recovery. 
Source: Hammett et al.,1995. 
New York	 In 1989, the AIDS Counseling and Education (ACE) 
Program was established by female inmates in New 
York’s Bedford Hills Correctional Facility. The pro-
gram was established because of inmates’ fears of 
HIV transmission and concerns that HIV-infected 
inmates might be stigmatized. Inmates were selected 
as peer educators and received training and certifica­
tion by the New York State Department of Education. 
Peer educators then took responsibility for training 
all inmates and correctional staff. 
Source: Hammett et al.,1995. 
Rhode Island	 A high percentage of persons in Rhode Island who 
have been diagnosed with HIV are in the state prison 
system. The Rhode Island Department of Health, in 
conjunction with the State Department of 
Corrections and the Brown University AIDS Program, 
instituted a program to improve the health of HIV-
infected inmates, both during their incarceration and 
after their release. Services offered include HIV coun­
seling and testing, medical management, substance 
abuse counseling and treatment, and discharge plan­
ning. 
Source: Hammett et al.,1995. 
Despite these barri e r s , p reve n t i on planners and pro g ram managers should pro-
mote i n t e ra g e n cy coll a b o ra t i on to foster more effe c t i ve HIV preve n t i on effort s . Ex­
amples include better collaboration between: 
• correctional institutions and the essential services that discharged inmates will need in 
the community (e.g., drug treatment, HIV prevention programs designed for parolees, 
housing, job preparedness) 
• agencies addressing homelessness, mental illness, drug dependence, and HIV prevention 
for hard-to-reach populations 
• school-based health clinics and health education programs that are working with youth 
at risk for drug use or HIV, and community-based organizations and religious organi­
zations that are addressing prevention issues for youth 
For those inv o lved in planning or implementing HIV preve n t i on pro g ra m s , t h e 
message is cl e a r. To make com mu n i ty pro g rams serving drug users and their sex 
partners the most effective, substantial efforts must be made to: 
• identify all the pro grams working with drug users in any cap ac i ty; b ring them toge t h er 
so that philosophical and cultural differences can be identified and understood 
• provide cross-training for the staff of the organizations that need to cooperate 
• develop “structural” relationships (e.g., memoranda of understanding, qualified service 
organization agreements) that will facilitate cooperation 
• identify ways to continually maintain and enhance established linkages 
Some examples of inter-agency efforts appear in Exhibit K. 
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Inter-Agency HIV Prevention Efforts

New York City	 In 1992, the ADAPT program in New York City 
received a waiver from the state department of 
health to establish a syringe exchange program. 
Program staff members issued cards to injection 
drug users. The cards identified these individuals as 
registered participants of the needle exchange pro-
gram. As such, any needles they obtained through 
the program were exempt from the prescription law. 
Staff members apprised and updated local law 
enforcement officials of program activities through 
reports and presentations. If an individual who was 
in possession of an illicit needle was apprehended, 
police could call the program staff to verify whether 
the drug user was registered in the program’s per­
sonalized, computer numbering system. 
Source: Lurie et al.,1993. 
San Francisco	 The AIDS office of the San Francisco Department of 
Public Health (SFDPH), the San Francisco Unified 
School District, community-based organizations, and 
the religious community have put in place an exten­
sive youth-centered collaborative to reach youth at 
risk for drug abuse, HIV infection, and other prob­
lems. The collaborative allows both in- and out-of-
school youth to work as paid agency staff and volun­
teers in agencies that serve youth. A few examples 
include the placement of youth in Central City 
Hospitality House and Larkin Street Youth Centers to 
work with homeless and runaway youth, and the 
placement of Latino youth in the Real Alternatives 
Program. Community Substance Abuse Services, 
also a part of SFDPH, funds community-based orga­
nizations to provide substance abuse education in 
the schools. 
Source: Valerie Kegebein,MPH,Chief, HIV Prevention Planning, 
Policy and Health Education,AIDS Office, San Francisco Department of 
Public Health 
Key Questions for HIV Prevention

Planners and Program Managers

The foll owing key questions related to PA RT 4 may be helpful in guiding HI V 
prevention planners and program managers as they plan, develop, implement, and 
support prevention programs for drug users and their sex partners: 
■	 Who are the decision makers in your com mu n i ty whose support is needed t o 
s u c c e s s f u lly implement HIV preve n t i on pro g rams for drug users? 
■	 How might these community leaders’ attitudes, beliefs, and values 
influence the support of various types of prevention interventions? 
■	 Are there prescription requirements for the purchase of syringes or drug 
paraphernalia penalties for possession of syringes in your community? 
Do pharmacy regulations limit the ability of pharmacists to sell syringes 
to persons who may be drug users? 
■	 Are drug users who are found in possession of syringes arrested and 
jailed or fined? 
■	 Are drug treatment programs in your community receptive to “risk 
reduction” counseling for their clients? 
■	 Which federal, state, and local laws and regulations may affect HIV 
prevention efforts in your area? 
■	 What means are available to improve com mu n i ca t i on among serv i c e 
p roviders assisting drug users and still protect client pri v a cy and the ri g h t 
to con fid e n t i a l i ty ? 
■	 Is modification of existing state or local laws and regulations or agency 
policies and practices to enhance the effectiveness of HIV prevention 
programs an option? 
■ A re existing AIDS Se rvice Organiza t i ons providing services to drug users? 
■	 What kinds of existing HIV prevention programs are offered to drug 
users and staff in the jails, prisons, and other criminal justice agencies 
(e.g., juvenile facilities, probation and parole departments) in your com­
munity? 
■	 Are staff of these programs serving on your state or local HIV 
Prevention Community Planning Group? 
■	 Are persons in drug treatment or persons still actively using drugs serv­
ing on your state or local HIV Prevention Community Planning Group 
or inv o lved in any way in preve n t i on planning in your state or com mu n i ty ? 
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National Library of Medicine (NLM)

Food and Drug Administration (FDA)

Health Resources and Services Administration (HRSA)

National Institute on Drug Abuse (NIDA)

National Resources 
American Foundation for AIDS Research (AmFAR)

Center for AIDS Prevention Studies (CAPS)

U.S. Conference of Mayors

State Resources 
National Alliance of State and Territorial AIDS Directors (NASTAD) 
National Association of State Alcohol and Drug Abuse Directors 
(NASADAD) 
Community Epidemiology Work Group 
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Ordering Information for Documents 
Referenced in the HPDU Resource Book 
R E S O U R C E S

There are many sources of materials and information related to HIV and drug use 
that can be helpful to Com mu n i ty Planning Groups and others inv o lved in HI V 
prevention efforts. However, knowing what resources are available and how to ac­
cess those resources can sometimes be challenging. 
PA RT 5 is designed to help HIV preve n t i on planners and pro g ram managers iden­
t ify available inform a t i on re s o u rces related to HIV and drug use. Sp e c i fica lly, 
PA RT 5 will: 
• provide descriptions of federal government agencies and selected national and state 
level nongovernmental organizations involved in HIV prevention among drug users; 
• provide information on the Community Epidemiology Wo rk Group (discussed in PA RT 2 ) 
and the Supplement to HIV/AIDS Surveillance Project (discussed in PART 3); and 
• provide contact and ordering information for publications and organizations refer­
enced in this document. 
Please note that this part of the HPDU Resource Book is not intended to prov i d e 
information directly related to getting technical assistance in the development, im­
p l e m e n t a t i on , or ev a l u a t i on of HIV preve n t i on activities with drug users. Ra t h e r, 
it is a listing of inform a t i on re s o u rces that can provide educa t i onal materials and 




The fe d e ral gove rnment provides a wide range of inform a t i on on HIV/AIDS that is 
available in both paper and electronic form a t s . Sp e c i fic inform a t i on on drug use and 
HIV/AIDS can be obtained through a vari e ty of diffe rent agencies and institutes. A 
c om p re h e n s i ve litera t u re search will inv o lve using the re s o u rces listed below. 
To streamline the process of seeking inform a t i on and materi a l s , users should al­
w ays start their search by contacting either the CDC Na t i onal AIDS Cleari n g-
house (NAC) or the Na t i onal Clearinghouse on Alcohol and Drug Inform a t i on 
( N CA D I ) . These cl e a ringhouses are re p o s i t o ries of gove rn m e n t - p roduced re p o rt s 
and educa t i onal materi a l s . Another major source of inform a t i on is the Na t i on a l 
Library of Medicine, which provides access to the wealth of academic HIV/AIDS 
literature through the free database, AIDSLINE. A description of each resource is 
provided below, including service and contact information. 
Centers for Disease Control and Prevention 
http://www.cdc.gov 
1600 Clifton Road, NE 
Atlanta, GA 30305 
The Centers for Disease Control and Prevention (CDC) assesses the status and 
characteristics of the AIDS epidemic and the prevalence of HIV infection, and 
supports, through financial and technical assistance, the design, implementation, 
and evaluation of HIV prevention and education activities. CDC’s HIV/AIDS 
prevention initiatives are carried out primarily through the Division of HIV/AIDS 
Prevention National Center for HIV, STD, and TB Prevention (NCHSTP) 
(http://www.cdc.gov/nchstp/hiv_aids/dhap.ht). CDC’s HIV/AIDS information 
dissemination is carried out through the National AIDS Clearinghouse (NAC), 
described below. 

























The CDC National AIDS Clearinghouse (NAC) is the nation’s reference, referral, 
and distri b u t i on service for HI V / A I D S - related inform a t i on . The Cleari n g h o u s e 
c o ll e c t s , o r g a n i ze s , and disseminates materials and inform a t i on on HIV infe c t i on 
to people and organiza t i ons working in the field of HI V / A I D S . A ll of the Clear­
inghouse’s services are designated to facilitate sharing of information and resources 
among Clearinghouse users on education and prevention services, published mate-
rials, research findings, and trends. 
S E RVICES AVA I L A B L E 
C o m p rehensive re f e rence and re f e rral services. R e fe rence specialists are 
available to assist preve n t i on planners, p ro g ram managers, and staff locate infor­
m a t i on on various aspects of HIV/AIDS preve n t i on by ca lling the Cleari n g h o u s e 
d i re c t ly (1-800-458-5231). R e fe rence specialists can provide inform a t i on thro u g h 
the following two search services: 
• Standard Search Series: These literature searches are pre-produced by 
Clearinghouse staff. They include information on a variety of current 
HIV/AIDS-related topics including HIV and drug use. 
• Customized search: Reference specialists are available to help in planning and 
conducting a search strategy specific to individual needs. They can execute 
searches over the phone and send the results, along with the documents to 
requestors. 
HIV/AIDS-Related Databases.The Clearinghouse provides access to a number of 
HIV/AIDS- related databases. These databases, which are listed below, can be a c­
cessed through NAC ONLI N E1, a com p u t e ri zed inform a t i on netw o rk that offers a 
direct link to the Clearinghouse’s comprehensive information collection. Users can 
access the databases directly through NAC ONLINE, or they can contact a refer­
ence specialist at the Clearinghouse (1-800-458-5231) to conduct a search. 
• Educational Materials Database: consists of nearly 15,000 descriptions of 
prevention materials, many of which are available directly from the 
Clearinghouse. 
• Resources and Services Database: descriptions of nearly 20,000 organiza t i o n s 
that provide HIV/AIDS preve n t i o n , e d u ca t i o n , and social services. 
1.	 NAC ONLINE can be accessed directly using a modem by following these instructions: 
A. Set your communications software to dial 1-800-851-7245 
B. Set the options for 8 data bits, no parity, 1 stop bit, full duplex 
C. Complete a new user questionnaire 
Full access to the NAC ONLINE system will be provided after your registration form is processed. 
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• Funding Database: includes private and government funding opportunities 
for community-based HIV/AIDS service organizations. 
• Comprehensive School Health Education Database: includes information on 
resources to help educate children and young adults about HIV/AIDS. 
• AIDS Daily Summary Database: consists of abstracts of HIV/AIDS-related 
articles from major newspapers, wire services, medical journals, and news 
magazines. 
• Conference Database: describes HIV/AIDS-related meetings, seminars, and 
workshops. 
• CDC Morbidity and Mortality Weekly Report (MMWR) Database: 
includes all HIV/AIDS-related articles issued in the MMWR series. 
• Periodicals Database: contains bibliographic information for HIV/AIDS-
related newsletters and journals. 
• Federal Information Database: includes Federal press releases and statements 
on HIV/AIDS. 
Fax on Demand Service (NAC FAX). This is a re l a t i ve ly new service of the 
Clearinghouse that provides information directly by fax machine, 24 hours a day, 7 
d ays a week. D o c u m e n t s , i n cluding CDC fact sheets, s u rve i llance re p o rt tables, 
and information on Clearinghouse services, are available free through this service. 
Publications Distribution. Single and bulk copies of CDC educa t i onal bro ch u re s , 
p o s t e r s , re p o rt s , and videotapes are available from the Clearinghouse upon re q u e s t . 
Internet Services. The Clearinghouse maintains an Internet mailing list, gopher 
server, Webpage, the AIDSNEWS Listserv, and an anonymous File Transfer Pro­
tocol (FTP) site through which it provides general inform a t i on , accepts re fe re n c e 
questions, and accepts orders for free publications. (http://www.cdcnac.org) 
• AIDSNEWS Listserv: This listserv sends out daily, c u r rent aware n e s s 
information to subscribers including: the AIDS Daily Summary, confer­
ence inform a t i on , announcements of re l evant CDC publica t i on s , lists of 
newly acquired NAC publications, and new treatment information. 
To join the AIDSNEWS Listserv send an Internet email message to the following 
a d d re s s : l i s t s e rv @ c d c n a c . a s p e n s ys . c om with the foll owing command in the subject 
l i n e : s u b s c ribe aidsnews (your first name your last name). You will be prompted for 
f u rther inform a t i on . 
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CDC Hotline and Telephone Information Services 
C DC has a vari e ty of teleph one services for the general public that can be used by 
prevention planners and program managers to answer specific questions about 
HIV/AIDS. 
(800) 342-AIDS (English Hotline) 
(800) 344-SIDA (Spanish Hotline) 
(800) 243-7012 (Hotline for TTY/TDD users) 
(404) 332-4570 (Statistics Information Line) 
(404) 332-4555 (Voice Information System) 
(404) 332-4565 (Fax Information Service) 
CDC National AIDS Hotline. The CDC Na t i onal AIDS Hotline is a toll - f re e 
HI V / A I D S - related inform a t i on service that provides con fidential inform a t i on , refer­
rals, and educational materials to the public. The Hotline operates 24 hours a day, 
7 days a week (see above for phone numbers). 
CDC Automated Telephone Services. The CDC HIV/AIDS Statistics Infor­
m a t i on Line provides current statistics on HIV infe c t i on and AIDS. C D C’s Vo i c e 
I n f o rmation Syste m p rovides up-to-date inform a t i on on a vari e ty of health-re l a t e d 
t o p i c s , i n cluding HI V / A I D S . To re c e i ve free faxes on a vari e ty of HI V / A I D S -
related topics, ca ll the CDC Fax Inform a t i on Se rvice (see above for ph one numb e r s ) . 
5-6 Resources 
Substance Abuse and Mental Health 







(301) 443-8956 (Office of Communications)





SAMHSA’s mission is to improve the quality and availability of prevention, treat­
ment, and rehabilitation services in order to reduce illness, death, disability, and 
cost to society resulting from substance abuse and mental illnesses. SAMHSA 
administers the Alcohol, Drug Abuse, and Mental Health Services Block Grant 
and other grant programs that provide states and localities with support for sub-
stance abuse and mental illness treatment and prevention programs. 
SAMHSA is composed of three Centers that carry out the agency’s mission of pro­
viding substance abuse and mental health services: 
• The Center for Mental Health Services (CMHS) heads efforts to speed the 
application of mental health treatments for patients with mental illness. 
• The Center for Substance Abuse Prevention (CSAP) leads the federal efforts 
to prevent alcohol and other drug abuse in the US. 
• The Center for Substance Abuse Treatment (CSAT) designs pro grams to 
i m p ro ve treatment services and make them more ava i l a ble to those in n e e d. 















S A M H S A’s Center for Substance Abuse Preve n t i on (CSAP) sponsors the Na t i on a l 
C l e a ringhouse for Alcohol and Drug Inform a t i on (NCA D I ) , the one-stop resource 
for federal alcohol and drug information. NCADI is the world’s largest resource for 
current information and materials concerning substance abuse prevention. It pro-
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vides current p rint and audiovisual materials about alcohol and other dru g s , i n cl u d­
ing materials explaining the risk of HIV transmission from sharing needles during 
injection drug use and from unsafe behaviors stemming from the effects of sub-
stance abuse. NCADI’s resources include scientific findings; databases on preven­
tion programs and materials, field experts, federal grants, and market research; and 
information about organizations and groups concerned with alcohol and other 
drug problems. 
S E RVICES AVA I L A B L E 
Bibliographic Research. N CADI maintains six databases containing ove r 
80,000 studies on alcohol and drugs and preve n t i on . The public may access all 
N CADI databases through NCA D I’s We b p a g e, P REV LINE located at (http : / / 
www.health.org).They also can access the databases onsite in the Resource Center 
( w h i ch is located in Rock v i ll e, MD and is open to the public, M on d ay thro u g h 
Fri d ay, 9:00am till 5:00pm ) , or they may request assistance from the inform a t i on 
s e rvices staff over the teleph one (800-NCA D I - 6 4 ) . C u s t om i zed searches in the 
f o rm of annotated bibliogra phies from alcohol and other drug databases also are 
available upon request. 
Publications Distribution. NCADI houses culturally diverse prevention materi­
a l s , t a i l o red for use by pare n t s , t e a ch e r s , yo u t h , c om mu n i t i e s , and preve n t i on pro­
fessionals. It publishes a quarterly catalog that contains the references to hundreds 
of educational materials related to alcohol and drug abuse, organized by target au-
d i e n c e . M a ny of these publica t i ons can be downloaded from NCA D I’s We b p a g e, 
(http://www.health.org). 
Prevention Pipeline. This is a bimonthly publication by CSAP on emerging pre­
vention science, educational materials, and program profiles. Contact NCADI for 
ordering information. 
The National Resource Center for the Prevention and Treatment of 
Alcohol, Tobacco, and Other Drug Abuse, and Mental Illness in Wo m e n 
is a coll a b o ra t i ve effort between CSAP, C S AT, C M H S , S A M H S A’s Office for 
Wom e n’s Se rvices (OW S ) , and the Maternal and Child Health Bureau (MCHB), 
p a rt of the Health Resources and Se rvices Ad m i n i s t ra t i on (HRS A ) .The Center pro­
vides an Inform a t i on and Refe r ral line at (800) 354-8824 or (703) 836-8761 and a 
d i rect line (modem to modem) for PREMIS (the Center’s specialized inform a t i on 
database and electronic com mu n i ca t i ons system (800) 354-8825. 
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Regional Alcohol and Drug Awareness (RADAR) Network. This is an 
international communications network that distributes prevention information and 
provides a nationwide linkage of alcohol and other drug information centers locat­
ed in every state. A listing of these centers and their corresponding webpages can 
be found at http://www.health.org. 
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(800) 638-8480 (MEDLARS Service Desk)

The National Library of Medicine (NLM) is the world’s largest research library 
serving a single scientific and professional field. The Library collects materials 
exhaustively in all major areas of the health sciences. It produces the MEDLARS 
(Medical Literature Analysis and Retrieval System) databases to offer online and 
Internet access to the contents of medical and public health literature. 
S E RVICES AVA I L A B L E 
Databases. NLM produces three databases focusing on HIV/AIDS incl u d i n g : 
AIDSLINE, AIDSTRIALS, and AIDSDRUGS. Any major search for literature on 
HIV/AIDS should include a database search of A I D S L I N E. Online access to all 
three databases is free of charge. 
AIDSLINE: Contains references to the published literature on HIV/AIDS with 
a focus on the biomedical, epidemiologic, oncologic, public health, and social 
and behavioral science literature. It contains citations (with abstracts if avail-
able) to journal art i cl e s , m on o g ra ph s , meeting abstracts and papers, and re-
ports from 1980 to the present. 
AIDSTRIALS: Contains information about HIV/AIDS related clinical trials. 
AIDSDRUGS: Contains descriptive information about each drug beign tested in 
HIV/AIDS Clinical trials. 
A I D S LINE and its related databases can be accessed in seve ral ways . Public li­
b ra ries and unive r s i ty libra ries often have access to these databases. The NLM 
s o ftw a re pack a g e, G rateful Med and Internet Grateful Med also give users access 
to these databases. For more inform a t i on on how to access the AIDSLINE data-
bases through Grateful Med contact the MED LA RS Se rvice Desk at (800) 
638-8480 or visit Internet Grateful Med at http : / / i g m . n l m . n i h . gov. For inform a­
t i on on local libra ries that have access to these databases and other health re-
s o u rc e s , ca ll the Na t i onal Ne tw o rk of Libra ries of Medicine at (800) 338-7657. 
An inform a t i on specialist will provide a re fe r ral to local unive r s i ty and medical 
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libraries that are willing to provide non-affiliated users with library services such as 
online database searching, access to journal literature, books, and audiovisuals. 
The NLM Webpage. The NLM Webpage (http : / / w w w. n l m . n i h . gov) prov i d e s 
t i m e ly health inform a t i on to com munities affected by the HIV infe c t i on . It pro­
vides access to the HI V / A I D S - related inform a t i on available through NLM includ­
ing the Guide to NIH AIDS Information Resources, the monthly AIDS bibliog­
raphy, access to the abstracts from the XI International Conference on AIDS, and 
links to many other high quality HIV/AIDS Webpages outside NLM. It also pro­
vides a link to Internet Grateful Med and available NLM databases. 
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Phone:(301) 443-3170 (Consumer Affairs)

(301) 443-0104 (Clinical Trials)

(800) TRIALS-A (Clinical Trials)

(800) 222-0185 (online connect)

The FDA is responsible for assuring the safety and effectiveness of drugs, biolog­
ics, vaccines, and medical devices used in the diagnosis, treatment, and prevention 
of HIV infection, AIDS, and AIDS-associated opportunistic infections. FDA 
works also with the blood banking industry to help ensure the safety of the nation’s 
blood supply. The agency is a co-sponsor of the AIDS Clinical Trials Information 
Service. 
S E RVICES AVA I L A B L E : 
The FDA Webpage. The FDA Webpage (http : / / w w w. fd a . gov) provides users 
with a wealth of inform a t i on on biologics, f o o d s , human dru g s , m e d i cal dev i c e s 
and radiological health, toxicology, and field operations. It contains a sophisticated 
s e a rch engine that enables users to search all the documents located on the FDA 
We b p a g e . M a ny documents can be found on the topics of HIV/AIDS and sub-
stance abuse that can then be downloaded or printed directly. 
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Phone:(800) 933-3413 (National HIV Telephone Consulting Service)

(301) 443-6364 (HIV Clinical Conference Call Series)

(301) 443-6364 (AIDS Education and Training Centers)

(800) 362-0071 (National Pediatric HIV Resource Center)

(301) 443-4588 (Clinical Issues Subcommittee)

HRSA administers education and training programs for health care providers and 
community service workers who care for AIDS patients. HRSA administers pro-
grams funded by the Ryan White CARE Act to demonstrate how communities 
can organize their health care resources to develop an integrated, comprehensive 
system of care for those with AIDS and HIV infection. 
S E RVICES AVA I L A B L E 
National HIV Telephone Consulting Service. This toll-free service provides in-
f o rm a t i on on dru g s , cl i n i cal tri a l s , and the latest treatment methods to phys i c i a n s 
and other health ca re pro fe s s i onals who have questions about providing ca re to 
people with HIV infe c t i on or AIDS. A ll staff members are health pro fe s s i on a l s 
with extensive experience in outpatient and inpatient pri m a ry ca re of people with 
HI V- related diseases. The service is available from 10:30 a.m. to 8 p. m . M on d ay 
through Friday, Eastern time (see above for phone number). 
HIV Clinical Conference Call Series. In coll a b o ra t i on with the Na t i onal Insti­
tute of All e r gy and Infectious Diseases (NIAID), H RSA offers intera c t i ve, t o ll -
f ree audio telecon fe rences during which pri m a ry health ca re providers from many 
disciplines have the opport u n i ty to discuss timely cl i n i cal issues with intern a t i on-
ally renowned clinical experts (see above for phone number). 
AIDS Education and Training Centers (AETCS). HRSA supports a network of 
17 re g i onal centers that serve as re s o u rces for educating health pro fe s s i onals in 
prevention, diagnosis, and care of HIV-infected patients. The centers train prima­
ry care providers to incorporate HIV prevention strategies into their clinical prac­
t i c e s , a l ong with helping them diagnosis, c o u n s e l , and ca re for HI V- i n fected per-
s ons and their families. To find the name and ph one number for the AETC in 
your area contact the AIDS ETC Program (see above for phone number). 
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National Pediatric HIV Resource Center. The Bureau of Maternal and Child 
H e a l t h , H RS A , s u p p o rts the Na t i onal Pe d i a t ric HIV Resource Center, w h i ch of­
fers a range of services to professionals caring for children, youth, and families af­
fected by HIV infection. The Resource Center provides consultation, technical as­
s i s t a n c e, p o l i cy analys i s , and cl i n i cal tra i n i n g. The center is accessible from 9 a.m. 
to 5 p.m. Eastern time and can be reached by calling 1- (800) 362-0071, fax: (201) 
485-2752, or by writing to the National Pediatric HIV Resource Center, 15 South 
Ninth Street, Newark, NJ 07107. 
Clinical Issues Subcommittee. The Clinical Issues Su b c ommittee of the 
HRSA AIDS Advisory Committee was established to facilitate timely dissemina­
t i on of inform a t i on about new deve l o pments in cl i n i cal re s e a rch , d rug deve l o p­
ment, and policies on HIV/AIDS into language relevant for practicing caregivers, 
principally those supported by HRSA’s HIV/AIDS-related programs. NIAID and 
the NIH Office of AIDS Research have participated in all its activities. For infor­
mation, contact Pe a rl Ka t z , Ph D, AIDS Pro g ram Offic e, Health Resources and Se r-
vices Ad m i n i s t ra t i on , 5600 Fishers La n e, R o ck v i ll e, MD 20857; (301) 443-4588. 
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Phone: (301) 443-6245 (Publications)

(800) 729-6686 (National Clearinghouse on Al c ohol and Drug 
Information) 
(703) 487-4650 (National Technical Information Service) 
(301) 443-6543 (Community Epidemiologic Work Group) 
(301) 443-6046 (AIDS Work Group) 
Fax: (301) 468-6433 (NCADI) 
(703) 321-8547 (NTIS) 
The National Institute on Drug Abuse (NIDA) is a part of the National Institutes 
of Health (NIH) and is the nation’s lead agency responsible for conducting and 
disseminating research on drug abuse and addiction to improve prevention, treat­
ment, and policy. 
S E RVICES AVA I L A B L E 
NIDA Publications. N I DA produces many pro fe s s i onal and scientific publica­
tions as well as public education materials on the results of its research. All NIDA 
publications are available either through NCADI or the National Technical Infor­
m a t i on Se rvice (NTIS) (see ph one numbers above for inform a t i on on these ser­
vices or to request a copy of NIDA’s publications catalog). Publications include: 
NIDA Notes: Published bimonthly, this newsletter reports on advances in 
the field of drug abuse, identifies resources, promotes exchanges of infor­
m a t i on , and seeks to improve com mu n i ca t i on among cl i n i c i a n s , re-
searchers, administrators, and policymakers. 
Co m m u n i ty Al ert Bulletins: Produced peri o d i ca lly, these bulletins addre s s 
n ew and emerging drug abuse issues that warrant special attention (e.g. , 
bleach disinfection for HIV prevention). 
NIDA Cap s u l e s : These factsheets provide concise summaries of issue 
areas for the press and the public. 
Research Dissemination and Application Packages: This series of education­
al products (including videotapes) focuses on re s e a rch-based drug tre a t­
ment strategies and techniques. 
Resources 5-15 
Research Monograph Series: These monographs report on state-of-the-art drug 
abuse re s e a rch fin d i n g s , p roblem are a s , and tech n o l o g i e s , i n cluding AIDS 
prevention and treatment. 
Clinical Report Series: This series provides information from NIDA’s research 
programs, including those focusing on AIDS prevention and treatment. 
S ervices Research Monograp h s : These mon o g ra phs present findings from the 
latest drug abuse treatment services research on a range of topics. 
R e s e a rch Report Seri e s : These re p o rts simplify the science of re s e a rch fin d i n g s 
for the educated lay public, legislators, educational groups, and practitioners. 
Pu blic Education Materi a l s : These include multi-media materials for public ed­
u ca t i on and science educa t i on campaigns related to drug abuse and addiction . 
Internet Services. The NIDA Webpage (http://www.nida.nih.gov) has extensive 
links to other webpages focusing on substance abuse. It also has inform a t i on on 
NIDA grants and contracts, communications and documents, events, committees, 




This section highlights several national resource organizations that are involved in 
HIV prevention among drug users. 
American Foundation for AIDS Research 
(AmFAR) 
Los Angeles 	(http://www.amfar.org) 
5900 Wilshire Blvd., 23rd Floor 
Los Angeles, CA 90036 (Main Office) AmFAR 
New York	 733 3rd Avenue, 12th Floor 
New York, NY 10017 (East Coast Office) 
Washington	 1828 L Street, NW, Suite 802 
Washington, DC 20036 (Policy Office) 
Phone:(213) 857-5700 (LA) 
(212) 682-7440 (NY) 
(202) 331-8600 (DC) 
The American Foundation for AIDS Research (AmFAR) is a national, non-
profit public foundation fighting AIDS through grant-making programs in bio­
medical and clinical research, education for AIDS prevention, and public policy 
development. AmFAR has played a lead role in supporting and conducting 
research on needle exchange. 
S E RVICES AVA I L A B L E 
Am FAR publishes a dire c t o ry of re s e a rch initiative s , i n f o rm a t i on softw a re, 
b i l i ngual handbooks, and a newsletter. 
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Center for AIDS Prevention Studies (CAPS) 
http://www.epibiostat.ucsf.edu/capsweb

74 New Montgomery, Suite 600







The Centers for AIDS Prevention Studies (CAPS) at the University of California 
at San Francisco is committed to preventing HIV, using the expertise of multiple 
disciplines, and an applied and community-based perspective within a university 
setting. 
S E RVICES AVA I L A B L E 
CAPS provides bibliogra phies of all the HIV/AIDS preve n t i on re s e a rch con d u c t e d 
by CAPS researchers. These bibliographies are extensive and are cross referenced 
by author and subject area. 
HIV Prevention Facts Sheets. CAPS produces summaries of specific topics 
dealing with HIV/AIDS prevention. Topics for the Fact Sheets are chosen on the 
basis of timeliness, what the commun i ty needs to know, and what scientific matters 
a re of particular import a n c e . A ll Fact Sheets are available in English and in Sp a n i s h . 
Titles of the Fact Sheets incl u d e : 




Does Needle Exchange Work?

What are Women’s HIV Prevention Needs?

What is Testing’s Role in HIV Prevention?

Can Clinicians Help with HIV Prevention?

Can HIV Preve n t i on Make a Diffe rence for Men Who Have Sex With Men?

What are Adolescents’ HIV Prevention Needs?

What are Young Gay Men’s HIV Prevention Needs?

Does Sex Education Work?

What is the Role of HIV Testing at Home?

Is HIV Prevention a Good Investment?

What are Inmates’ HIV Prevention Needs?

Can Theory Help in HIV Prevention?

What are African Americans’ HIV Prevention Needs?

What are Homeless People’s HIV Prevention Needs?

What are Latinos’ HIV Prevention Needs?

5-18 Resources 
Are Informal Caregivers Important in AIDS Care?

What are Sex Workers’ HIV Prevention Needs?

We Know What Wo rks in HIV Preve n t i on : Why Aren't We Doing More of It?

What are Substance Abusers’ HIV Prevention Needs?

How are Heterosexual Men Reached in HIV Prevention?

Can HIV Prevention Programs be Adapted?

What are Women Who Have Sex With Women’s HIV Prevention Needs?

How is Science Used in HIV Prevention?

The CAPS Fact Sheets may be downloaded from the CAPS Webpage (http : / / 
w w w. e p i b i o s t a t . u c s f. e d u / ca p s w e b ) , or ord e red through the mail. To be placed on 
the CAPS mailing list, contact CAPS directly. 
United States Conference of Mayors (USCM) 
http://www.btg.com/USCM/home.html









The United States Conference of Mayors (UCSM) is the non-partisan organiza­
t i on of mayors of cities with populations of 30,000 or more . T h e re are about 1,050 
s u ch cities in the country today. USCM con t ributes to deve l o pment of national urban 
policy on various issues, including AIDS and drug abuse. 
S E RVICES AVA I L A B L E 
Since 1985, the CDC-sponsored USCM HIV/AIDS Program has supported 180 
c om mu n i ty-based organiza t i ons and local health depart m e n t s . In addition to di­
rect funding, USCM provides tech n i cal assistance to organiza t i ons ca r rying out 
HIV preve n t i on activities. T h e AIDS Information Exch a n ge is the official publica­
t i on of the USCM AIDS/HIV Pro g ra m . USCM also produces various re p o rts 
on the topic of HIV/AIDS preve n t i on that are available by contacting the USCM 




National Alliance of State and Territorial 
AIDS Directors (NASTAD) 










The National Alliance of State and Territorial AIDS Directors (NASTAD) repre­
sents HIV/AIDS program managers in each US state and territory. Members are 
responsible for administering AIDS care, prevention, education, and supportive 
service programs, including those funded under Title II of the Ryan White CARE 
Act. 
S E RVICES AVA I L A B L E 
NA S TAD provides tech n i cal assistance to health departments and com mu n i ty 
g roups in HI V p reve n t i on com mu n i ty planning and social mark e t i n g, i n cl u d i n g 
d i s t ri b u t i on of a mon t h ly Com mu n i ty Planning Bulletin and a quart e rly So c i a l 
M a rketing Update to all AIDS directors and com mu n i ty planning co-ch a i r s . Se rv i c e s 
i n clude peer-based, onsite tech n i cal assistance, w o rkshops and policy papers as 
w e ll as national con fe re n c e s . A NA S TAD “ C ommittee on HIV Preve n t i on and 
Substance Users” focuses on issues and programs for this population. 
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National Association of State Alcohol and Drug 
Abuse Directors (NASADAD) 










The Na t i onal Association of State Alcohol and Drug Abuse Dire c t o r s 
(NASADAD) is a private, not-for-profit, educational organization whose mem­
bership consists of directors of US State and Territorial Alcohol and Drug Abuse 
Agencies.The primary purpose of NASADAD is to serve as an information clear­
inghouse and tech n i cal assistance re s o u rce for state alcohol and drug abuse agencies. 
S E RVICES AVA I L A B L E 
NA S A DAD is inv o lved in a number of HI V- related activities including work-
shops and training to state agencies in HIV prevention. It fosters the development 
of sound policies related to HIV prevention among drug users. 
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The Division of Epidemiology and Prevention Research







The Com mu n i ty Epidemiology Wo rk Group (CEWG ) , s p on s o red by the 
National Institute on Drug Abuse (NIDA) is a network of researchers from major 
metropolitan areas of the United States, Canada, and Mexico. The CEWG’s pri­
mary objective is to provide ongoing community-level public health surveillance of 
drug use and abuse, through the collection and analysis of epidemiologic and 
ethnographic research data. 
S E RVICES AVA I L A B L E 
The CEWG provides current descriptive and analytical information regarding the 
nature and patterns of drug abuse, emerging trends, and characteristics of vulnera­
ble populations. For more information, contact the CEWG directly. 
The HPDU Resource Book cites two recent CEWG publications: 
J oh n s on , Bassin and Sh a w, I n c . ( Si lver Sp ri n g, M D ) . E p i d e m i o l o gic trends in dru g 
abuse, volume I: highlights and executive summary. Rockville (MD): National I n s t i­
tute on Drug Abuse, D i v i s i on of Epidemiology and Preve n t i on Research ; 1 9 9 5 
June. NIH Publication No. 95-3990. (NTIS ID#PB96-101449) 
This CEWG document may be obtained at a cost of $21.50 by con t a c t i n g :

The National Technical Information Service (NTIS)







J oh n s on , Bassin and Sh a w, I n c . ( Si lver Sp ri n g, M D ) . E p i d e m i o l o gic trends in dru g 
abuse, volume II: community epidemiology work group, proceedings. Rockville (MD): 
National Institute on Drug Abuse, Division of Epidemiology and Prevention Re-
s e a rch ; 1995 June. N IH Pu b l i ca t i on No. 9 6 - 3 9 9 1 . This document is no lon g e r 
available through NTIS. 
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If state or local health departments are interested in becoming inv o lved with the 











O rdering Information for Documents Referenced

in the HPDU Resource Book

The following CDC and AED source documents may be ord e red free of 
c h a rge from the National AIDS Clearinghouse by calling 1-800-458-5231 
Academy for Educational Development. Handbook for HIV prevention community 
planning. Washington (DC): Academy for Educational Development; 1994 April. 
Contract No.: 200-91-0906. Funding provided by the Centers for Disease Control 
and Prevention. CDC NAC Ordering No. D071 
Academy for Educa t i onal Deve l o pm e n t . What intervention studies say about 
ef f e ctiveness:a resource for HIV prevention community planning groups. Washington, 
DC: Academy for Educational Development: 1996 May. Contract No.: 200-91-
0906. Funding provided by the Centers for Disease Control and Prevention. CDC 
NAC Ordering No. D922 
Centers for Disease Con t rol and Preve n t i on , D i v i s i on of HIV/AIDS Preve n t i on ; 
Council of State and Te r ri t o rial Epidemiologists. S u gge s ted guidelines for devel o p i n g 
an epidemiologic pro file for HIV prevention community planning. Atlanta (GA): 
Centers for Disease Con t rol and Preve n t i on ; 1995 June. C DC NAC Ord e ri n g 
No. D875 
How to locate the journal articles 
and books referenced in this document 
The journal art i cles and books re fe renced in the HPDU Resource Book can be 
a cq u i red through local college or unive r s i ty libra ri e s . Users not affiliated with a 
c o llege or unive r s i ty libra ry, can contact the Na t i onal Ne tw o rk of Libra ries of 
Medicine (NNLM) at 1-800-338-7657. A libra rian will provide a re fe r ral to a 
l o cal and/or re g i onal academic libra ry willing to provide document delive ry serv i c e . 
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A E VA L U ATION STUDY SUMMARY FORMS FOR
I N T E RVENTIONS ADDRESSING DRUG USERS

E a ch summary in Appendix A describes a study conducted on a specific 
i n t e rve n t i on with a particular target gro u p. These summaries will help 
prevention planners and program managers consider interventions for par­
ticular target groups in the drug-using population. The contents of this ap­
pendix provide the following information: 
• Summaries of selected peer-reviewed journal articles of evaluation studies 
completed on HIV prevention interventions conducted with drug users. 
• Information on the: 1) authors of the article, 2) the journal where the article 
was publ i s h e d, 3) the ta r get and study populations ad d re s s e d, 4) the objective ( s ) 
of the intervention for risk behavior, 5) the objective(s) of the intervention for 
determinants of risk behavior, 6) the taxonomy category and intervention 
description, 7) the evaluation methods, and 8) the evaluation findings. 
• Comments on special implications or usefulness of the study or intervention. 
E VA L U ATION STUDY SUMMARY FORMS FOR

I N T E RVENTIONS ADDRESSING DRUG USERS

A rt i cles in the peer-rev i ewed litera t u re are often written for academic audiences and 
c ontain mu ch inform a t i on that is useful for their purp o s e s , but difficult for planners 
and pro g ram staff to interp ret and apply. Based on suggestions from re p re s e n t a t i ves of 
C om mu n i ty Planning Gro u p s , we focused attention on three key aspects of the stud­
ies included in the appendix: the target population , the descri p t i on of the interve n t i on 
based on CDC’s suggested taxon om y, and the findings on demon s t rated effe c t i ve­
n e s s . To accomplish this, we created a standard Evaluation Study Su m m a ry Fo rm to 
help ca p t u re consistent inform a t i on as we rev i ewed each art i cl e . The box below lists 
the elements of the Su m m a ry Fo rm , with a brief defin i t i on of each . C DC’s taxon om y 
f ra m ew o rk adapted from Holtgra ve, Va l d i s e r ri , and West (1994), is shown in Exhibit L. 
We hope that these summaries will help preve n t i on planners and pro g ram man­
agers interp ret and incorp o rate ev a l u a t i ons of effe c t i veness into their decision 
m a k i n g. In addition , with the Evaluation Study Su m m a ry Fo rm we hope to pro-
vide a useful fra m ew o rk for continued efforts to interp ret emerging re s e a rch on 
HIV prevention intervention effectiveness. 
Evaluation Study Summary Form

Target and Study Populations: The target population is the population for whom the inter­
vention was developed. The study population is that part of the population that participated 
in the evaluation and is typically more restricted than the target population. 
Objective(s) of the Intervention for Risk Behavior: The intervention is described in 
terms of the specific HIV risk behavior(s) it was designed to influence. 
Objective(s) of the Intervention for Determinants of Risk Behaviors: The intervention 
is described in terms of the determinants through which it is intended to have its desired 
effect. 
Taxonomy Category and Intervention Description: The intervention is categorized in 
terms of the Suggested Taxonomy from the Overview of HIV/AIDS Prevention Interventions: 
An Approach to Examining Their Effectiveness. A description of the intervention is pro v i d e d . 
Evaluation Methods: The sample size, study design, measures, and analysis techniques are 
described. 
Evaluation Findings: Three types of findings are reported — effectiveness at influencing risk 
behaviors, effectiveness at influencing the determinants of risk behaviors, and implementa­
tion issues. 
C o m m e n t s : This section includes comments on special implications or usefulness of the study 
or intervention. 
A-2 Evaluation Study Summary Forms for Intervention Addressing Drug Users 




Category I. Counseling, Testing, Referral, and Partner Notification (CTRPN) 






























Risk Reduction in Sexual Behavior: 

A Condom Giveaway Program in a Drug Abuse Treatment Clinic

Calsyn DA, Meinecke C, Saxon AJ, Stanton V

American Journal of Public Health 1992;82(11):1536-1538 

Target and Study Populations

Target population. The intervention was designed for male injection drug users re­

ceiving outpatient drug abuse treatment.

Study population. The intervention was evaluated in a sample of men receiving out-

patient drug abuse treatment at the Ve t e rans Affairs Medical Center, Se a t t l e,

Wa s h i n g t on , d u ring December 1989 and remaining in treatment through May

1990. The men were primarily white (77 percent); 22 percent were African Amer­

ican. About half were employed.

Objective(s) of Intervention for Risk Behavior 
To increase the use of condoms during vaginal intercourse. 
Objective(s) of Intervention for Determinants of Risk Behavior 
To increase accessibility of condoms. 
Taxonomy Category and Intervention Description 
Health education/risk reduction program that is institution based. 
The intervention consisted of providing free access to a variety of styles of individ­
u a lly packaged con d oms in an outpatient drug abuse treatment center. The con-
d oms were made re a d i ly available throughout the clinic (e.g. , staff offic e s , re­
strooms, therapy rooms). Most clients attended an AIDS education class in which 
the correct use of con d oms was demon s t rated and a free starter pack of con d om s 
was distributed. 
Evaluation Methods 
B e f o re the give a w ay pro g ra m , p a rticipants completed a self-re p o rt question n a i re 
assessing con d om purch a s e, b rand pre fe re n c e, p o s s e s s i on , use history, and use 
within preceding two mon t h s . The question n a i re was repeated four months aft e r 
the interve n t i on began. Baseline and foll ow-up values for dich o t omous question s 
were compared by contingency table analysis using the McNemar test. A Wilcox­
on sign-ranks test was used for continuous measures. The article reports on the 93 
of the clients (90 percent) who completed both baseline and foll ow-up question­
naires. 
A-4 Evaluation Study Summary Forms for Intervention Addressing Drug Users 
Evaluation Findings 
The interve n t i on was effe c t i ve at improving behavior. A modest, but statistica lly 
significant increase occurred in condom use during vaginal intercourse. Specifical­
ly, use of condoms during vaginal intercourse increased from 20 percent at baseline 
to 34 percent at four months after the initiation of the condom giveaway program. 
T h e re was also a statistica lly significant increase in the pro p o rt i on of the sample 
possessing condoms from 59 percent before to 76 percent four months after. 
Without a con t rol group it is difficult to con clude that the increases are attri b u t­
able to the give a w ay pro g ra m . H ow eve r, this ev a l u a t i on study suggests that in-
c reasing access to con d oms may increase the possession and use of con d om s 
among clients of a drug abuse treatment clinic. 
Comments 
This study ill u s t rates the role that free access to a vari e ty of styles of individually 
p a ckaged con d oms can play in influencing con d om use. Although con d oms are 
available in stores and ph a rm a c i e s , f ree offe rings of a vari e ty of styles may elimi­
nate barriers to purchase and increase the likelihood that individuals will be carry­
ing condoms at times they may engage in sexual activity. 
Evaluation Study Summary Forms for Intervention Addressing Drug Users A-5 
AIDS and the Transition to Illicit Drug Injection — Results of a 
Randomized Trial Prevention Program 
Des Jarlais DC, Casriel C, Friedman SR, Rosenblum A 
British Journal of Addiction 1992;87(3):493-498 
Target and Study Populations





Study population. The impact of the intervention was evaluated in a study conduct­
ed between 1986 and 1988 with 104 participants from New Yo rk City who were 
using heroin intranasally (“sniffing”) as their primary route of heroin use and who 
had injected no more than 60 times in the previous two ye a r s . Pa rticipants were 
re q u i red to be HIV antibody or hepatitis B antibody negative in status. None of 
the subjects seroconverted for HIV during the follow-up period. The mean age of 
the sample was 27 years, and the mean level of education completed was nearly 13 
ye a r s . The sample was pre d om i n a n t ly male (70 perc e n t ) , white (51 percent) or 
African American (26 percent), and heterosexual (78 percent). 
Objective(s) of Intervention for Risk Behavior 
To decrease HIV exposure due to needle-use practices by reducing injection . 
To increase the use of bleach and condoms. 
Objective(s) of Intervention for Determinants of Risk Behavior 
To increase knowledge about HIV transmission and prevention. 
To improve skills in cleaning needles and using condoms. 
Taxonomy Category and Intervention Description 
Health educa t i on / risk re d u c t i on interve n t i on using gro u p - l eve l , p e e r - m e d i a t e d 
counseling emphasizing risk reduction for injection drug users. 
The interve n t i on was theory based and consisted of four 60 to 90-minute group ses­
s i ons that took place over a two-week peri o d . The sessions included basic inform a­
t i on about HI V / A I D S , d rug use and drug injection , sexual behavior and 
HI V / A I D S , and seeking entry into drug abuse treatment pro g ra m s . The session s 
w e re led by two trainers and inv o lved didactic materi a l s , g roup discussion , and ro l e 
p l aying of cri t i cal situation s , s u ch as refusing an offer of injection or seeking entry 
into drug abuse treatment pro g ram when on e’s non-injected drug use became too h e a v y. 
I n s t ru c t i ons on safer injection pro c e d u re s , s u ch as using bleach to decon t a m i n a t e 
injection equipment, were provided. 
A-6 Evaluation Study Summary Forms for Intervention Addressing Drug Users 
Evaluation Methods 
Eligible participants were randomly assigned to the four-session intervention pro-
g ram or to the con t rol con d i t i on . Assessments were made at baseline, b e f o re the 
intervention, and at follow up, about nine months after the intervention. At base-
line, all participants took part in a lengthy intake and data collection process. Par­
ticipants were interviewed on drug use history, sexual behavior history, and knowl­
edge of HIV/AIDS. They provided a urine sample for drug testing. They received 
basic information about AIDS, including HIV counseling, and were asked to give 
a blood sample for HIV testing. Ne a rly 90 percent decided to take the test. A ll 
p a rt i c i p a n t s , i n cluding those who decided against HIV testing, w e re also re q u i re d 
to give a blood sample for hepatitis B testing. Fo ll ow-up data coll e c t i on incl u d e d 
an interv i ew cove ring drug and sexual behavior since the intake peri o d , a t t i t u d e s 
t ow a rd HI V / A I D S , and a second blood sample for HIV and/or hepatitis B test-
i n g. Due to intensive foll ow-up effort s , 83 subjects (80 percent) were successfully 
followed up at a mean of 8.9 months. Univariate and multivariate analyses predict­
ing drug injection at foll ow up were conducted to assess the impact of the inter­
vention as well as to determine factors associated with injection. 
Evaluation Findings 
The interve n t i on was effe c t i ve in reducing injection drug use. In com p a ri s on to 
the control group, intervention participants had a significantly lower level of injec­
tion at follow up. However, it did not prevent all drug injection. In fact, 15 percent 
of the persons assigned to the interve n t i on injected during the foll ow-up peri o d , 
compared to 33 percent of those assigned to the control group. 
There was no evidence that the intervention was effective at improving safer sexu­
al practices. For example, reported condom use increased for both the intervention 
and the control group from about 26 percent at baseline to about 49 percent at fol­
low up. 
Comments 
An intensive four-session AIDS/drug injection preve n t i on pro g ram was effe c t i ve in 
reducing the level of injection use of heroin and cocaine during the foll ow-up peri­
o d . The high foll ow-up rate ach i eved in this study among drug users, who were not 
associated with treatment pro g ra m s , i n d i cates the fe a s i b i l i ty of this appro a ch . 
Evaluation Study Summary Forms for Intervention Addressing Drug Users A-7 
Preventing HIV/AIDS in Drug-Abusing Incarcerated Women Through





El-Bassel N, Ivanoff A, Schilling RF, Gilbert L, Borne D, Chen DR

Social Work Research 1995;10(3):131-141

Target and Study Populations

Ta r get population. The interve n t i on was designed for adult women with a re c e n t

history of significant drug use, currently incarcerated but scheduled for release.

S tudy population. The impact of the interve n t i on was evaluated in a study of 145

incarcerated women 18-55 years of age, convicted and serving a sentence between

t h ree months and one year at New Yo rk City’s Rikers Island Jail and who were

s cheduled for release within 10 weeks. The women re p o rted recent history of sig­

n i ficant drug use (three or more times a week during the three months before the

arrest); 16 percent self-reported to be HIV seropositive. The sample was primarily





Objective(s) of Intervention for Risk Behavior 
To increase the practice of safe sex (abstinence or always condom use during vagi­
nal intercourse). 
Objective(s) of Intervention for Determinants of Risk Behavior 
To increase knowledge of HIV/AIDS transmission and prevention.

To improve problem solving, coping, and condom use skills.

To enhance social support.

Taxonomy Category and Intervention Description 
Health educa t i on / risk re d u c t i on interve n t i on using gro u p - l eve l , n on-peer m e d i a te d 
c o u n s e l i n g, e m phasizing skills and social support and delive red in a pri s on setting. 
The interve n t i on consisted of 16 two-hour group sessions held twice a week in 
jail. The sessions included about 10 participants and were led by two group facili­
tators.The facilitators were selected for similarity to participants, had three days of 
training, and received weekly individual and group supervision. The content of the 
s e s s i ons was theory based and emph a s i zed skill building and social support en-
h a n c e m e n t . Se s s i ons to improve skills at solving pro b l e m s , coping with high-ri s k 
s i t u a t i on s , and using con d oms included introducing and modeling skills by facili­
tators, practice by participants during the session, and homework assignments. So­
cial support was enhanced by assisting participants in identifying informal and 
f o rmal sources of support and services and in making contact with these sourc e s . 
A-8 Evaluation Study Summary Forms for Intervention Addressing Drug Users 
Participants shared successes and problems in making these contacts.The compar­
i s on was a standard HIV/AIDS inform a t i on interve n t i on typ i cal of most jails, 
with three two-hour educational group sessions about HIV prevention. 
Evaluation Methods 
At baseline, i n ca rc e rated women were ra n d om ly assigned to the interve n t i on 
( s k i lls and social support) or con t rol (inform a t i on) gro u p. Pa rticipants were inter-
viewed several times during the study period: at baseline; at the exit interview two 
to seven days before re l e a s e ; in the com mu n i ty within two days of re l e a s e ; and at 
on e, t h re e, s i x , and 12 months foll owing re l e a s e . The interv i ews assessed demo-
g ra phic ch a ra c t e ri s t i c s , HIV/AIDS know l e d g e, coping skill s , e m o t i onal support , 
p e rc e i ved vulnera b i l i ty, d rug use, and sexual behavior during 30 days (30 days be-
f o re arrest for baseline and past 30 days for foll ow ups). Sa fe sexual practice was 
defined as used condoms always or not having vaginal intercourse. This article re-
ports on the results comparing baseline to one-month follow up from 49 interven­
tion participants and 52 control participants. Logistic regression analyses using di­
chotomized versions of the six outcome variables were conducted. 
Evaluation Findings 
There was some evidence of the effectiveness of the skills and social support inter­
ve n t i on on two key determinants of behavior: coping skills and social support . 
There was no evidence of the effectiveness of skills and social support intervention 
on perceived vulnerability to HIV, sexual self-efficacy, or HIV/AIDS knowledge. 
Of approx i m a t e ly 200 women who were initially re c ru i t e d , 159 met the eligibility 
criteria and completed the baseline assessment. Between baseline and the first ses­
s i on of the interve n t i on , 14 participants were lost because of unplanned release or 
t ra n s fer to another facility, leaving a total of 145 part i c i p a n t s . Am ong those who 
w e re assigned to the skills and social support interve n t i on gro u p, 19 percent at-
tended three or fewer session s , 28 percent attended four to 12 session s , and 52 
p e rcent attended 13 or more session s ; a m ong those in the inform a t i on gro u p, 8 6 
percent attended the three sessions. 
Comments 
AIDS has become the leading cause of death among female inmates.This research 
d e m on s t rates the fe a s i b i l i ty of implementing a skill-building and social support 
i n t e rve n t i on for drug-using women in a jail setting. The results indicate that a 
skills and social support intervention may be more effective than simply providing 
AIDS information. 
Evaluation Study Summary Forms for Intervention Addressing Drug Users A-9 
The Long-Term Outcome of a Personal Network-Oriented HIV 
Prevention Intervention for Injection Drug Users: The SAFE Study 
Latkin CA, Mandell W, Vlahov D, Oziemkowska M, Celentano DD 
American Journal of Community Psychology 1996;24(3):341-364 
Target and Study Populations





S tudy population. The interve n t i on was evaluated with a sample of 117 pre d om i­
nantly unemployed, African American men with a median age of 40 living in Bal­
t i m o re, M D. Most were re c ruited by word of mouth from a larger epidemiologic 
study on the natural history of HIV/AIDS infe c t i on among injection drug users. 
As participants in the larger study, t h ey had re c e i ved HIV/AIDS counseling and 
testing every 6 months; 24 percent were HIV seropositive. Individuals selected for 
the study were still active ly engaging in HIV risk behaviors despite part i c i p a t i on 
in the larger study. They injected cocaine and heroin, 80 percent shared needles in 
the previous 6 months and were part of a dru g - s h a ring netw o rk . T h ey were re­
quired to bring at least four members of their networks to the intervention. 
Objective(s) of Intervention for Risk Behavior 
To decrease HIV/AIDS-related needle sharing behavior. 
Objective(s) of Intervention for Determinants of Risk Behavior 
To increase awareness of the danger of needl e - s h a ring among members of dru g 
networks and increase awareness of where sterile syringes are available. 
To increase the social norms of drug-sharing networks related to not sharing used 
needles and drug injection equipment. 
To increase assert i veness skills in avoiding high-risk behaviors and settings, s k i lls i n 
cleaning injection equipment and identifying where sterile syringes are available. 
Taxonomy Category and Intervention Description 
Health educa t i on / risk re d u c t i on interve n t i on using gro u p - l eve l , p e e r - m e d i a t e d , 
risk-reduction training in a clinic setting. 
The group intervention procedure used self-help, network-centered, and psychoe­
d u ca t i onal appro a ches to behavior ch a n g e . The interve n t i on pro g ram was highly 
s c ripted and was facilitated by former heroin users who maintained contact with 
and were respected by active drug users in Baltimore . The interve n t i on incl u d e d 
six interactive group sessions using the role play method. 
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Evaluation Methods 
B e f o re the interve n t i on , a ll part i c i p a n t s , n e tw o rk members, and con t rol gro u p 
members answered questions about their dru g - s h a ring netw o rks and completed a 
s u rvey on demogra phic back g ro u n d , HI V / A I D S - related behavior, and drug use. 
T h ey indicated how often they injected hero i n , c o ca i n e, or heroin and coca i n e ; 
h ow often they shared needles or cook e r s ; and how often they injected drugs in 
shooting gall e ri e s . Pa rticipants were ra n d om ly assigned to interve n t i on and con­
trol groups, and all were reinterviewed 18 months later. For the analysis, interven­
t i on part i c i p a n t s , but not their netw o rk members, w e re com p a red with members 
of the control group. 
Evaluation Findings 
Of the 411 individuals told they were eligible for the study, 293 enro lled in and 
117 completed the study. The interve n t i on was effe c t i ve in significa n t ly re d u c i n g 
HI V / A I D S - risk behaviors among interve n t i on participants who were HI V 
s e ron e g a t i ve . At the 18-month foll ow up, i n t e rve n t i on participants who were 
k n own to be seron e g a t i ve re p o rted significa n t ly less needle sharing and injecting 
of heroin and cocaine and marginally less sharing of cookers than did participants 
in the control group. There was no significant difference between the groups when 
it came to attendance at shooting gall e ri e s . Se ro p o s i t i ve individuals in the inter­
ve n t i on group re p o rted higher levels of injecting drugs and sharing needles and 
cookers than did those who did not receive the intervention. 
The interve n t i on was also effe c t i ve in changing determinants of risk behavior. 
Some interve n t i on participants re p o rted that they no longer associated with indi­
viduals who continued to insist on sharing needl e s . This was ve ri fied by a signifi­
cant re d u c t i on in the size of the netw o rks of interve n t i on part i c i p a n t s , c om p a re d 
with con t rol group members. I n t e rve n t i on participants were also slightly more 
likely than control group members to report that they and their network members 
cleaned their needles and discussed HIV/AIDS. 
Comments 
The greater associations between perc e p t i on of netw o rk members’ risk behaviors, 
greater reduction in size of drug networks, and a trend toward increased frequency 
of discussing HIV/AIDS in the interve n t i on gro u p, c om p a red with the con t ro l 
g ro u p, suggest that the netw o rk appro a ch for reducing risk behaviors is mediated 
by social influence processes. This study points out the potential importance of ex­
amining and intervening in personal netw o rk processes as a stra t e gy for 
HIV/AIDS reduction among injection drug users. 
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Outcome of Psychoeducation for HIV Risk Reduction 
Malow RM, West JA, Corrigan SA, Pena JM, Cunningham SC

AIDS Education and Prevention 1994;6(2):113-125.

Target and Study Populations

Ta r get Po p u l a t i o n . The interve n t i on was designed for Afri can Am e ri can men re­

ceiving inpatient drug abuse treatment.

S tudy Po p u l a t i o n . The interve n t i on was evaluated with a sample of 152 Afri ca n

Am e ri can male inpatients of the Ve t e ra n’s Affairs Drug Dependence Tre a t m e n t

Pro g ram in New Orl e a n s . Pa rticipants were ch ronic substance users with coca i n e

dependence but did not have psych i a t ric or cognitive impairm e n t s . Pa rt i c i p a n t s

had an ave rage age of 36 ye a r s , a ve rage schooling of 13 ye a r s , and a mean IQ of 105.

Objective(s) of Intervention for Risk Behavior 
To reduce risk of HIV exposure due to sexual practices. 
To reduce number of sex partners. 
Objective(s) of Intervention for Determinants of Risk Behavior 
To increase knowledge about HIV transmission and prevention.





To increase perceived susceptibility to HIV.

Taxonomy Category and Intervention Description 
Health educa t i on / risk re d u c t i on , g ro u p - l evel counseling, n on-peer mediated, i n 
treatment setting. 
The theory-based interve n t i on was delive red in groups of six to eight individuals. A 
cl i n i cal psychologist administered two-hour group sessions on three con s e c u t i ve days . 
The first session developed ra p p o rt with patients, p e r s on a l i zed the t h reat of HI V, 
p rovided inform a t i on about HI V, discussed needle shari n g, and demons t rated pro p e r 
n e e dle steri l i za t i on pro c e d u re s . The second session focused on safer sexual pra c t i c e s , 
c on d om use, c on d om use nego t i a t i on , and skills-building exe rc i s e s . The final session 
rev i ewed the knowledge and skills imparted in prior sessions and d i scussed in detail 
HIV serostatus testing. The delive ry of the interve n t i on was guided by a manual. T h e 
c om p a ri s on group re c e i ved the same inform a t i on as did the i n t e rve n t i on group but in 
the form of pre re c o rded audiovisual and printed material with minimal intera c t i on . 
Evaluation Methods 
Adults who had agreed to participate were ra n d om ly assigned to either the skill -
based interve n t i on or the inform a t i on - on ly com p a ri s on gro u p. Baseline data were 
A-12 Evaluation Study Summary Forms for Intervention Addressing Drug Users 
c o llected at least 10 days after hospital admission ; f o ll ow-up data were coll e c t e d 
immediately after the intervention and again after three months. Standardized in­
s t ruments were used to assess HIV know l e d g e, p e rc e i ved susceptibility to HI V, 
anxiety about health consequences, response-efficacy, self-efficacy, communication 
s k i ll s , and con d om use skill s . D e m o g ra phic and back g round inform a t i on was col­
lected through personal interviews. Sexual behavior in the preceding three months 
was used to create a two-level overall measure of sexual risk behavior. 
Pa rticipants who were abstinent, m on o g a m o u s , or mu l t i p a rt n e red but with 100 
p e rcent con d om use were cl a s s i fied as “l ower ri s k . ” Those who had multiple part­
ners or did not alw ays use con d oms were cl a s s i fied as “higher ri s k . ” An a lysis of 
variance and chi-square tests were used to assess impact. 
Evaluation Findings 
The interve n t i on was effe c t i ve in decreasing one aspect of sexual risk behavior, 
p ro p o rt i on having more than one part n e r. M o re specifica lly, in the interve n t i on 
g ro u p, 47.5 percent participants re p o rted having more than one partner at thre e -
month follow up, compared to 76 percent at the baseline. This decrease was statis­
tically significant. In the comparison group, the change from 76 percent at baseline 
to 59 percent at the three-month follow up was not statistically significant. 
Results suggest that the interve n t i on might be effe c t i ve at improving the ove ra ll 
m e a s u re of sexual risk behavior. Am ong participants in the skill-based interve ntion 
group, the proportion classified as higher risk reduced from 75 percent at baseline 
to 32 percent at the thre e - m onth foll ow up; a m ong participants in the i n f o rm at i on -
on ly com p a ri s on gro u p, the pro p o rt i on cl a s s i fied as higher risk reduced from 75 
p e rc e n t to 48 perc e n t . Both these improvements were statistica lly significa n t . H ow eve r, 
c on t ra ry to expectation s , the improvement in the interve n t i on g roup was not signifi­
cantly greater statistically than the improvement in the comparison group. 
The interve n t i on was effe c t i ve in improving two determinants of sexual risk behavior. 
Communication skills and condom use skills of participants immediately after the 
intervention were significantly higher in the intervention group than in the control 
group. 
Out of 235 con s e c u t i ve admissions to the inpatient drug abuse treatment facility, 
75 percent met the eligibility cri t e ria for this study, and 65 percent (152) actually 
c onsented to part i c i p a t e . Seve n ty percent of the participants attended all interve n t i on 
sessions and completed all assessments. 
Comments 
This study demonstrated that communication skills, condom use skills, and sexual 
risk behavior of ch ronic substance users can be improved through group session s 
provided in an inpatient treatment setting. 
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Evaluation of Two AIDS Education Programs 
for Impoverished Latina Women 
Nyamathi AM, Flaskerus J, Bennett C, Leake B, Lewis C

AIDS Education and Prevention 1994;6(4)296-309

Target and Study Populations

Ta r get population. The interve n t i on was designed for adult Hispanic women who

are homeless and/or drug-abusing.

S tudy population. The interve n t i on was evaluated with a sample of 213 impove r­

ished women in Los Angeles who had identified themselves within the past six

m onths as being drug users (intra venous or non - i n t ra ve n o u s ) , sexual partners of

i n j e c t i on drug users, sex work e r s , having been diagnosed with an STD, having had

u n p rotected sex with two or more part n e r s , or as being hom e l e s s . The part i c ip a n t s

w e re re c ruited through homeless shelters and drug re c ove ry pro g ra m s . The m a j o ri ty

of the participants were born in the United States or Mexico, w e re single, u n e m-

p l oye d , and Catholic. Their mean age was 31 years and the mean years of educa­

tion completed was 10. Only four of the women were HIV-positive at baseline.

Objective(s) of Intervention for Risk Behavior 
To reduce risk of HIV exposure due to needle-use practices. 
To reduce the number of sex partners. 
Objective(s) of Intervention for Determinants of Risk Behavior 
To increase knowledge about HIV transmission and prevention.

To improve skills in using condoms and cleaning needles.

To improve problem- and emotion-focused coping responses.

To decrease levels of distress and depression.

Taxonomy Category and Intervention Description 
Health educa t i on / risk re d u c t i on interve n t i on using gro u p - l evel counseling by 
health educators. 
Two cultura lly - s e n s i t i ve HIV/AIDS educa t i on pro g rams were administered by 
t rained Hispanic nurse counselors and outre a ch workers using a detailed scri p t . T h e 
on e - h o u r, t ra d i t i onal pro g ram provided HIV/AIDS educa t i on and re fe r ral to com­
mu n i ty re s o u rc e s . The women watched a video, “A l i c i a , ” that emph a s i zed cultura l 
ch a ra c t e ri s t i c s , i n cluding the stigma associated with HIV/AIDS among Hispanics, 
and re c e i ved basic educa t i on on HIV/AIDS tra n s m i s s i on and preve n t i on . T h ey re-
c e i ved HIV counseling and had blood drawn for HIV testing. C on d om s , b l e a ch , a n d 
p a m phlets were provided fre e . The secon d , m o re specialized two-hour pro g ra m 
added three com p on e n t s : d e m on s t ra t i on of ri s k - reducing stra t e g i e s , i n cluding con-
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d om use and n e e dle cleaning skill s ; d i s c u s s i on of problem-focused coping re s p on s e s ; 
and self-esteem and self-con t rol enhancement. 
Evaluation Methods 
The convenience sample of women from 13 homeless shelters and/or eight dru g 
recovery programs were randomized by site into the specialized (98) or traditional 
(135) interve n t i on gro u p s . Assessments of sociodemogra ph i c , c o g n i t i ve, p s ych o-
logic, and behavioral variables using nine instruments translated into Spanish and 
b a ck t ranslated to ch e ck semantic validity were made at baseline and at two weeks 
a fter the interve n t i on . Va riables included perc e p t i on of current con c e rns about 
s u rv i v a l , h o p e l e s s n e s s , d rug addiction , and pare n t i n g ; a p p raisal of threat to well -
being; knowledge of and attitudes toward HIV/AIDS; problem- and emot i on - f o­
cused coping behaviors; d i s t re s s ; and depre s s i on . Ac c u l t u ra t i on was assessed with a 
12-item sca l e . Risk behavior was assessed with items on multiple part n e r s , d ru g 
u s e, and intra venous drug use. Repeated measures analysis of variance and l o g -l i n e a r 
models were used with data from the 213 participants available for foll ow up. 
Evaluation Findings 
Both interve n t i ons were effe c t i ve in improving potential cognitive, c o p i n g, and psy­
chologic determinants of risk behavior. For example, p e rfect knowledge scores in-
c reased from 17 percent to 76 percent in the specialized group and from 19 percent to 
76 percent in the tra d i t i onal interve n t i on gro u p. D i s t ress scores decreased from means 
of 49 to 31 for participants in the specialized gro u p, and from 47 to 32 for those in 
the tra d i t i onal gro u p. Similar and statistica lly significant improvements for both 
g roups were seen with measures of current con c e rn s , d e p re s s i on , and use of coping 
s t ra t e g i e s . 
The results suggest the interve n t i on may be effe c t i ve at facilitating some short -
t e rm change in risk behavior. Lon g e r - t e rm foll ow-up assessments are needed. 
About 20 percent of eligible women who were approached declined to participate 
due to lack of time. Almost all (91 percent) of the original sample were located at 
the two-week follow up. 
Comments 
Women in both the specialized and traditional education programs improved their 
k n owledge of and attitudes tow a rd HI V / A I D S , b e n e fited in terms of decre a s e d 
levels of distress and depression, and developed improved coping responses. These 
fin d i n g s , w h i ch re p l i cate a larger study with a pre d om i n a n t ly Afri can Am e ri ca n 
sample of homeless and drug-addicted wom e n , suggest that even short - t e rm in-
t e rve n t i ons incorp o rating general ri s k - re d u c t i on content may be useful for a sub­
stantial number of impoverished women. 
Evaluation Study Summary Forms for Intervention Addressing Drug Users A-15 
Increasing The Use of Bleach and Condoms Among Injecting Drug





Rietmeijer CA, Kane MS, Simons PZ, Corby NH, Wolitski RJ, Higgins DL,





Target and Study Populations

Target population. The intervention was designed for injection drug users.

S tudy population. The interve n t i on was evaluated with a sample of 890 stre e t -

re c ruited injection drug users in Denve r, C o l o ra d o. The majori ty were male; 3 4

p e rcent were Afri can Am e ri ca n , 33 percent white and 31 percent Hispanic. T h e

a ve rage age was about 36 ye a r s ; HIV sero p revalence was 5.1 perc e n t . T h ey were

compared with 1,107 injection drug users recruited in Long Beach, California, the

comparison city that did not receive the intervention.

Objective(s) of Intervention for Risk Behavior 




To increase the use of condoms for vaginal intercourse with occasional partners.

To increase the use of condoms for vaginal intercourse with steady partners.

Objective(s) of Intervention for Determinants of Risk Behavior 
To increase knowledge about HIV transmission and prevention. 
To improve access to bleach kits and condoms. 
Taxonomy Category and Intervention Description 
Health education/risk reduction, community-level intervention using peer and 
non-peer street and community outreach. 
As part of a five - c i ty, t h e o ry-based pro g ram known as the AIDS Com mu n i ty 
D e m on s t ra t i on Pro j e c t s , volunteers discussed and distributed interve n t i on kits 
with small-media behavior interve n t i on materials (bro ch u re s , p a m ph l e t s , flye r s , 
and newsletters containing role model stori e s ) , b l e a ch kits, and con d oms to indi­
viduals in high-risk populations in Denver on a mon t h ly basis over a 2.5-year peri o d . 
This interve n t i on was provided to hard - t o - re a ch injection drug users on a on e - t o - on e 
basis by both peer and non-peer volunteers (persons known to and trusted by the 
target gro u p ) . Volunteers were re c ruited by project outre a ch workers through 
re fe r rals from other service organiza t i ons or re fe r rals from current or former vol­
u n t e e r s . The volunteers re c e i ved training at regular intervals in basic HI V / A I D S 
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e d u ca t i on , ro l e - p l aying intera c t i on s , methods of street appro a ch and non - t h re a te n i n g 
c onve r s a t i on , and methods for dealing with individuals who refuse materi a l s . 
Evaluation Methods 
Ten thre e - m onth data coll e c t i on periods (waves) were completed using standard i ze d 
instruments in high-risk areas of the intervention and comparison cities. Of these, 
t h ree were completed before the interve n t i on was implemented in June 1991; 
three more (July 1991 to May 1992) were used to measure the early effects of in­
tervention; and four (June 1992 to December 1993) assessed full implementation. 
During each wave, every third person was approached by interview staff and a set 
of screening questions was used to determine the re s p on d e n t’s drug injection and 
sexual behavior. This was foll owed by a full question n a i re for those who had used 
i n j e c t i on drugs within the past 30 days , had shared injection equipment within the 
past 60 days or had vaginal intercourse during the past 30 days . A total of 13,145 
individuals were approached for interview during the study period. Of these, 2,599 
met the eligibility cri t e ria and consented to the full interv i ew. A fter re m oval of 
d uplicates and sex traders, 890 interviews were available for analysis in Denver and 
1,107 in Long Beach . M u l t i v a riate logistic re g re s s i on models were con s t ructed to 
analyze the effect of exposure to the intervention. 
Evaluation Findings 
The interve n t i on was effe c t i ve at increasing both needle cleaning and con s i s t e n t 
c on d om use over the time of the study. The pro p o rt i on of participants who re p o rt e d 
c onsistent use of bleach to clean needles increased significa n t ly from baseline (20 
percent) to early implementation (16 percent) to full implementation (29 percent) 
in the intervention city; but decreased from 22 percent at baseline to 12 percent at 
e a rly and full implementation in the com p a ri s on city. In addition , c onsistent con d om 
use during vaginal intercourse with occa s i onal partners i n c reased significa n t ly from 
2 percent at baseline to 7 percent at early implementation and to 24 percent at full 
i m p l e m e n t a t i on in the interve n t i on city, but decreased from 12 percent to 10 perc e n t 
in the com p a ri s on city. Rates of consistent con d om use with steady partners 
did not change significa n t ly in the interve n t i on city and remained stable (2 per-
cent) in the com p a ri s on city. At full implementation , the measure of exposure 
to the interve n t i on using unprompted re c o g n i t i on re a ched 32 percent in the 
i n t e rve n t i on city. 
Comments 
This study demon s t rates that a com mu n i ty-based HIV preve n t i on pro g ram ca n 
h a ve a significant positive effect on consistent needle cleaning and con d om use 
with occa s i onal partners among hard - t o - re a ch injection drug users. Similar inter­
ventions may be useful in other communities at risk for HIV infection. 
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Comparison of Education Versus Behavioral Skills Training 
Interventions in Lowering Sexual HIV-Risk Behavior 
of Substance-Dependent Adolescents 
St. Lawrence JS, Jefferson KW, Alleyne E, Brasfield TL

Journal of Consulting and Clinical Psychology 1995;53(1):154-157

Target and Study Populations





S tudy population. The interve n t i on was evaluated with a sample of adolescents re­

ceiving drug-abuse treatment at a residential facility in Jackson, Mississippi. Thir­

ty-four adolescents participated in the study. Most (73 percent) were male; 84 per-

cent were white, and 16 percent were Afri can Am e ri ca n . The mean age was 15.6

ye a r s . E i g h ty percent of the participants were sexually active, and 15 percent had

been treated for a sexually transmitted disease within the previous two months.

Objective(s) of Intervention for Risk Behavior 
To decrease the incidence of high-risk sexual behavior. 
Objective(s) of Intervention for Determinants of Risk Behavior 
To increase knowledge about HIV/AIDS and risk behavior.

To produce more favorable attitudes tow a rd HIV/AIDS preve n t i on and con d om use.

To increase internal health locus of control.

To increase interpersonal and technical skills necessary to decrease risk behavior.

To increase self-efficacy in the use of interpersonal and technical skills.

Taxonomy Category and Intervention Description 
Health educa t i on / risk re d u c t i on interve n t i on using gro u p - l eve l , n on-peer mediate d 
skills training. 
This behavioral skills training interve n t i on , based on cognitive - b e h a v i o ral pri n c i-
p l e s , c onsisted of six weekly, 90-minute group session s . Se p a rate sessions were 
c onducted for males and females and were led by group leaders re p re s e n t a t i ve of 
the race and gender of the part i c i p a n t s . The first two sessions focused on HIV/AIDS 
e d u ca t i on and training and skill rehearsal in correct con d om use. T h ree session s 
p rovided training in assert i ve partner nego t i a t i on and com mu n i ca t i on skills  related 
to engaging in sexual activities. 
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Evaluation Methods 
The 34 participants were ra n d om ly assigned to behavioral skills training or to re­
ceive a standard educational intervention that provided risk-reduction information 
but no skills training. All participants were tested before and two months after the 
i n t e rve n t i on on HIV/AIDS knowledge and attitudes tow a rd preve n t i on . T h e 
AIDS Knowledge Te s t , the Attitudes Tow a rd HIV Preve n t i on Measure, H e a l t h 
Locus of Con t rol Sca l e, and the Con d om Attitude Sca l e — R evised were amon g 
the tests used. Pa rticipants estimated their risk for infe c t i on on the basis of their 
behavior in the previous two months and role played high-risk sexual behavior 
scenarios. Univariate and chi-square tests were used to analyze differences between 
the groups following the intervention. 
Evaluation Findings 
The interve n t i on was effe c t i ve in decreasing the incidence of high-risk behavior. 
C om p a red with participants in the educa t i on con d i t i on , those who re c e i ved 
b e h a v i o ral skills training re p o rted significa n t ly lower rates of coerc i on into un­
wanted sexual activity (15.4 percent versus 5.3 percent), exchanging sex for money 
(15.4 percent versus 0 percent), exchanging sex for drugs (23.1 percent versus 10.5 
percent), and engaging in casual sex (23.1 percent versus 10.5 percent). These self-
reported changes were substantiated by the residential treatment program’s records 
on the number of sexually transmitted diseases tre a t e d . Du ring the two mon t h s 
following the intervention, six of those in the education-only group required treat­
ment; only one in the behavioral training group required treatment. 
The interve n t i on was effe c t i ve in changing the determinants of risk behavior. 
C om p a red with participants in the educa t i on con d i t i on , those who re c e i ved be-
h a vi o ral skills training demon s t rated significa n t ly increased knowledge about 
HI V / A I D S , m o re favorable attitudes tow a rd preve n t i on and con d om use, i n c re a s e d 
s e l f - e f fica cy, and greater re c o g n i t i on of personal vulnera b i l i ty. T h ey attached higher 
value to sexual safety in relationships and were less inhibited about using condoms. 
C om p a rable changes were not evident in the adolescents who participated in the 
education-only groups. 
Comments 
This intervention demonstrates the value of behavioral skills training in promoting 
risk-behavior changes in substance-dependent adolescents. 
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Building Skills of Recovering Women Drug Users 
to Reduce Heterosexual AIDS Transmission 
Schilling RF, El-Bassel N, Schinke SP, Gordon K, Nichols S 
Public Health Reports 1991;106(3)297-304 
15-Month Follow Up of Women Methadone Patients Taught Skills to 
Reduce Heterosexual HIV Transmission 
El-Bassel N, Schilling RF

Public Health Reports 1992;107(5)500-504

Target and Study Populations





S tudy population. The interve n t i on was evaluated with a sample of 91 Afri ca n

Am e ri can and Hispanic women enro lled for at least three months in one of five

clinics in a large methadone maintenance program in the Bronx in New York City.

The majori ty of the women were Hispanic (64 percent) or Afri can Am e ri can (36

p e rc e n t ) , b e tween the ages of 21 and 42 and had some high school educa t i on .

Public assistance and food stamps were the major sources of income.

Objective(s) of Intervention for Risk Behavior 
To increase use of condoms. 
Objective(s) of Intervention for Determinants of Risk Behavior 
To increase knowledge about HIV transmission and prevention. 
To increase skills in condom use, communication, and negotiation. 
Taxonomy Category and Intervention Description 
Health education/risk reduction, group-level counseling led by non-peers. 
The skills-building interve n t i on consisted of five two-hour group sessions offe re d 
s i mu l t a n e o u s ly to groups of 9 or 10 part i c i p a n t s . The first two sessions prov i d e d 
i n f o rm a t i on on HIV/AIDS tra n s m i s s i on and preve n t i on techniques thro u g h 
v i d e o, visual pre s e n t a t i on s , and didactic group exe rcises designed to help part i c i p a n t s 
identify their own high-risk sexual behaviors and discuss barriers they encounter 
in adopting safer sex pra c t i c e s . Du ring the third session , members discussed their 
n e g a t i ve associations with con d om s , p racticed con d om use skill s , and role playe d 
n e go t i a t i on of con d om use. Du ring the final two session s , p a rticipants pra c t i c e d 
a s s e rt i ve n e s s , p roblem solv i n g, and com mu n i ca t i on skills by participating in 
s c e n a rios inv o lving safer sex and by role playing scripted scenarios and 
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s c e n a rios re flecting their own live s . A single-session HIV/AIDS inform a t i on -on ly 
control group received information routinely provided by the clinic. Sessions w e re 
led by experienced female drug counselors who had re c e i ved 20 hours of training. 
Evaluation Methods 
Participants were tested and randomly assigned to one of two conditions: 48 to the 
five - s e s s i on skills-building interve n t i on and 43 to a single-session HIV/AIDS 
information-only comparison condition. Follow-up data were collected two weeks 
a fter com p l e t i on of the interve n t i on and again at 15 mon t h s . The initial and foll ow -
up assessments inv o lved sexual and dru g - risk behavior and attitudes, HI V / A I D S 
k n ow l e d g e, and locus of con t ro l . Seve ral scenarios administered at foll ow up were 
designed to measure social skills and assert i veness in implementing safe sex in 
d i f fe rent high-risk situation s . An a lysis of variance was the pri m a ry statistica l 
method employed. 
Evaluation Findings 
The interve n t i on was effe c t i ve at influencing con d om use behavior. Those in the 
skill-building intervention group showed significantly greater levels of condom u s e 
than those in the con t rol group at both the two-week and 15-month foll ow ups. 
The interve n t i on was effe c t i ve at influencing potential determinants of behavior 
immediately after the intervention. Participants in the skills-building intervention 
s h owed significa n t ly high levels of taking con d oms from cl i n i c s , ca r rying cond om s , 
feeling com f o rtable talking about sex, b e l i eving that AIDS can be preve n t e d , a n d 
believing they could eliminate the risk of exposure to the AIDS virus than those in 
the comparison group at the two-week follow up. Most of these group differences 
had deteriorated by the 15-month follow up. 
Of 100 eligible women first con t a c t e d , 85 agreed to part i c i p a t e . Fi fteen were added to 
b ring the initial study sample up to 100. Of these, on ly 91 completed the baseline, t h e 
intervention, and the two-week follow up assessment. At 15 months, 62 study p a r­
ticipants re m a i n e d . Sk i lls-building p a rticipants had high rates of group attendance a n d 
p ro g ram re t e n t i on , e s p e c i a lly at two weeks, suggesting that i nv o lvement in gro u p 
interventions could enhance retention rates at methadone maintenance programs. 
Comments 
The study demon s t rates that skill - b u i l d i n g, p reve n t i ve interve n t i ons composed of 
multiple sessions and conducted in treatment settings may have promise as useful 
HIV preve n t i on strategies for drug-using wom e n . Since many of the changes deteri­
o rated over time, p ro g ram planners should consider booster sessions or other 
methods of maintaining changes in risk behavior. 
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Reducing HIV Needle Risk Behaviors Among Injection-Drug Users 
in the Midwest: An Evaluation of the Efficacy of Standard 
and Enhanced Interventions 
Siegal HA, Falck RS, Carlson RG, Wang J

AIDS Education and Prevention 1995;7(4):308-319

Target and Study Populations

Ta r get population. The interve n t i on was designed for adult HIV seron e g a t i ve, i n­

jection drug users who are not currently in treatment.

S tudy population. The impact of the interve n t i on was evaluated with a sample of

i n j e c t i on drug users re c ruited from Dayt on and Columbus, O h i o, a low HIV sero­

p revalence are a . Seven indigenous outre a ch workers re c ruited the participants f rom

March 1989 through September 1990 using opportunistic and chain-referral sam­

pling techniques. All participants were over 18.The majority were African Am e ri­

can (75 perc e n t ) , male (74 perc e n t ) , and high school graduates (65 perc e n t ) . T h e

participants reported injecting heroin (61 percent), cocaine (77 percent), and s p e e d

b a ll (43 percent) daily, w e e k ly, or occa s i on a lly during the previous six months. Of the

initial recruits who elected voluntary and confidential HIV counseling and testing,

1.5 percent were confirmed seropositive by Western blotting. Only HIV seronega­

tives participated in the intervention study.

Objective(s) of Intervention for Risk Behavior 
To decrease HIV exposure due to needle-use practices. 
Objective(s) of Intervention for Determinants of Risk Behavior 
To increase knowledge about HIV transmission and prevention. 
To improve skills in using condoms and in cleaning needles. 
Taxonomy Category and Intervention Description 
Two health educa t i on / risk re d u c t i on interve n t i ons on risk re d u c t i on for injection 
d rug users, both using non-peer mediated counseling, one individual and on e 
group counseling. 
The standard interve n t i on was delive red at a field office and consisted of a on e -
hour session , d u ring which a counselor-educator rev i ewed the inform a t i on in 
counseling and provided details on HIV disease and modes of tra n s m i s s i on . T h e 
i n s t ru c t i onal session was foll owed by a videotape of role plays ill u s t rating pro p e r 
c on d om use and needle cl e a n i n g. A ri s k - re d u c t i on kit containing bleach , w a t e r, 
condoms, and brochures was distributed. The enhanced intervention added to the 
s t a n d a rd interve n t i on three one- to two-hour sessions on the pathology of HI V 
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disease, drug addiction, and safer sex. These were delivered over a one-month pe­
riod in group sessions of three to five people. The interventions were theory based. 
A ll the participants re c e i ved voluntary and con fidential HIV counseling and test­
ing as well as knowledge of results. 
Evaluation Methods 
Eligible participants (drug injection in past six mon t h s , at least 18 years of age, 
and not in dru g - t reatment pro g ram in previous 30 days) completed the baseline 
assessment and were offe red voluntary and con fidential HIV counseling and testing. 
Of eligible part i c i p a n t s , 98 percent agreed to re c e i ve scre e n i n g, and 95 percent of 
those screened re t u rned seven to 10 days later to re c e i ve re s u l t s . B e f o re re c e i v i n g 
results, all seronegative participants took part in the standard intervention. Partici­
pants were assigned in altern a t i on to re c e i ve the standard or enhanced interve n t i on . 
Standard participants were asked to return in six months for follow-up assessment; 
enhanced interve n t i on participants were asked to re t u rn for three additional session s 
in the foll owing month and then asked to re t u rn for six-month foll ow-up assessment. 
For the purposes of this study, risk level for exposure to HIV with respect to needl e 
use was defined as ‘s a fe’ if the participant re p o rted alw ays using a new needl e, 
a lw ays cleaning needles and syringes with bleach before each use, or not injecting 
d ru g s . Na t i onal standard i zed instruments were used. The art i cle re p o rts on analys e s 
of the 232 standard participants who completed the six-month foll ow up and the 
149 enhanced participants who completed all three enhanced sessions and the six-
month follow up. 
Evaluation Findings 
Both standard and enhanced interve n t i ons appeared to be effe c t i ve at improv i n g 
n e e dle pra c t i c e s . The enhanced interve n t i on showed more effe c t i veness than the 
s t a n d a rd in helping those using unsafe practices become more safe, but did not 
appear to be more effe c t i ve than the standard at helping those using safer needl e 
p ractices maintain those pra c t i c e s . At the baseline assessment, 28 percent of both 
s t a n d a rd and enhanced interve n t i on participants re p o rted safe needle pra c t i c e . At 
f o ll ow up, the pro p o rt i on engaging in safe practices increased to 66 percent among 
s t a n d a rd and 73 percent among enhanced interve n t i on part i c i p a n t s . C on t ra ry to 
e x p e c t a t i on s , t h e re was no statistica lly significant diffe rence between the two i n t e r­
ve n t i ons in the degree of improvement ove ra ll . When the analysis was limited to 
the participants who re p o rted unsafe needle practices at baseline, the pro p o rt i on 
engaging in safe practices at follow up was 58 percent among the standard and 71 
p e rcent among the enhanced. This diffe rence in improvement was statistica lly 
s i g n i fica n t . The art i cle re p o rts results on the determinants of tra n s i t i on from u n s a fe 
to safe needle practices and indicates that daily injectors were less likely to make 
this transition than non-daily injectors. 
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It is important to note that 171 of the participants (49 percent) assigned to the 
enhanced condition returned and completed all three enhanced sessions. 
Comments 
The high re t u rn rate for all three sessions as well as its effe c t i veness at improv i n g 
n e e dle practices with at least some segments of the population ill u s t rates the potential 
of this enhanced interve n t i on . Fu rt h e r, the findings show the need to cons i d e r 
d i ffe rences among injection drug users (daily versus non - d a i ly, re d u c t i on ve r s u s 
maintenance) in designing effe c t i ve interve n t i ons to reduce unsafe needle pra c t i c e s . 
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Psychoeducational Group Approach: 
HIV Risk Reduction in Drug Users 
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Target and Study Populations





S tudy population. The impact of the interve n t i on was evaluated in two outp a t i e n t 
t reatment population s : 50 injection drug users participating in a methadone m a i n­
tenance pro g ram and 98 active heroin users participating in 21-day outp a t i e n t 
m e t h a d one detox i fica t i on . A ll participants had extensive previous experience in 
d rug treatment pro g rams and were re a ched through clinics of the Substance A b u s e 
Services at San Francisco General Hospital. The participants were primarily 30 to 
49 years of age, m o s t ly unemploye d , and almost all hetero s e x u a l . The majori ty 
w e re male (65 perc e n t ) . About half were white, 20 percent were Afri can Am e ri­
can, and 20 percent were Hispanic. 
Objective(s) of Intervention for Risk Behavior 
To decrease shared unsterilized needle use and to increase condom use. 
Objective(s) of Intervention for Determinants of Risk Behavior 
To increase knowledge of HIV transmission and prevention. 
To improve syringe sterilization and condom use skills. 
Taxonomy Category and Intervention Description 
Health educa t i on / risk re d u c t i on , g ro u p - l eve l , n on-peer mediated counseling in a 
clinic setting. 
The two to three sessions, for a total of six hours, included didactic presentation of 
facts about HIV transmission, group discussions to personalize risk, structured e x-
e rcises and hom ew o rk to build skill s , and social intera c t i ons to increase coh es i on 
and build trust between leaders and part i c i p a n t s . The interve n t i on was theory based, 
and its protocol was standard i zed in a training manual. The sessions with coh o rt s 
of five to eight participants occurred at the clinic during clinic dispensing h o u r s 
and were held within a one-week peri o d . The sessions were led by a tw o-to three-
p e r s on team of two psychologists and one para p ro fe s s i on a l . A ll participants also 
re c e i ved written materials on the con n e c t i ons among alcoh o l , d ru g s , s e x , a n d 
HI V / A I D S ; s a fer sexual pra c t i c e s ; p e rinatal tra n s m i s s i on ; s yringe steri l i za t i on ; a n d 
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condom use. Participants assigned to the comparison group received only the writ-
ten information. 
Evaluation Methods 
The interve n t i on was evaluated with two con t ro lled studies; both used ra n d om 
assignment and com p a red the interve n t i on to inform a t i on - on ly com p a ri s on 
participants. Knowledge and attitudes about HIV/AIDS, syringe sterilization and 
c on d om use skill s , and needle use and sexual practices were assessed at baseline, 
and at immediate and thre e - m onth foll ow up. Actual skills were assessed with 
i n t e rv i ewer ratings while participants demon s t rated the correct way to clean the 
syringe with containers of bleach and water and the correct way to use a condom. 
Evaluation Findings 
Ove ra ll , the study provides evidence of the fe a s i b i l i ty of conducting gro u p - l eve l 
counseling interve n t i ons with injection drug users in outpatient settings. In addition , 
the ev a l u a t i on demon s t rates the effe c t i veness of the interve n t i on in terms of im­
provements in the determinants of risk behaviors. However, there was no evidence 
of effectiveness in changing either needle use or sexual risk practices. 
With respect to the outpatient methadone maintenance clients, the level of partic­
i p a t i on was high. That is, most (80 percent) of those who agreed to part i c i p a t e 
c ompleted at least three hours of the interve n t i on . The art i cle re p o rts on the 
47 (94 percent) participants who provided immediate and thre e - m onth foll ow - u p 
i n t e rv i ew s . Using repeated measures analyses of variance that com p a red interve n t i on 
to com p a ri s on part i c i p a n t s , the interve n t i on demon s t rated a statistica lly significa n t 
impact on factual knowledge about HI V / A I D S , k n owledge about sexual ri s k -
reduction practices, drug-related self-efficacy, sex-related self-efficacy, and condom 
use skills at the immediate follow up. The differences for syringe sterilization skills 
w e re in the expected dire c t i on but were not statistica lly significa n t . Si g n i ficant 
impact at the thre e - m onth foll ow up was seen on ly for the two knowledge items. 
T h e re was no evidence of impact on behavior; s h a red needle use and unpro t e c t e d 
sexual activity started low at the baseline and remained low. 
With respect to the outpatient detoxification clients, the level of participation was 
moderate. That is, most (65 percent) of those who agreed to participate completed 
at least three hours of the interve n t i on . The art i cle re p o rts on the 60 (61 perc e n t ) 
participants who provided immediate and three-month follow-up interviews. The 
i n t e rve n t i on demon s t rated a statistica lly significant impact on factual know l e d g e 
about HI V / A I D S , k n owledge about sexual ri s k - re d u c t i on pra c t i c e s , and actual 
c on d om skills at the immediate foll ow up. Two of these impacts (impact on 
k n owledge about sexual ri s k - re d u c t i on practices and actual con d om skills) were 
also statistica lly significant at the thre e - m onth foll ow up. Although the main 
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a n a lyses revealed no statistica lly significant impact on needle-use pra c t i c e s , s u b-
a n a lyses that re m oved distort i on due to outliers suggested improvement in needle use. 
Comments 
Effectiveness at influencing behavior was not demonstrated in these studies. How-
eve r, the level of part i c i p a t i on and the effe c t i veness on determinants suggest that 
g ro u p - l evel counseling in outpatient settings is an interve n t i on wort hy of furt h e r 
exploration. 
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Effects of an Intervention Program on AIDS-Related Drug and 
Needle Behavior Among Intravenous Drug Users 
Stephens RC, Feucht TE, Roman SW

American Journal of Public Health 1991;81(5):568-571

Target and Study Populations

Target and population. The intervention was designed for injection drug users cur­

rently not in treatment.

S tudy population. The interve n t i on was evaluated with a sample of injection dru g 
users who were recruited from February 1988 through August 1989 in Cleveland, 
O h i o, a low HIV sero p revalence are a . The sample was pre d om i n a t e ly male and 
A f ri can Am e ri can with a median age of 36. Ve ry few (10 percent) were curre n t ly 
in outpatient treatment. Users who were in some institutional setting or in another 
intervention program were excluded. 
Objective(s) of Intervention for Risk Behavior 
To decrease HIV exposure due to needle-use practices. 
Objective(s) of Intervention for Determinants of Risk Behavior 
To improve skills in using condoms and in cleaning needles. 
Taxonomy Category and Intervention Description 
Health educa t i on / risk re d u c t i on interve n t i on , using individual-level counseling 
with non-peer counselors. 
The interve n t i on was delive red on e - on - one by a pro fe s s i on a lly trained health 
e d u ca t o r and lasted from 45 to 60 minutes. The session provided basic inform a t i on 
about HIV tra n s m i s s i on using a segment from a fil m ; discussed sexual risk re d u c t i on 
and con d om use; c ove red ways to reduce risk due to injection drug use (cl e a n i n g 
with bleach, not using drugs, not using drugs intravenously, not sharing needles or 
works); and ended with information on HIV testing. All participants re c e i ved a kit 
of materials including bleach , c on d om s , and bro ch u res about HI V / A I D S . 
Evaluation Methods 
I n t e rv i ews were conducted immediately before the interve n t i on session and from 
t h ree to five months after the interve n t i on . Results on change over time for the 
322 (80 percent) participants who provided both baseline and follow-up informa­
tion are reported in this article. Needle-risk behavior in the two months preceding 
the interview was assessed two ways: five dichotomous measures of sharing works, 
sharing cookers, using drugs intravenously, using others’ works and cleaning works 
A-28 Evaluation Study Summary Forms for Intervention Addressing Drug Users 
with bleach and two measures of the fre q u e n cy of sharing others’ w o rks and cl e a n i n g 
with bleach. 
Evaluation Findings 
Results com p a ring baseline to foll ow-up interv i ews indicated statistica lly signifi­
cant decreases in needle risk behaviors over time. Although these results suggest 
the potential effe c t i veness of the interve n t i on , the data re p o rted in this art i cl e 
make it difficult to determine the extent to which these diffe rences are due to the 
intervention. The article comments on other analyses available by request. 
Comments 
The favorable findings are worthy of further exploration, given the special needs of 
this population. 
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Syringe and Needle Exchange as HIV Prevention 
for Injection Drug Users 
Watters JK, Estillo MJ, Clark GL, Lorvick J 
JAMA 1994;271(2):115-120 
Target and Study Populations

Ta r get population. The interve n t i on was designed for injection drug users (IDUs )

who are at risk for HIV infection from sharing contaminated needles and syringes.

S tudy population. The study was conducted with 752 IDUs from San Fra n c i s c o 
from Fall 1991 through Spring 1992. Clients were most often between the ages of 
31-40 (49 perc e n t ) , male (69 perc e n t ) , A f ri can Am e ri can (56 percent) or Cau­
casian (30 percent), and been through some kind of drug treatment in the last five 
years (53 percent). 
Objective of Intervention for Risk Behavior 
To decrease syringe sharing among IDUs. 
Objective of Intervention for Determinants of Risk Behavior 
To increase IDUs access to sterile injection equipment. 
Taxonomy Category and Intervention Description 
Health educa t i on / risk re d u c t i on using street and com mu n i ty outre a ch to active 
I D Us . 
This volunteer-based syringe exchange pro g ram operated in the evenings (6 to 8 
p.m.) and had mobile teams assigned to street corners in neighborhoods with high 
d rug use and hom e l e s s n e s s . Although ill e g a l , the interve n t i on operated without 
major disru p t i on from police and with tacit approval of two successive mayo ral 
a d m i n i s t ra t i on s . Pro g ram volunteers provided a on e - f o r - one exchange in which a 
s t e ri l e, single-use insulin syringe was exchanged for each syringe deposited in 
a bioh a za rdous waste container by the cl i e n t . Limits on the number of syri n g e s 
p ro g ram clients were permitted to exchange changed during the course of the 
s t u d y. By the end of the study there were no limits on numbers of syringes 
e xch a n g e d . Volunteers also distributed 1-oz (80-mL) bottles of bleach , c on d om s , 
c o t t on and alcohol wipes and provided re fe r rals to drug tre a t m e n t , HIV testing 
and counseling, and other social and medical services on request. 
Evaluation Methods 
Data for the study came from two sourc e s . Pro g ram re c o rds on client contacts and 
e xchange of syringes were maintained during the study (1991-1992) and from when 
the pro g ram was first implemented (1988). In addition , data were deri ved from the 
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Urban Health St u d y, a semiannual survey of IDUs re c ruited in natural settings in 
t h ree inner-city com munities in San Francisco where the interve n t i on was loca t e d . 
A fter obtaining informed con s e n t , Urban Health Study participants were interv i ew e d 
with a standard question n a i re dealing with AIDS know l e d g e, m e d i ca l , d rug u s e, 
and sexual histori e s , and knowledge of HIV/AIDS risk behaviors. R e s p on d e n t s 
w e re paid for their part i c i p a t i on and given pre- and post-test counseling, a n d 
g i ven re fe r rals to medical and social services by trained staff. The interve n t i on 
study used data from 11 semiannual cross-sectional surveys collected as part of the 
Urban Health Study between December 1986 and June 1992 (n=6216). Sp e c i fic 
items used from the survey included demogra phic data as well as re s p ondents 
re p o rted visits to syringe exchange and their source of syri n g e s . Items on the 
n e g a t i ve impacts of syringe exchange included changes in self-re p o rted fre q u e n cy 
of injection over time, changes in the age distri b u t i on of the cross section s , a n d 
p ro p o rt i on of re s p ondents re p o rting first injection during the previous ye a r. Syri n g e 
e xchange was examined by assessing the re l a t i onship between re p o rted syringe 
e xchange use in the past year and re p o rted needle sharing based on self-re p o rt e d 
number of needle-sharing partners in the 30 days prior to interview. 
O n e - w ay analysis of variance (ANOVA) with Sch e f fe’s test for multiple com p a r-
i s ons was used to identify diffe rences in the mean number of syringes exch a n g e d 
and the re p o rted fre q u e n cy of injection over successive cross section s . D i f fe re n c e s 
in the pro p o rt i on of IDUs who used the syringe exchange more than 25 times in 
the past year and pro p o rt i on of new injectors over time were assessed using the 
Mantel-Haenszel x2 test for trend. 
Evaluation Findings 
At the end of the study, 45 percent of the participants reported “usually” obtaining 
injection equipment from the syringe exchange, and 61 percent reported using the 
p ro g ram within the past ye a r. Du ring the six years before the study ended, the median 
re p o rted fre q u e n cy of injection declined from 1.9 injections per day to 0.7, t h e 
mean age increased from 36 to 42 ye a r s , and the percentage of new initiates into 
i n j e c t i on drug use decreased from 3 percent to 1 perc e n t . Six independent factors 
w e re found to be associated with syringe shari n g. Pro t e c t i on from syringe shari n g 
was associated with the use of syringe exch a n g e, having re c e i ved HIV testing and 
c o u n s e l i n g, c on d om use, older age, and Afri can Am e ri can ra c e . I n j e c t i on of coca i n e 
was a predictor for syringe sharing. The strength of association between use of the 
s yringe exchange pro g ram and not sharing syringes was greatest in injection dru g 
users younger than the median age of 40 years. 
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Comments 
The results of the evaluation suggested that, when available, syringe exchange pro-
g rams are used by IDUs . In addition , re d u c t i on in syringe sharing among IDUs 
was associated with use of syringe exchange pro g rams and voluntary HIV testing 
and counseling. Results do not support the belief that syringe exchange pro g ra m s 
stimulate increased drug abuse in terms of frequency of injection or recruitment of 
new and/or younger users. 
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B SUMMARIES OF RESOURCES THAT ADDRESS 
BEHAVIORAL THEORIES AND RESEARCH ON 
HIV PREVENTION INTERVENTIONS WITH DRUG USERS

E a ch re s o u rce listed in Appendix B rev i ews and comments on aspects of 
HIV preve n t i on interve n t i ons which will help preve n t i on planners and 
p ro g ram managers in con s i d e ring pro g ram activities. The contents of this 
appendix provides the following information: 
• Brief summaries of selected books, monographs, book chapters, and articles on 
effectiveness literature 
• Content highlights 
• A bibliography 
Summaries of Resources that Address 
Behavioral Theories and Research on 
HIV Prevention Interventions with Drug Users 
Appendix B presents summaries of selected book s , m on o g ra ph s , chapters of 
b o ok s , and art i cl e s . The book s , chapters of book s , and mon o g ra phs describe vari­
ous types of HIV preve n t i on interve n t i on s , e x p l o re the determinants of behavior, 
and outline special cultural issues and factors of particular re l evance to diffe re n t 
g roups defined by ra c e / e t h n i c i ty, g e n d e r, a g e, and sexual ori e n t a t i on . We selected 
these materials to expand on and enhance the information that is presented in the 
Evaluation Summary Forms in Appendix A. For each resource, we provide a sum-
m a ry page that contains an abstract and highlights of the key areas on which the 
authors focused. 
Preve n t i on planners and pro g ram managers can rev i ew these summaries to deter-
mine if a re s o u rce has inform a t i on re l evant to their particular planning needs. 
They can also look for information on target population, type of intervention, and 
research on effectiveness. 
The foll owing summaries are adapted from book jack e t s , p rom o t i onal descri p-
t i on s , and the Na t i onal Libra ry of Medicine’s (NLM) MED LI N E / A I D S LI N E 
a rt i cle abstra c t s . In cases where an abstract is unavailable, t h ey are drawn from 
opening paragraphs in the articles themselves. 
Summaries of Resources that Address Behavioral Theories 
B-2 and Research on HIV Prevention Interventions with Drug Users 
The Context of HIV Risk Among Drug Users 
and Their Sexual Partners 
Battjes RJ, Sloboda Z, Grace WC, editors 
Na t i onal Institute on Drug Abuse Research Mon o g ra ph Se ries 143. R o ck v i ll e 
( M D ) : Na t i onal Institutes of Health; 1 9 9 4 . Available from : Na t i onal Institute on 
Drug Abuse, NIH Publication No. 94-3750. 
This mon o g ra ph is based on papers that were presented at a tech n i cal rev i ew 
meeting on “The Context of HIV Risk Am ong Drug Users and Their Se x u a l 
Partners” held on April 22-23, 1993. The meeting’s purpose was to review research 
on drug use and sexual behaviors of drug users associated with HIV transmission, 
and develop a research agenda for future directions. The meeting was convened by 




A Contextual Perspective on HIV Risk 
Battjes RJ, Sloboda Z, Grace WC 
Heterosexual Males 
HIV Risk Behaviors of Heterosexual Male Drug Users 
Needle RH 
Injection and Sexual Risk Behaviors of Male Heterosexual Injecting Drug Users 
Stephens RC, Alemagno SA 
HIV/AIDS Risks Among Male, Heterosexual Non-injecting Drug Users 
Who Exchange Crack for Sex 
Inciardi JA 
Women 
Context of HIV Risk Behavior Among Female Injecting Drug Users and Female 
Sexual Partners of Injecting Drug Users 
Hartel D 
Female Drug Abusers and the Context of Their HIV Tra n s m i s s i on Behaviors 
Allen K 
Summaries of Resources that Address Behavioral Theories 
and Research on HIV Prevention Interventions with Drug Users B-3 
Factors Associated with Sexual Risk of AIDS in Women 
O’Leary A 
Men Who Have Sex With Men 
Drug Use and HIV Risk Am ong Gay and Bisexual Men: An Ove rv i ew 
Battjes RJ 
Substance Use and HIV-Transmitting Behaviors Among Gay and Bisexual Men 
Ostrow DG 
Drug Use and HIV Risk Among Male Sex Workers: 
Results of Two Samples in San Francisco 
Waldorf D 
Adolescents 
HIV Risk in Drug-Using Adolescents 
Smeriglio VL 
HIV Risk in Adolescents: The Role of Sexual Activity and 
Substance Use Behaviors 
Boyer CB, Ellen, JM 
Going Nowhere Fast: Methamphetamine Use and HIV Infection Rotherum-Borus 
MJ, Luna GC, Marotta T, Kelly H 
Measurement Issues 
The Context of Risk: Methodological Issues 
Sloboda Z 
Bringing the Context in From the Cold: Substantive, Technical, and Statistical 
Issues for AIDS Research in the Second Decade 
Brunswick AF 
The Context of Risk: E t h n o g ra phic Con t ri b u t i ons to the Study of Drug Use and HI V 
Koester SK 
Assessing the Reliability and Validity of Self-Reported Risk Behavior, 
Gibson DR, Young M 
Future Directions for Studies on the Context of HIV Risk 
Grace WC, Battjes RJ, Sloboda Z 
Summaries of Resources that Address Behavioral Theories 
B-4 and Research on HIV Prevention Interventions with Drug Users 
Social Networks, Drug Abuse, and HIV Transmission 
Needle RH, Coyle SL, Genser SG, Trotter RT, editors 
Na t i onal Institute on Drug Abuse Research Mon o g ra ph Se ries 151. R o ck v i ll e 
( M D ) . Na t i onal Institutes of Health; 1 9 9 5 . Available from : Na t i onal Institute on 
Drug Abuse, NIH Publication No. 95-3889. 
This mon o g ra ph is based on papers that were presented at a tech n i cal rev i ew 
meeting on “ Social Ne tw o rk s , Drug Abuse and HIV Tra n s m i s s i on” held on Au g u s t 
1 9 - 2 0 , 1 9 9 3 . The NIDA - s p on s o red meeting examined the “social netw o rk re s e a rch 
paradigm and its application to the study of drug use and HIV transmission.” The 
studies rev i ewed focused on drug abuse and its re l a t i onship to HIV tra n s m i s s i on 
within the context of a vari e ty of netw o rks (e.g. , d rug injectors, sex work e r s , s i b l i n g s 
and other relatives, and sexual partners). Four main conclusions were drawn from 
the data: 1) network characteristics affect behavioral practices as well as the chance 
of HIV infe c t i on ; 2) migra t i on and transient groups affect the incidence of vira l 
transmission of other network groups; 3) the adoption of individual risk behaviors 
is affected by netw o rk membership ch a ra c t e ristics and netw o rk norm s ; and 
4) “network-oriented interventions aimed at diffusing information about HIV and 
at changing tra n s a c t i onal patterns have been successful at introducing behaviora l 
change among network members, reducing high-risk behaviors, accelerating readi­
ness for treatment, and limiting the spread of HIV.” 
Highlights: 
Introduction: the Social Network Research Paradigm 
Needle RH, Coyle SL, Genser SG, Trotter RT 
Social Networks in Disease Transmission: the Colorado Springs Study 
R o t h e n b erg RB, Woodhouse DE, Po t terat JJ, Muth SQ, D a rrow W W, K l o vdahl AS 
Using Dyadic Data for a Network Analysis of HIV Infection and Risk Behaviors 
Among Injecting Drug Users 
Neaigus A, Friedman SR, Goldstein M, Ildenfonso G, Curtis R, Jose B 
Injecting Drug Us e, C h a ra c t e ristics of Si g n i ficant Ot h e r s , and HIV Risk Behaviors 
Price RK, Cottler LB, Mager D, Murray KS 
Sibling Homophily in HIV Infection: Biopsychosocial Linkages in an 
Urban African American Sample 
Brunswick AF, Messeri PA, Dobkin J, Flood MT, Yang A 
Summaries of Resources that Address Behavioral Theories 
and Research on HIV Prevention Interventions with Drug Users B-5 
Focal Networks and HIV Risk Among African American 
Male Intravenous Drug Users 
Frey FW, Ab ru tyn E, M e t z ger DS, Woody GE, O’ B rien CP, Trusiani P 
A Comparison of Drug Use Networks Across Three Cities 
Williams ML, Zhuo Z, Siegal HA, Robles RR, Trotter RT, Jones A 
E t h i cal and Legal Issues in Social Ne tw o rk Research : the Real and the Ideal 
Woodhouse DE, Po t terat JJ, R o t h e n b erg RB, D a rrow W W, K l o vdahl AS, Muth SQ 
Ne tw o rk Models for HIV Ou t re a ch and Preve n t i on Pro g rams for Drug Users 
Trotter RT, Bowen AM, Potter JM 
A Pe r s onal Ne tw o rk Ap p ro a ch to AIDS Preve n t i on : an Experimental Pe e r 
Group Intervention for Street-Injecting Drug Users: the SAFE Study 
Latkin CA 
Promising Social Ne tw o rk Research Results and Su g g e s t i ons for a Research Agenda 
Friedman SR 
Summaries of Resources that Address Behavioral Theories 
B-6 and Research on HIV Prevention Interventions with Drug Users 
Preventing AIDS in Drug Users and Their Sexual Partners 
Sorensen JL, Wermuth LA, Gibson DR, Choi KH, Guydish JR, Batki SL 
New York: Guilford Press; 1991 
The book presents the results of seve ral San Francisco experiments aimed at pre-
venting AIDS among drug users and their sex part n e r s . The authors present re-
search findings that support the proposition that targeted AIDS prevention efforts 
can be effective. Although the bulk of the work presented occurred in San Francis-
c o, the findings are placed in the context of extensive inve s t i g a t i ons of other re-
s e a rch gro u p s , cl i n i c i a n s , and national and intern a t i onal experts about public policy. 
The book discusses AIDS, d rug use, sexual behaviors, and theories of ch a n g e . T h i s 
is foll owed by chapters that suggest how to prevent AIDS by action with drug users 
and their sexual part n e r s . The final part of the book makes con cluding re c om m e n-
d a t i ons about disseminating preve n t i on pro g rams and forming effe c t i ve policies. 
Highlights: 
AIDS and Drug Use 
Introduction: the AIDS-drug Connection Sorensen JL 
Cases: Implications for AIDS Prevention Wermuth LA 
Needle Sharing, Needle Cleaning, and Risk Behavior Change Among 
Injection Drug Users Guydish JR, Golden E, Hembry K 
Unsafe Sex and Behavior Change Shoi KH, Wermuth LA 
Theoretical Background Gibson DR, Catania JA, Peterson JL 
Preventive Interventions with Drug Users and Their Sexual Partners 
Drug Abuse Treatment for HIV-infected Patients Batki SL, London J 
Group Counseling to Prevent AIDS Sorensen JL, London J, Morales ES 
Individual Counseling Gibson DR, Lovell-Drache J 
Reaching and Counseling Women Sexual Partners Wermuth LA, Robbins 
RL, Choi KH, Eversley R 
Social Implications 
Adopting Effective Interventions Sorensen JL, Guydish JR 
Policy Implications Wermuth LA, Sorensen JL, Franks P 
Summaries of Resources that Address Behavioral Theories 
and Research on HIV Prevention Interventions with Drug Users B-7 
Harm Reduction: A Public Health Response 
to the AIDS Epidemic Among Injecting Drug Users 
Des Jarlais DC, Friedman SR, Ward TP

Annual Review of Public Health 1993;14:413-450.

This art i cle presents an ove rv i ew of the harm re d u c t i on appro a ch to HIV preve n t i on

a m ong injecting drug users (IDUs ) . It begins with a discussion of the epidemiology

of HIV infe c t i on among IDUs , outlining the importance of preventing infe c t i on

in drug-using populations.The authors then summarize what is understood under

the harm re d u c t i on perspective, i . e . , that problems associated with psych o a c t i ve

d rug use are not direct results of drug use as such , but rather drug use behavior,

and there f o re HIV preve n t i on efforts must focus on specific behaviors that put

d rug users at risk for HI V. In this perspective, t h e re is no single best solution to

p reventing HIV infe c t i on among drug users; d rug users are seen as capable of

making ra t i onal choices re g a rding their HIV risk behaviors, and importance is

placed on overcoming the marginalization of drug users by society. Several types of

HIV preve n t i on pro g rams and appro a ches for IDUs that m ay be part of a harm

re d u c t i on stra t e gy are descri b e d , i n cluding syringe e xch a n g e s ; ove r - t h e - c o u n t e r

a v a i l a b i l i ty of sterile injection equipm e n t ; d rug abuse tre a t m e n t , o u t re a ch , a n d

b l e a ch distri b u t i on pro g ra m s ; HIV counseling and testing; and the form a t i on of

drug users’ organizations aimed at promoting risk reduction strategies from within

d rug-using population s . Pragmatic con c e rns related to the harm re d u c t i on appro a ch

a re discussed, s u ch as questions about whether and how behavior change can be

maintained over time, and what role sexual risk behaviors play. Finally, philosophic

concerns related to this approach are presented, including whether or not the harm

re d u c t i on perspective appears to con d one illicit drug use.

Highlights: 
Early Epidemiology of HIV Infection Among IDUs

Heterosexual and Perinatal Transmission from IDUs

Rapid Transmission of HIV Among IDUs

Non-AIDS Illnesses Associated with HIV Among IDUs





The Harm Reduction Pe r s p e c t i ve on Preve n t i on of HIV Infe c t i on Am ong IDUs

HIV Prevention Programs for IDUs

How Much Prevention is Needed for Success?

Harm Reduction and HIV Prevention: Pragmatic Concerns

Harm Reduction and HIV Prevention: Philosophic Concerns

Summaries of Resources that Address Behavioral Theories 
B-8 and Research on HIV Prevention Interventions with Drug Users 
HIV/AIDS Prevention For Injecting Drug Users 
Des Jarlais DC

New York: Beth Israel Medical Center; 1995 June

This document discusses the results of major interve n t i on studies (mainly, t h e

NA D R / ATOM pro j e c t ) , t h e o ries of social and behavioral ch a n g e, and the

l e g a l / p o l i t i cal system related to HIV/AIDS preve n t i on among the injection dru g

u s e r s . The applica t i on of social and behavioral theories of change to HI V / A I D S

prevention strategies is discussed.

Highlights: 
The Evolution of AIDS Preve n t i on for Reducing HIV Tra n s m i s s i on Am ong IDU

Theories of HIV Prevention Programming

Using Psychological Theories of Health-Related Behavior

Social Change Theories of HIV Risk Reduction Among Injecting Drug Users

Providing Means for Behavior Change

Absence of Harmful Effects of Providing Means for Safer Injection

Effectiveness: HIV Incidence in Outreach/Bleach Distribution Projects

The Effectiveness of Bleach as a Disinfectant for Drug Injection Equipment

HIV Incidence and Syringe Exchange

Integrating Multiple Prevention Programs

Current Problematic Issues in Preventing HIV Infection Among Injecting Drug

Users in the United States

Summaries of Resources that Address Behavioral Theories 
and Research on HIV Prevention Interventions with Drug Users B-9 
Social Intervention Against AIDS Among Injecting Drug Users 
Friedman SR, Neaigus A, Des Jarlais DC , So t h e ran JL, Woods J, Su fian M,

Stepherson B, Sterk C

British Journal of Addiction 1992; 87(3):393-404.

Many drug injectors continue to engage in behaviors that lead them to become in­

fected with HIV in spite of a wide variety of public health programs. In addition,

m a ny persons have begun to inject drugs in spite of knowing the risks of AIDS.

The authors argue that the inadequacy of current efforts to prevent these behav­

iors suggests that social interve n t i ons be tried to complement current pro g ra m s

(almost all of which have an individual focus). Evidence that social factors such as

peer pre s s u re and the social re l a t i ons of race affect risk behavior is pre s e n t e d . So c i a l

i n t e rve n t i ons discussed include organizing drug injectors against AIDS in ways

analogous to those in which gays organized against the epidemic, and finding ways

to change large-scale social relationships that predispose people to inject drugs.

Highlights: 
The State of the Art—and the Need for Improvement 
Peer effects on risk and risk reduction 
Heterogeneity of drug injection scenes 
Race/ethnicity, risk and risk reduction 
Collective Action Against AIDS 
Changing the Social Structure 
Summaries of Resources that Address Behavioral Theories 
B-10 and Research on HIV Prevention Interventions with Drug Users 
Assessing the Social and Behavioral Science Base for HIV/AIDS 
Prevention and Intervention: Workshop Summary 
and Background Papers 
Institute of Medicine, National Academy of Sciences 
Washington (DC): National Academy Press; 1995. 
In June 1995, the Institute of Medicine (IOM), with support from the Office of 
AIDS Research at the Na t i onal Institutes of Health, c onvened a workshop com­
mittee to consider the contributions of the social and behavioral sciences to AIDS 
prevention, assess the current understanding of the epidemic, draw new insights to 
help guide further re s e a rch on the complex issues associated with the epidemic, 
and identify important re s e a rch questions and re l evant methodologies needed for 
the future . This re p o rt summari zes the pre s e n t a t i ons and discussions of the work s h o p 
with re fe rence to key insights from the com m i s s i oned back g round and re s p on s e 
p a p e r s . The workshop extended the rev i ew of preve n t i ve interve n t i ons targeted at 
individual behavior change found in the 1994 IOM report, AIDS and Behavior: An 
I n tegra ted Ap p ro ach. Focused on more social-level analys e s , this summary and the 




Understanding the epidemic 
Learning from lives: individuals within a social context 
Understanding high-risk communities 
Making a difference: controlling the epidemic through social intervention 
Evaluating results 
Background Papers 
HIV/AIDS Prevention: Models of Individual Behavior in Social and 
Cultural Contexts Ewart CK 
R e s p on s e : What do People Need to Know About AIDS? Fi s ch h o f f, B 
Response: Cognitive Psychology, Social Networks, and AIDS 
Heckathron DD 
Social Science Intervention Models for Reducing HIV Transmission 
Friedman SR, Yypijewska C 
Response to Social Science Intervention Models for Reducing HIV 
Transmission Connors MM 
Summaries of Resources that Address Behavioral Theories 
and Research on HIV Prevention Interventions with Drug Users B-11 
On the Concept of Community Laumann EO 
Community Disintegration and Public Health: A Case Study of New York 
City Fullilove RE 
R e s p on s e : Societal Instability Pe r s p e c t i ve : R e l evance to HI V / A I D S 
Prevention Turshen M 
C om mu n i ca t i on Campaigns for HIV Preve n t i on : Using Mass Media in 
the Next Decade Flora JA, Maiback EW, Holtgrave D 
Summaries of Resources that Address Behavioral Theories 
B-12 and Research on HIV Prevention Interventions with Drug Users 
Mexican American Intravenous Drug Users’ Needle-Sharing 
Practices: Implications for AIDS Prevention 
Mata AG, Jorquez JS

I n : M ay V M , Albee GW, S chneider SF, e d i t o r s . Pri m a ry prevention of A I D S : p sy ­

chological approaches. Newbury Park CA: Sage Publications; 1989.

This chapter discusses intra venous drug use and needl e - s h a ring practices amon g

Mexican Americans, potential influences promoting and/or deterring these behav­

i o r s , and how these behaviors have been affected by the HIV epidemic. It begins

with a histori cal rev i ew of substance abuse among Mexican Am e ri cans and de-

s c ribes socioecon omic and cultural factors that affect preve n t i on efforts amon g

ethnic minori t i e s . It then con cludes with re c om m e n d a t i ons for the deve l o pm e n t

of preve n t i on pro g rams among Mexican Am e ri can drug users and suggests ways

in which to inv o lve their social netw o rks (i.e., sexual part n e r s , families and ch i l­

dren) in these prevention efforts.

Highlights: 
Background and Historical Context











Active IV drug users in treatment

Active IV drug users out of treatment

Sexual partners, families, and children

Summaries of Resources that Address Behavioral Theories 
and Research on HIV Prevention Interventions with Drug Users B-13 
Preventing HIV Transmission: The Role of Sterile Needles and Bleach 
Normand J, Vlahov D, Moses LE, editors





This book is the result of a legislative dire c t i ve ( J u ly 1992 ADAMHA Reorgani­

za t i on AC T) that requested the Na t i onal Research Council (NRC) and the Instit u t e

of Medicine (IOM) to conduct a study to determine the effe c t i veness of needl e

e xchange and bleach distri b u t i on pro g ra m s . A panel was created and re l evant 

re s e a rch was gathered and analyze d . D e s c ribed in this book is re s e a rch re l evant to

the effects of such pro g rams on drug use ra t e s , IDU behaviors, and the spread of

AIDS and hepatitis among IDUs and their sexual part n e r s . Also discussed are

characteristics associated with effective programs, and recommendations for future

research and evaluation methods applicable to the evaluation of such programs.

Highlights: 
Dimensions of the Problem 
The epidemiology of HIV/AIDS

The epidemiology of injection drug use







The Impact of Needle Exchange and Bleach Distribution Programs 
The effectiveness of bleach as a disinfectant of injection drug equipment

The effects of needle exchange programs

Directions for future research





Summaries of Resources that Address Behavioral Theories 
B-14 and Research on HIV Prevention Interventions with Drug Users 
Interventions for Sexual Partners of HIV-Infected 
or High-Risk Individuals 
Padian NS, Wijgert J, O’Brien TR

In: DiClemente RJ, Petterson JL, editors. Preventing AIDS: theories and methods of

behavioral interventions. New York: Plenum Press; 1994.

In this chapter the authors assess partner notifica t i on and HIV antibody testing 
and counseling pro g ra m s . T h ey describe in detail the design and results of a cou­
ple-counseling protocol from the California Pa rtner Study and discuss the com­
plexities of identifying partners of HIV infected and high risk individuals, and the 
e f fects of HIV antibody testing, c o u n s e l i n g, and AIDS educa t i on on behavior 
ch a n g e . The chapter con cludes with a discussion of the limitations and stre n g t h s 
( i . e . , e x t e rnal and internal validity, and subject re c ruitment and attri t i on) of all of 
these approaches. 
Highlights: 
Review of Relevant Interventions 
Partner notification 
Success in identifying partners 
Confidentiality 
The Effect of HIV Antibody Testing, Counseling, and AIDS Education on 
Behavior Change 
Couple Counseling in the California Partner Study 
Nature of the intervention 
Effects of the intervention 
Limitations of Interventions 
External validity 
Subject recruitment and attrition 
Internal validity 
Conclusions 
Summaries of Resources that Address Behavioral Theories 
and Research on HIV Prevention Interventions with Drug Users B-15 
HIV/AIDS Prevention for Drug Users in Natural Settings 
Watters JK, Guydish J

I n : DiClemente RJ, Pe t e r s on JL, e d i t o r s . Preventing AIDS: t h e o ries and methods of

behavioral interventions. New York: Plenum Press; 1994.

In this ch a p t e r, the authors discuss HIV preve n t i on interve n t i ons that have targeted

I D Us in natural settings (mostly outre a ch pro g ra m s ) . First they present the histori ca l

b a ck g round of strategies used in tra d i t i onal drug treatment pro g rams and their

l i m i t a t i ons for HIV preve n t i on . The authors address benefits and ch a llenges of

developing and evaluating HIV prevention programs among drug users in natural

settings by describing various research and evaluation methodologies.

Highlights: 
Major Approaches to Drug Abuse Treatment and Prevention 
Limitations of Drug Treatment as an HIV Prevention Strategy 
Prevention Efforts in Natural Settings 
Community health outreach 
Syringe and needle exchange 
Challenges in Evaluating Programs in Natural Settings 
Summaries of Resources that Address Behavioral Theories 
B-16 and Research on HIV Prevention Interventions with Drug Users 
Drug-Using Women and HIV: Risk-Reduction and Prevention Issues 
Weissman G, Brown V

In: O’Leary A, Jemmott LS, editors. Women at risk: issues in the primary prevention

of AIDS. New York: Plenum Publishing Corporation; 1995.

This chapter discusses the educational, cultural, socioeconomic, psychological, and

phys i cal barriers drug-using women encounter, d e s c ribes some of the appro a ch e s

to ove rc ome them, and provides strategies to develop successful preve n t i on and

risk-reduction programs for drug-using women. The results of three major studies

(the Na t i onal AIDS Demon s t ra t i on Research (NADR) pro g ra m , the Non t ra d i­

tional Supports for Drug Using Women project, and the Women Helping to Em-

p ower and Enhance Lives (W H EEL) project) are discussed in depth, a l ong with









The sex-drug connection: multiplication of risk

Special features of crack use





Lack of social supports

Counseling, testing, and partner-notification issues

Outreach Issues 
Successful models of preventive intervention

Role of drug treatment programs in HIV prevention

Role of needle exchange programs

Summaries of Resources that Address Behavioral Theories 
and Research on HIV Prevention Interventions with Drug Users B-17 
C G L O S S A RY

Appendix C provides defin i t i ons for terms and acronyms used in this docu­










Going without, fasting. Abstinence-based 
approaches to drug treatment stress the complete 
cessation of drug use. 
The most serious form and final stage of HIV 
infection. AIDS is a severe collapse of the body’s 
natural ability to fight off infection, and usually 
results in death. Most people infected with HIV 
develop AIDS within ten years. Since January 
1993, all states and territories have been required 
to use the expanded AIDS surveillance case defi­
nition of the Centers for Disease Control and 
Prevention (CDC) for reporting AIDS cases. 
The expanded CDC case definition can be found 
in the CDC MMWR Morbidity and Mortality 
Weekly Report 1992 Dec 18;41(RR-17):1-19. 
A process by which a drug solution is transferred 
from one syringe to another. The plunger is 
removed from the syringe into which the drug 
will be transferred and the drug mixture is then 
squirted into the back of the syringe. 
“Backloading” can be an indirect transmission 
route for HIV if the syringe or the drug solution 
is contaminated with HIV-infected blood. 
A technique used by drug users to ensure that all 
of the drug in the syringe is injected. The user 
injects the drug into a vein, then pulls the 
plunger back several times, drawing blood into 
the syringe each time. The drug solution is then 
injected into the vein again. “Booting” results in 
a higher volume of residual blood in the syringe. 
Centers for Disease Control and Prevention. 
The Community Epidemiology Work Group. 
A condition, such as drug dependence, for which 










Direct sharing of 
syringes 
A network of individuals in which drug use takes 
place in private residences mainly among people 
who know each other. Members usually stay 
within social, cultural, economic, or geographic 
boundaries. 
Federal, state, or local laws designed to protect 
the privacy of those receiving treatment for drug 
abuse, HIV, STDs, and general medical or men­
tal health problems. 
A spoon or bottle top in which heroin powder is 
mixed with water and sometimes heated before 
injection. 
A piece of cotton or cigarette filter through 
which a drug solution is drawn. It removes 
undissolved particles that might clog a needle. 
A relatively inexpensive, smokable, form of 
cocaine. 
Places where crack users gather to purchase and 
smoke crack, exchange sex for crack or money to 
buy crack, or provide crack in exchange for sex. 
Depending on the geographic region, they are 
also known as “hit houses, “smoke houses,” and 
“resorts.” 
A medically supervised program in which drug 
users are weaned from their physical dependence 
on drugs. Most detoxification programs are run 
on an inpatient basis. Detoxification is also 
referred to as “detox.” 
This occurs when a person uses a syringe to 
inject a drug and then passes the syringe to 
another person, who in turn, uses it to inject 
drugs. This is an important potential transmis­











A term describing the severe gastrointestinal dis­
tress, muscle cramping, and other flu-like symp­
toms associated with heroin withdrawal. 
Drug treatment center. 
A process in which the drug solution is trans­
ferred from one syringe to another. The needle 
on the syringe receiving the solution is removed 
and the drug solution is squirted into the 
syringe’s hub or barrel. This is now relatively 
uncommon because most insulin syringes do not 
have removable needles. “Frontloading” can be an 
indirect transmission route for HIV if the syringe 
or drug solution is contaminated with HIV-
infected blood. 
An intervention approach that focuses on IDUs 
and their behaviors related to sharing injection 
equipment. Harm reduction acknowledges that 
drug users vary in their readiness and ability to 
abstain from drug use total ly. This approach sug­
gests that, based on the ways in which HIV is 
transmitted, some ways of engaging in drug use 
may be less prone to viral transmission than are 
others. Advocates of harm reduction propose 
multiple complementary solutions that operate 
simultaneously (e.g., drug abuse treatment, non 
injection of drugs, and providing sterile injection 
equipment and/or materials to disinfect used 
equipment). These strategies also are known as 
risk reduction strategies. 
The retrovirus isolated and recognized as the 
agent that causes AIDS. Over time, HIV leads 
to the collapse of the body’s immune system and 
onset of AIDS infections and conditions. 
Injection drug user. 
C-4 Glossary 












The process of preparing drugs for injection and 
dividing the portion among several users. One 
syringe may be used to prepare the drugs, 
although the syringe is not necessarily used by all 
the users to actually inject the drugs. HIV may 
be transmitted through this process through con­
tamination of the syringe, the rinsing water, or 
the cotton. 
A synthetic opiate used to limit discomforts 
associated with heroin withdrawal. 
A three-to-four day crack binge during which 
the user often does not sleep or eat. 
Men who have sex with men. 
National Academy of Sciences. 
National Institute on Drug Abuse, one of the 
agencies within the National Institutes of 
Health. 
A term referring to the sleepiness associated with 
a heroin high. 
National Research Council, an organization of 
the National Academy of Sciences. 
A network of drug users that is fairly relaxed in 
terms of its membership. Members may come 
from a variety of social, cultural, or geographic 
circles. 
One of the major categories of drugs; results in 
physical and psychological dependence. Heroin is 
a prominent example. 
Use of more than one drug over a period of time 














A technique for verifying whether a needle is in 
a vein. Once the needle is inserted, the user pulls 
back the syringe plunger before injecting the 
drug. If blood can be pulled into the syringe, it 
verifies that the point of the needle is in a vein. 
A return to drug use after a period of quitting. 
Small pieces of crack cocaine. 
A person who purchases drugs for a group of 
users. Runners can be direct or indirect links for 
the transmission of HIV through their drug use 
or sexual behaviors. 
The equipment used to prepare and inject drugs. 
A commercial establishment in which individuals 
gather to inject drugs or buy drugs; often situated 
in back rooms, basements, dark hallways, or 
abandoned buildings. Also known as “safe hous­
es” or “get-off houses.” 
A drug use technique that involves injecting a 
drug under the skin rather than directly into a 
vein. 
Injecting a drug by inhaling it; also ca lled “s n i f f-
i n g. ” 
Groups of people linked by various types of rela­
tionships and common bonds. 
A injectable combination of heroin and cocaine. 
One of the major categories of drugs; results in 
physical and psychological dependence. Cocaine, 
c ra ck , and amphetamines are prominent examples. 
A physical state that develops when an increasing 
amount of a drug is needed to achieve the same 
C-6 Glossary 
desired effect, or when a markedly reduced 
effects occurs from the continued used of the 
same amount of a drug. 
Triggers 	 Situations, locations, or objects that prompt a 
desire to return to drug use once a person has 
stopped. 
“Tweaking”	 A term referring to the facial or body twitching 
that can occur during a crack high. 
Webs	 A smaller group of people within a larger social 
network. 
Withdrawal	 Signs and symptoms typically experienced when 
a person stops using a drug on which he or she is 
physically dependent. Withdrawal symptoms can 
range from unpleasant to life-threatening, and 




Appendix D provides a bibliography listing all references used in develop­
ing the HPDU Resource Book. Information on how to acquire these and 
other materials and information can be found in PART 5: RESOURCES. 
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